array:23 [
  "pii" => "S1699258X08724616"
  "issn" => "1699258X"
  "doi" => "10.1016/S1699-258X(08)72461-6"
  "estado" => "S300"
  "fechaPublicacion" => "2008-09-01"
  "aid" => "72461"
  "copyright" => "Elsevier España S.L Barcelona"
  "copyrightAnyo" => "2008"
  "documento" => "article"
  "crossmark" => 0
  "subdocumento" => "fla"
  "cita" => "Reumatol Clin. 2008;4:172-82"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 8762
    "formatos" => array:3 [
      "EPUB" => 143
      "HTML" => 7205
      "PDF" => 1414
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S1699258X08724628"
    "issn" => "1699258X"
    "doi" => "10.1016/S1699-258X(08)72462-8"
    "estado" => "S300"
    "fechaPublicacion" => "2008-09-01"
    "aid" => "72462"
    "copyright" => "Elsevier España S.L Barcelona"
    "documento" => "article"
    "crossmark" => 0
    "subdocumento" => "fla"
    "cita" => "Reumatol Clin. 2008;4:183-90"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 64979
      "formatos" => array:3 [
        "EPUB" => 181
        "HTML" => 51568
        "PDF" => 13230
      ]
    ]
    "es" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Originales</span>"
      "titulo" => "&#191;Es la puntuaci&#243;n DAS28 el m&#233;todo m&#225;s adecuado para estimar la actividad de la artritis reumatoide&#63; Consideracionens clinim&#233;tricas y escenarios de simulaci&#243;n"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "183"
          "paginaFinal" => "190"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Is the DAS28 Score the Most Adequate Method to Estimate Activity in Rheumatoid Arthritis&#63; Clinimetric Considerations and Simulations Scenarios"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "f0015"
          "etiqueta" => "Figura 3"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr3.jpeg"
              "Alto" => 733
              "Ancho" => 934
              "Tamanyo" => 53194
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="sp0015" class="elsevierStyleSimplePara elsevierViewall">Participaci&#243;n m&#225;xima de cada uno de los componentes en el valor combinado del DAS28&#46; GH&#58; valoraci&#243;n global del paciente&#59; NAD&#58; recuento de articulaciones dolorosas&#59; NAT&#58; recuento de articulaciones tumefactas&#59; VSG&#58; velocidad de sedimentaci&#243;n globular&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Miguel &#193;ngel Belmonte Serrano"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "Miguel &#193;ngel"
              "apellidos" => "Belmonte Serrano"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X08724628?idApp=UINPBA00004M"
    "url" => "/1699258X/0000000400000005/v1_201305061804/S1699258X08724628/v1_201305061804/es/main.assets"
  ]
  "itemAnterior" => array:18 [
    "pii" => "S1699258X08724604"
    "issn" => "1699258X"
    "doi" => "10.1016/S1699-258X(08)72460-4"
    "estado" => "S300"
    "fechaPublicacion" => "2008-09-01"
    "aid" => "72460"
    "copyright" => "Elsevier Espa&#241;a S&#46;L Barcelona"
    "documento" => "simple-article"
    "crossmark" => 0
    "subdocumento" => "edi"
    "cita" => "Reumatol Clin. 2008;4:169-71"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 6055
      "formatos" => array:3 [
        "EPUB" => 155
        "HTML" => 4763
        "PDF" => 1137
      ]
    ]
    "es" => array:9 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
      "titulo" => "Perspectivas sobre la osteoporosis en los pa&#237;ses en desarrollo&#58; problema creciente&#44; recursos escasos"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "169"
          "paginaFinal" => "171"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Jorge Morales-Torres"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "Jorge"
              "apellidos" => "Morales-Torres"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X08724604?idApp=UINPBA00004M"
    "url" => "/1699258X/0000000400000005/v1_201305061804/S1699258X08724604/v1_201305061804/es/main.assets"
  ]
  "es" => array:19 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Originales</span>"
    "titulo" => "Revisi&#243;n sistem&#225;tica&#58; &#191;es eficaz y seguro el uso de AINE para los ancianos&#63;"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "172"
        "paginaFinal" => "182"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Est&#237;baliz Loza"
        "autores" => array:1 [
          0 => array:4 [
            "nombre" => "Est&#237;baliz"
            "apellidos" => "Loza"
            "email" => array:1 [
              0 => "eloza&#46;hcsc&#64;salud&#46;madrid&#46;org"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "&#42;"
                "identificador" => "cor1"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:1 [
            "entidad" => "Servicio de Reumatolog&#237;a&#46; Hospital Cl&#237;nico San Carlos&#46; Madrid&#46; Espa&#241;a"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor1"
            "etiqueta" => "&#42;"
            "correspondencia" => "Dra&#46; E&#46; Loza&#46; Servicio de Reumatolog&#237;a&#46; Hospital Cl&#237;nico San Carlos&#46; Profesor Martin Lagos&#44; s&#47;n&#46; 28015 Madrid&#46; Espa&#241;a&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "Systematic Review&#58; Is the Use of NSAIDs Effective and Safe in the Elderly&#63;"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "f0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 3933
            "Ancho" => 3110
            "Tamanyo" => 787416
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="sp0005" class="elsevierStyleSimplePara elsevierViewall">Flujo de la selecci&#243;n de los estudios&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="s0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0005">Introducci&#243;n</span><p id="p0005" class="elsevierStylePara elsevierViewall">El uso de antiinflamatorios no esteroideos &#40;AINE&#41; es muy frecuente en pacientes con enfermedades reum&#225;ticas&#44; especialmente en procesos degenerativos como la artrosis&#44; y en enfermedades inflamatorias como la artritis reumatoide&#46;</p><p id="p0010" class="elsevierStylePara elsevierViewall">De acuerdo con estudios en poblaci&#243;n general&#44; los ancianos parecen ser m&#225;s susceptibles a desarrollar eventos adversos relacionados con el uso de AINE&#44; especialmente de origen digestivo&#44; de hecho&#44; algunos estudios han puesto de manifiesto que los ancianos tienen un riesgo 5 veces mayor de toxicidad gastrointestinal por estos f&#225;rmacos<a class="elsevierStyleCrossRefs" href="#bb0005"><span class="elsevierStyleSup">1&#8211;3</span></a>&#46; M&#250;ltiples factores parecen estar implicados en el desarrollo de la toxicidad gastrointestinal inducida por los AINE en ancianos&#46; Entre &#233;stos destacan el da&#241;o directo en la mucosa digestiva&#44; la inhibici&#243;n de prostaglandinas protectoras end&#243;genas&#44; el aumento del tiempo de hemorragia y la posible disminuci&#243;n de la capacidad de eliminaci&#243;n de estos f&#225;rmacos que producir&#237;a mayores concentraciones sangu&#237;neas<a class="elsevierStyleCrossRefs" href="#bb0020"><span class="elsevierStyleSup">4&#44;5</span></a>&#46;</p><p id="p0015" class="elsevierStylePara elsevierViewall">Pero adem&#225;s&#44; y en probable relaci&#243;n con la inhibici&#243;n de prostaglandinas&#44; en pacientes ancianos se han descrito alteraciones en la funci&#243;n renal relacionadas con los AINE&#44; que pueden causar importantes cambios en el filtrado glomerular y en la presi&#243;n arterial&#44; y en pacientes con disfunci&#243;n ventricular&#44; un mayor riesgo de desarrollar insuficiencia card&#237;aca congestiva<a class="elsevierStyleCrossRefs" href="#bb0030"><span class="elsevierStyleSup">6&#44;7</span></a>&#46;</p><p id="p0020" class="elsevierStylePara elsevierViewall">A todo lo previamente comentado hay que a&#241;adir el hecho de que en los ancianos es muy frecuente la asociaci&#243;n de otras enfermedades y medicamentos que pueden influir en la toxicidad inducida por los AINE&#46; Por todo ello&#44; el uso de AINE en poblaciones de alto riesgo&#44; como los ancianos&#44; es de m&#225;ximo inter&#233;s y prioridad en nuestro medio&#44; y &#233;ste es el objetivo de la presente revisi&#243;n sistem&#225;tica&#46;</p></span><span id="s0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0010">Material y m&#233;todos</span><p id="p0025" class="elsevierStylePara elsevierViewall">Se realiz&#243; una revisi&#243;n sistem&#225;tica para analizar la seguridad del uso de AINE en ancianos&#46; Los criterios de selecci&#243;n de estudios fueron&#58;<ul class="elsevierStyleList" id="l0005"><li class="elsevierStyleListItem" id="o0005"><span class="elsevierStyleLabel">1&#46;</span><p id="p0030" class="elsevierStylePara elsevierViewall">Estudios que incluyeran ancianos con dolor de origen reum&#225;tico de m&#225;s de 1 mes de duraci&#243;n&#46; Se defini&#243; anciano como persona con edad o media de edad &#62; 60 a&#241;os&#46;</p></li><li class="elsevierStyleListItem" id="o0010"><span class="elsevierStyleLabel">2&#46;</span><p id="p0035" class="elsevierStylePara elsevierViewall">Estudios en que los pacientes tomaran alg&#250;n AINE&#46; No hubo restricci&#243;n en cuanto al tipo y la dosis del f&#225;rmaco&#44; pero se excluyeron los estudios en que los sujetos tomaran AINE a dosis antiagregantes y no analg&#233;sica&#47;antiinflamatoria&#44; as&#237; como los tratamientos t&#243;picos&#46;</p></li><li class="elsevierStyleListItem" id="o0015"><span class="elsevierStyleLabel">3&#46;</span><p id="p0040" class="elsevierStylePara elsevierViewall">Para evaluar la eficacia de los AINE&#44; se buscaron art&#237;culos que analizaran el dolor&#44; la funci&#243;n o la calidad de vida de los ancianos &#40;no se puso restricci&#243;n en cuanto al tipo de variable empleada para medir estos par&#225;metros&#41;&#46; A continuaci&#243;n&#44; y para valorar la seguridad del AINE&#44; se incluyeron estudios en los que analizaran algunas de las siguientes variables&#58; toxicidad gastrointestinal&#44; renal o cardiovascular &#40;tampoco se puso restricci&#243;n en cuanto al tipo de variable empleada en la medici&#243;n&#41;&#46;</p></li><li class="elsevierStyleListItem" id="o0020"><span class="elsevierStyleLabel">4&#46;</span><p id="p0045" class="elsevierStylePara elsevierViewall">En relaci&#243;n con el dise&#241;o de los estudios&#44; se incluyeron ensayos cl&#237;nicos &#40;EC&#41; Jadad 4&#8211;5 y estudios de cohortes de m&#225;xima calidad&#46; Se excluyeron los estudios en sujetos sanos voluntarios&#44; as&#237; como estudios en animales&#46; Finalmente&#44; en relaci&#243;n con el idioma&#44; se seleccionaron art&#237;culos en ingl&#233;s y espa&#241;ol&#46;</p></li></ul></p><p id="p0050" class="elsevierStylePara elsevierViewall">Se busc&#243; en las siguientes bases de datos electr&#243;nicas hasta diciembre de 2007&#58; MEDLINE &#40;desde 1960&#41;&#44; EMBASE &#40;desde 1980&#41; y Cochrane Library &#40;Central&#41;&#46; Se buscaron tanto t&#233;rminos MeSH como en formato texto libre&#46; No se pusieron l&#237;mites en cuanto a la fecha de publicaci&#243;n&#46; La estrategia de b&#250;squeda espec&#237;fica se detalla en las <a class="elsevierStyleCrossRefs" href="#t0005">tablas 1 y 2</a>&#46; No se realiz&#243; b&#250;squeda manual en lo publicado en congresos nacionales &#40;SER&#41; o internacionales &#40;ACR&#44; EULAR&#41; dado el gran volumen de art&#237;culos rescatados en las bases de datos electr&#243;nicas&#46; Un &#250;nico revisor analiz&#243; los art&#237;culos resultantes de la estrategia de b&#250;squeda&#44; as&#237; como el an&#225;lisis en detalle de los art&#237;culos incluidos&#46; El resultado de la b&#250;squeda primeramente se depur&#243; por t&#237;tulo y resumen o por art&#237;culo entero en caso de que no tuviera resumen&#44; mediante sesiones de 20<span class="elsevierStyleHsp" style=""></span>min de duraci&#243;n m&#225;xima&#46; Tras este proceso&#44; los art&#237;culos restantes se analizaron en detalle&#46; Finalmente&#44; se realiz&#243; una b&#250;squeda manual con las referencias de los art&#237;culos seleccionados para su an&#225;lisis en detalle&#46; Todas las referencias se recuperaron de internet y se introdujeron en el programa Procite 5&#46;1 para facilitar su gesti&#243;n&#46;</p><elsevierMultimedia ident="t0005"></elsevierMultimedia><elsevierMultimedia ident="t0010"></elsevierMultimedia><p id="p0055" class="elsevierStylePara elsevierViewall">Para evaluar la calidad metodol&#243;gica de los estudios incluidos&#44; se utiliz&#243;&#58; <span class="elsevierStyleItalic">a&#41;</span> para los EC&#44; la escala de Jadad<a class="elsevierStyleCrossRef" href="#bb0040"><span class="elsevierStyleSup">8</span></a> &#40;1 a 5&#59; se consider&#243; de buena calidad los estudios con Jadad de 3&#8211;5&#41;&#44; y <span class="elsevierStyleItalic">b&#41;</span> para los estudios de cohortes&#44; la escala de calidad de Oxford&#46;</p></span><span id="s0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0015">Resultados</span><p id="p0060" class="elsevierStylePara elsevierViewall">Los resultados de la b&#250;squeda se detallan en la <a class="elsevierStyleCrossRef" href="#f0005">figura 1</a>&#46; Finalmente se incluyeron 16 estudios que incluyeron a m&#225;s de 50&#46;000 ancianos&#44; con un seguimiento que vari&#243; desde 1 semana a 4 a&#241;os&#46; Destaca la gran diversidad en cuanto al tipo de AINE y las medidas de desenlace&#46; Se incluyeron 4 metaan&#225;lisis &#40;calidad 1a-b&#41;&#44; 9 EC &#40;Jadad 4&#41;&#44; 2 estudios de cohortes &#40;calidad 2a&#41; y un estudio de prevalencia &#40;calidad 2a&#41;&#46; La mayor&#237;a de estos estudios incluy&#243; a pacientes con osteoartrosis &#40;OA&#41; o artritis reumatoide &#40;AR&#41;&#46; En muchos de los estudios no estaba permitido el uso de protectores g&#225;stricos o no consta que los tomaran&#46; Los principales resultados de los estudios incluidos est&#225;n descritos en la <a class="elsevierStyleCrossRef" href="#t0015">tabla 3</a><a class="elsevierStyleCrossRefs" href="#bb0045"><span class="elsevierStyleSup">9&#8211;25</span></a>&#44; los art&#237;culos excluidos y el motivo de su exclusi&#243;n&#44; en la <a class="elsevierStyleCrossRef" href="#t0020">tabla 4</a><a class="elsevierStyleCrossRefs" href="#bb0130"><span class="elsevierStyleSup">26&#8211;106</span></a>&#46;</p><elsevierMultimedia ident="f0005"></elsevierMultimedia><elsevierMultimedia ident="t0015"></elsevierMultimedia><elsevierMultimedia ident="t0020"></elsevierMultimedia><p id="p0065" class="elsevierStylePara elsevierViewall">Seg&#250;n la evidencia de la presente revisi&#243;n sistem&#225;tica&#44; generalmente&#44; los AINE se han mostrado eficaces en el anciano para el control del dolor de origen reum&#225;tico &#40;en reposo&#44; con el movimiento&#44; nocturno&#41;&#44; la rigidez y la funci&#243;n articular<a class="elsevierStyleCrossRefs" href="#bb0045"><span class="elsevierStyleSup">9&#44;11&#8211;13&#44;15&#44;18&#44;24</span></a>&#44; sin poder precisarse qu&#233; AINE tiene un efecto mayor que otro&#46; En cuanto a los eventos adversos&#44; cabe destacar que presentan riesgo aumentado de cualquier evento gastrointestinal grave de cualquier origen<a class="elsevierStyleCrossRefs" href="#bb0055"><span class="elsevierStyleSup">11&#44;12</span></a>&#44; en especial los de origen gastrointestinal&#58; muerte u hospitalizaci&#243;n<a class="elsevierStyleCrossRef" href="#bb0115"><span class="elsevierStyleSup">23</span></a>&#44; hemorragia digestiva<a class="elsevierStyleCrossRefs" href="#bb0070"><span class="elsevierStyleSup">14&#44;19&#44;21</span></a>&#44; ulcus<a class="elsevierStyleCrossRefs" href="#bb0080"><span class="elsevierStyleSup">16&#44;17&#44;19&#8211;21&#44;25</span></a> u obstrucci&#243;n digestiva<a class="elsevierStyleCrossRefs" href="#bb0095"><span class="elsevierStyleSup">19&#44;21</span></a>&#59; sin poder realizar comparaciones entre todos los AINE&#46; Este riesgo disminuye al asociarse un protector g&#225;strico<a class="elsevierStyleCrossRefs" href="#bb0070"><span class="elsevierStyleSup">14&#44;19&#8211;21</span></a>&#46; En cuanto a los efectos cardiovasculares&#44; &#250;nicamente se pudo objetivar que el uso de rofecoxib se asoci&#243; a edema cl&#237;nicamente significativo y aumento en la presi&#243;n arterial &#40;PA&#41; sist&#243;lica&#46;</p><span id="s0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0020">Principales resultados de los metaan&#225;lisis</span><p id="p0070" class="elsevierStylePara elsevierViewall">Seg&#250;n Detora et al<a class="elsevierStyleCrossRef" href="#bb0045"><span class="elsevierStyleSup">9</span></a>&#44; en ancianos con OA&#47;AR&#44; el uso de rofecoxib &#40;12&#44;5&#47;25<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#41; fue m&#225;s eficaz que el placebo para mejorar su valoraci&#243;n global y el dolor al caminar&#46;</p><p id="p0075" class="elsevierStylePara elsevierViewall">Eisen et al<a class="elsevierStyleCrossRef" href="#bb0050"><span class="elsevierStyleSup">10</span></a> analizaron a ancianos con AR&#47;OA&#44; en los que valdecoxib &#40;10&#44; 20 o 40<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#41;&#44; en comparaci&#243;n con naproxeno 1&#46;000<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; ibuprofeno 2&#46;400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a y diclofenaco 150<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; se asoci&#243; a menor riesgo de s&#237;ntomas gastrointestinales moderados-severos&#46;</p><p id="p0080" class="elsevierStylePara elsevierViewall">Lisse et al<a class="elsevierStyleCrossRef" href="#bb0055"><span class="elsevierStyleSup">11</span></a> objetivaron que en ancianos con OA&#44; el celecoxib &#40;200 o 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#41; o el naproxeno 1&#46;000<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a mejoraron m&#225;s el &#237;ndice WOMAC que el placebo&#44; sin diferencias entre ellos&#46; No hubo diferencias en el n&#250;mero de eventos adversos graves&#46; El naproxeno tuvo mayor n&#250;mero de eventos adversos gastrointestinales que el placebo y que el celecoxib 200<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#46;</p><p id="p0085" class="elsevierStylePara elsevierViewall">En el metaan&#225;lisis de Schiff et al<a class="elsevierStyleCrossRef" href="#bb0060"><span class="elsevierStyleSup">12</span></a>&#44; en ancianos con OA&#44; el naproxeno 1&#46;000<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a o el ibuprofeno 1&#46;200<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a mejoraron el dolor en reposo o con los movimientos pasivos&#44; el nocturno&#44; el tiempo empleado para caminar 20<span class="elsevierStyleHsp" style=""></span>m y la rigidez matutina m&#225;s que el placebo&#46; No hubo diferencias en el n&#250;mero&#44; el tipo o la severidad de los eventos adversos&#46;</p></span><span id="s0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0025">Principales resultados de los EC &#40;no incluidos en los metaan&#225;lisis&#41;</span><p id="p0090" class="elsevierStylePara elsevierViewall">Bakshi et al<a class="elsevierStyleCrossRef" href="#bb0065"><span class="elsevierStyleSup">13</span></a> analizaron a ancianos con OA&#44; en los que diclofenaco 150<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a fue superior en cuanto a la mejor&#237;a del dolor en reposo&#44; dolor con el movimiento&#44; dolor a la presi&#243;n y la rigidez en reposo que el placebo&#46; No hubo diferencias en cuanto al dolor en la actividad diaria ni en el n&#250;mero de eventos adversos &#40;leves-moderados&#41;&#46;</p><p id="p0095" class="elsevierStylePara elsevierViewall">Chan et al<a class="elsevierStyleCrossRef" href="#bb0070"><span class="elsevierStyleSup">14</span></a>&#44; en pacientes ancianos con artritis y episodio de ulcus previo&#44; no objetivaron diferencias entre el celecoxib 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a y el diclofenaco 150<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#43; omeprazol 20<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a en sangrado gastrointestinal&#44; ulcus recurrente o dispepsia&#46;</p><p id="p0100" class="elsevierStylePara elsevierViewall">Por otro lado&#44; Earl et al<a class="elsevierStyleCrossRef" href="#bb0075"><span class="elsevierStyleSup">15</span></a>&#44; en pacientes con OA&#44; observarn que ibuprofeno 1&#46;600<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a o piroxicam 20<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a mejoraron el dolor articular y las horas de sue&#241;o&#46; S&#243;lo el ibuprofeno mejor&#243; la flexi&#243;n de la cadera y la rodilla&#44; y ninguno la rotaci&#243;n interna de la cadera&#46; No hubo diferencias en el n&#250;mero de eventos adversos y abandonos en el grupo con AINE&#46;</p><p id="p0105" class="elsevierStylePara elsevierViewall">Seg&#250;n Hawkey et al<a class="elsevierStyleCrossRefs" href="#bb0080"><span class="elsevierStyleSup">16&#44;17</span></a>&#44; en ancianos con OA&#44; el lumiracoxib 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a no se asoci&#243; con el ulcus gastroduodenal&#44; pero s&#237; el naproxeno 1&#46;000<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a y el ibuprofeno 2&#46;400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#46;</p><p id="p0110" class="elsevierStylePara elsevierViewall">En el estudio de Kareela et al<a class="elsevierStyleCrossRef" href="#bb0090"><span class="elsevierStyleSup">18</span></a>&#44; ancianos con AR e indometacina 150<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a mejoraron su rigidez matutina&#46; No hubo diferencias en comparaci&#243;n con los pacientes menores de 65 a&#241;os&#46;</p><p id="p0115" class="elsevierStylePara elsevierViewall">Seg&#250;n Koch et al<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a>&#44; en ancianos con AR el uso de AINE con misoprostol disminuye en un 40&#37; el riesgo de complicaci&#243;n gastrointestinal grave en comparaci&#243;n con el AINE solo&#46;</p><p id="p0120" class="elsevierStylePara elsevierViewall">Regula et al<a class="elsevierStyleCrossRef" href="#bb0100"><span class="elsevierStyleSup">20</span></a> estudiaron a ancianos con AR&#47;OA con AINE y pantoprazol 20 o 40<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a u omeprazol 20<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; sin objetivar diferencias en la aparici&#243;n de eventos adversos gastrointestinales leves o graves&#46;</p><p id="p0125" class="elsevierStylePara elsevierViewall">En el EC de Silverstein et al<a class="elsevierStyleCrossRef" href="#bb0105"><span class="elsevierStyleSup">21</span></a>&#44; en ancianos con AR&#44; el uso de AINE se asoci&#243; a mayor riesgo de evento adverso grave &#40;ulcus&#44; hemorragia&#44; obstrucci&#243;n&#41;&#44; <span class="elsevierStyleItalic">odds ratio</span> &#91;OR&#93; &#61; 2&#44;48 &#40;intervalo&#44; 1&#44;48-4&#44;14&#41;&#46;</p><p id="p0130" class="elsevierStylePara elsevierViewall">Whelton et al<a class="elsevierStyleCrossRef" href="#bb0110"><span class="elsevierStyleSup">22</span></a>&#44; en ancianos con OA&#44; no encontraron diferencias en el aumento de PA diast&#243;lica ni en la aparici&#243;n de insuficiencia card&#237;aca &#40;primer episodio&#41; entre los que tomaron celecoxib 200<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a o rofecoxib 25<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#46; S&#237; hubo m&#225;s pacientes con edema cl&#237;nicamente significativo y aumento de la PA sist&#243;lica en el grupo rofecoxib&#46;</p></span><span id="s0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0030">Principales resultados de los estudios de cohortes</span><p id="p0135" class="elsevierStylePara elsevierViewall">En el estudio de Fries et al<a class="elsevierStyleCrossRef" href="#bb0115"><span class="elsevierStyleSup">23</span></a> el riesgo de hospitalizaci&#243;n o muerte por evento gastrointestinal de los AINE de los pacientes con AR fue&#58; en mayores de 60 a&#241;os&#44; OR &#61; 2&#44;7&#59; en mayores de 65 a&#241;os&#44; OR &#61; 2&#44;4&#59; en mayores de 70 a&#241;os&#44; OR &#61; 2&#44;0&#44; y en mayores de 75 a&#241;os&#44; OR &#61; 2&#44;2 &#40;todos los resultados son estad&#237;sticamente significativos&#41;&#46;</p><p id="p0140" class="elsevierStylePara elsevierViewall">En la cohorte de Le Loet<a class="elsevierStyleCrossRef" href="#bb0120"><span class="elsevierStyleSup">24</span></a>&#44; en ancianos con enfermedad reum&#225;tica que hab&#237;an tomado ketoprofeno 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; la valoraci&#243;n global del m&#233;dico fue buena&#47;excelente en un 74&#44;4&#37;&#44; y seg&#250;n los pacientes&#44; la tolerabilidad del f&#225;rmaco fue buena&#47;excelente en un 85&#37;&#46; Hubo eventos adversos relacionados con el f&#225;rmaco en el 15&#44;3&#37; de los pacientes&#46;</p></span><span id="s0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0035">Estudio de prevalencia</span><p id="p0145" class="elsevierStylePara elsevierViewall">Seg&#250;n Cheatum et al<a class="elsevierStyleCrossRef" href="#bb0125"><span class="elsevierStyleSup">25</span></a>&#44; en pacientes con AR&#47;OA en tratamiento con AINE&#44; la prevalencia de ulcus gastroduodenal fue&#58; en el grupo de 60&#8211;69 a&#241;os&#44; del 29&#37;&#59; en el de 70&#8211;79 a&#241;os&#44; del 34&#37;&#44; y en los mayores de 80 a&#241;os&#44; del 32&#37;&#46;</p></span></span><span id="s0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0040">Discusi&#243;n</span><p id="p0150" class="elsevierStylePara elsevierViewall">Hemos analizado los resultados de eficacia cl&#237;nica &#40;en el tratamiento del dolor y funci&#243;n y calidad de vida&#41; y de seguridad &#40;gastrointestinal&#44; cardiovascular&#44; renal&#41; de los AINE en el tratamiento de enfermedades reum&#225;ticas en ancianos&#44; mediante la revisi&#243;n sistem&#225;tica de la literatura&#46; El objetivo es contribuir con la evidencia cient&#237;fica publicada a la hora de generar un consenso sobre el uso de AINE en ancianos&#46;</p><p id="p0155" class="elsevierStylePara elsevierViewall">En cuanto a la eficacia&#44; seg&#250;n los resultados obtenidos&#44; hay datos que apoyan el uso de los AINE para el dolor y otros s&#237;ntomas de origen reum&#225;tico en ancianos<a class="elsevierStyleCrossRefs" href="#bb0045"><span class="elsevierStyleSup">9&#44;11&#8211;13&#44;15&#44;18&#44;24</span></a>&#46; Pero&#44; dada la diversidad de AINE empleados en los estudios y las distintas variables utilizadas para medir la eficacia&#44; es dif&#237;cil definir si un AINE es claramente m&#225;s eficaz que otro en los ancianos con dolor reum&#225;tico&#46; Tampoco queda muy clara la magnitud de sus efectos que&#44; en general&#44; seg&#250;n lo publicado&#44; no parece muy llamativa&#44; aunque hay que tener en cuenta el contexto en el que se utilizan &#40;b&#225;sicamente ancianos con artritis reumatoide y artrosis&#41;&#46;</p><p id="p0160" class="elsevierStylePara elsevierViewall">En cuanto a su seguridad&#44; en primer lugar es de destacar que&#44; seg&#250;n un estudio transversal<a class="elsevierStyleCrossRef" href="#bb0125"><span class="elsevierStyleSup">25</span></a>&#44; la prevalencia de ulcus gastroduodenal en ancianos con enfermedad reum&#225;tica en tratamiento con AINE es considerable&#44; mayor en el grupo de 70&#8211;79 a&#241;os de edad&#46; Este hecho se complementa con los datos que se desprenden de un estudio de cohortes y de otros EC&#44; en que se evidencia un riesgo aumentado de cualquier tipo de evento adverso grave&#44; especialmente los de origen gastrointestinal &#40;hospitalizaci&#243;n o muerte<a class="elsevierStyleCrossRef" href="#bb0115"><span class="elsevierStyleSup">23</span></a>&#44; hemorragia digestiva<a class="elsevierStyleCrossRefs" href="#bb0070"><span class="elsevierStyleSup">14&#44;19&#44;21</span></a>&#44; ulcus<a class="elsevierStyleCrossRefs" href="#bb0080"><span class="elsevierStyleSup">16&#44;17&#44;19&#8211;21&#44;25</span></a> u obstrucci&#243;n digestiva<a class="elsevierStyleCrossRefs" href="#bb0095"><span class="elsevierStyleSup">19&#44;21</span></a>&#41;&#46; En estudios de poblaci&#243;n general&#44; el riesgo descrito de evento gastrointestinal grave es incluso mayor<a class="elsevierStyleCrossRef" href="#bb0015"><span class="elsevierStyleSup">3</span></a>&#46; Esto pudiera deberse a que actualmente en reumatolog&#237;a se prescribe AINE a los ancianos en momentos de dolor agudo y no tanto como tratamiento continuo y cr&#243;nico&#46; S&#243;lo un art&#237;culo de los incluidos analiz&#243; eventos adversos cardiovasculares<a class="elsevierStyleCrossRef" href="#bb0110"><span class="elsevierStyleSup">22</span></a>&#44; donde no hubo diferencia significativa de aumento de PA diast&#243;lica ni en la aparici&#243;n de insuficiencia card&#237;aca &#40;primer episodio&#41; entre celecoxib y rofecoxib&#46; Pero hubo m&#225;s pacientes con edema cl&#237;nicamente significativo y aumento en la PA sist&#243;lica en el grupo rofecoxib&#46; De nuevo es dif&#237;cil establecer qu&#233; AINE presenta un mejor perfil de seguridad&#46;</p><p id="p0165" class="elsevierStylePara elsevierViewall">Por &#250;ltimo&#44; cabe se&#241;alar que en los art&#237;culos seleccionados el uso de protectores g&#225;stricos se asoci&#243; a reducci&#243;n del riesgo de ulcus gastroduodenal en ancianos<a class="elsevierStyleCrossRefs" href="#bb0095"><span class="elsevierStyleSup">19&#8211;21</span></a>&#46; Aunque al igual que con la eficacia y la seguridad&#44; es dif&#237;cil establecer cu&#225;les son mejores que otros&#46;</p><p id="p0170" class="elsevierStylePara elsevierViewall">Pero todos estos resultados hay que tomarlos con cautela por los siguientes motivos&#58; una de las principales dificultades de la revisi&#243;n ha sido la falta de definici&#243;n homog&#233;nea del concepto anciano&#44; es decir&#44; actualmente a qu&#233; edad y&#47;o qu&#233; condiciones consideramos las propias de un ser humano anciano&#46; Otra dificultad a&#241;adida es que&#44; en general&#44; en los EC y en otros estudios&#44; suele ser muy escaso el n&#250;mero de ancianos incluidos&#44; lo que hace que se muestren pocos datos de ellos&#44; por lo que puede que no se est&#233; describiendo correctamente lo que sucede en la pr&#225;ctica diaria con este grupo de poblaci&#243;n&#46; En la presente revisi&#243;n&#44; se puso un corte en los 60 a&#241;os&#44; cuando es posible que sea diferente &#40;en t&#233;rminos de eficacia y seguridad de los AINE&#41; tener 60 o 79 a&#241;os&#46; Y como se ha visto&#44; hay pocos an&#225;lisis de subgrupos de edad entre ancianos que puedan estudiar este fen&#243;meno&#46; Otra posible limitaci&#243;n es que la dificultad para ajustar por todas las variables que en el anciano con enfermedad reum&#225;tica puedan influir en las variables de resultado estudiadas&#44; que pueden potencialmente modificar los resultados expuestos &#40;uso concomitante de otras medicaciones&#44; enfermedades&#44; etc&#46;&#41;&#46; Por &#250;ltimo&#44; comentar tambi&#233;n la falta de estudios de calidad que confirmen el efecto en las funciones renal y card&#237;aca en ancianos que toman AINE&#44; en art&#237;culos ya publicados en otro tipo de poblaciones&#46;</p><p id="p0175" class="elsevierStylePara elsevierViewall">En conclusi&#243;n&#44; los AINE son eficaces en los ancianos para el tratamiento del dolor de origen reum&#225;tico&#44; si bien el riesgo de evento adverso grave es mayor&#44; por lo que ser&#237;a recomendable&#44; por un lado&#44; el uso de gastroprotectores siempre que se utilicen&#44; adem&#225;s de individualizar en cada caso el uso de los AINE&#44; ya que hay otras alternativas de tratamiento del dolor de origen reum&#225;tico que se han demostrado muy seguras y eficaces en los ancianos&#44; como los analg&#233;sicos o los esteroides a dosis bajas&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:7 [
        0 => array:2 [
          "identificador" => "xpalclavsec112552"
          "titulo" => "Palabras clave"
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec112553"
          "titulo" => "Key words"
        ]
        2 => array:2 [
          "identificador" => "s0005"
          "titulo" => "Introducci&#243;n"
        ]
        3 => array:2 [
          "identificador" => "s0010"
          "titulo" => "Material y m&#233;todos"
        ]
        4 => array:3 [
          "identificador" => "s0015"
          "titulo" => "Resultados"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "s0020"
              "titulo" => "Principales resultados de los metaan&#225;lisis"
            ]
            1 => array:2 [
              "identificador" => "s0025"
              "titulo" => "Principales resultados de los EC &#40;no incluidos en los metaan&#225;lisis&#41;"
            ]
            2 => array:2 [
              "identificador" => "s0030"
              "titulo" => "Principales resultados de los estudios de cohortes"
            ]
            3 => array:2 [
              "identificador" => "s0035"
              "titulo" => "Estudio de prevalencia"
            ]
          ]
        ]
        5 => array:2 [
          "identificador" => "s0040"
          "titulo" => "Discusi&#243;n"
        ]
        6 => array:1 [
          "titulo" => "Bibliograf&#237;a"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2008-02-15"
    "fechaAceptado" => "2008-05-16"
    "PalabrasClave" => array:2 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec112552"
          "palabras" => array:4 [
            0 => "Antiinflamatorios no esteroideos"
            1 => "Ancianos"
            2 => "Eficacia"
            3 => "Seguridad"
          ]
        ]
      ]
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Key words"
          "identificador" => "xpalclavsec112553"
          "palabras" => array:4 [
            0 => "Non-steroidal anti-inflammatory drugs"
            1 => "Elderly"
            2 => "Efficacy"
            3 => "Safety"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "es" => array:1 [
        "resumen" => "<span class="elsevierStyleSectionTitle">Objetivo</span><p id="sp0035" class="elsevierStyleSimplePara elsevierViewall">Analizar la eficacia y la seguridad de los antiinflamatorios no esteroideos &#40;AINE&#41; en ancianos&#46;</p> <span class="elsevierStyleSectionTitle">M&#233;todos</span><p id="sp0040" class="elsevierStyleSimplePara elsevierViewall">Revisi&#243;n sistem&#225;tica&#46; Se defini&#243; una estrategia de b&#250;squeda bibliogr&#225;fica sensible en MEDLINE &#40;desde 1961&#41;&#44; EMBASE &#40;desde 1980&#41; y Cochrane Library &#40;hasta diciembre de 2007&#41;&#59; se defini&#243; la poblaci&#243;n &#40;ancianos&#58; sujetos mayores de 60 a&#241;os&#44; con enfermedades reum&#225;ticas&#41;&#44; la intervenci&#243;n &#40;AINE&#41; y los resultados&#59; variables de eficacia &#40;dolor&#44; funci&#243;n&#44; calidad de vida&#41; y de seguridad &#40;toxicidad gastrointestinal&#44; renal y cardiovascular&#41;&#46; Se incluyeron ensayos cl&#237;nicos &#40;EC&#41; de 4-5 en la escala de Jadad y estudios de cohortes de m&#225;xima calidad&#46;</p> <span class="elsevierStyleSectionTitle">Resultados</span><p id="sp0045" class="elsevierStyleSimplePara elsevierViewall">Se seleccionaron 101 art&#237;culos para lectura en detalle&#44; de los que se incluyeron 16&#44; que analizaron m&#225;s de 50&#46;000 ancianos&#44; con un seguimiento que vari&#243; desde 1 semana a 4 a&#241;os&#46; Destaca la gran diversidad en cuanto al tipo de AINE y las medidas de desenlace&#46; Se incluyeron 4 metaan&#225;lisis&#44; 9 EC&#44; 2 estudios de cohortes y un estudio de prevalencia&#46; La mayor&#237;a de estos estudios analizaron a pacientes con osteoartrosis o artritis reumatoide&#46; Los AINE en el anciano se han mostrado eficaces para el control del dolor de origen reum&#225;tico&#44; la rigidez y la funci&#243;n articular&#44; pero presentan un riesgo aumentado de cualquier evento grave&#44; especialmente gastrointestinal &#40;muerte&#44; hospitalizaci&#243;n&#44; hemorragia&#44; ulcus u obstrucci&#243;n digestiva&#41;&#46; Este riesgo disminuye al asociarse un protector g&#225;strico&#46;</p> <span class="elsevierStyleSectionTitle">Conclusiones</span><p id="sp0050" class="elsevierStyleSimplePara elsevierViewall">De acuerdo con la evidencia recogida&#44; el uso de AINE es eficaz para el tratamiento de ancianos con enfermedades reum&#225;ticas&#44; aunque tambi&#233;n presenta un riesgo aumentado de evento adverso grave&#44; sobre todo de origen gastrointestinal&#46;</p>"
      ]
      "en" => array:1 [
        "resumen" => "<span class="elsevierStyleSectionTitle">Objective</span><p id="sp0055" class="elsevierStyleSimplePara elsevierViewall">To analyze the efficacy and safety of nonsteroidal anti-inflammatory drugs &#40;NSAID&#41; in the elderly&#46;</p> <span class="elsevierStyleSectionTitle">Methods</span><p id="sp0060" class="elsevierStyleSimplePara elsevierViewall">We performed a systematic review using a sensitive search strategy&#46; All studies published in MEDLINE &#40;since 1961&#41;&#44; EMBASE &#40;since 1961&#41; and Cochrane Library &#40;up to December 2007&#41; were selected&#46; We defined the population &#40;elderly as subjects aged 60 years or above with musculoskeletal diseases&#41;&#44; the intervention &#40;use of NSAID&#41;&#44; and the results related to efficacy &#40;pain&#44; function and quality of life&#41; and safety &#40;gastrointestinal&#44; cardiovascular or renal toxicity&#41;&#46;</p><p id="sp0065" class="elsevierStyleSimplePara elsevierViewall">Randomized clinical trials &#40;RCT&#41;&#44; &#40;Jadad 4 or 5&#41; and high quality cohort studies were included&#46;</p> <span class="elsevierStyleSectionTitle">Results</span><p id="sp0070" class="elsevierStyleSimplePara elsevierViewall">A total of 101 studies were analyzed in detail&#44; and 16 were included&#46; More than 50&#44;000 patients aged 60 years or above were analyzed from 1 week&#44; up to 4 years&#46; Different NSAID were included as well as different outcomes&#46; Four meta-analyses&#44; 9 RCT&#44; 2 cohort studies&#44; and one cross-sectional study were included&#46; NSAID are effective for the treatment of musculoskeletal pain&#44; stiffness or joint function&#46; However&#44; NSAID are associated with an increased risk of any serious adverse events&#44; especially serious gastrointestinal adverse events &#40;death&#44; hospitalization&#44; bleeding&#44; ulcers&#44; obstruction&#41;&#46; This risk decreased with the use of proton pump inhibitors&#46;</p> <span class="elsevierStyleSectionTitle">Conclusions</span><p id="sp0075" class="elsevierStyleSimplePara elsevierViewall">Based on the evidence&#44; NSAID in the elderly are effective for the treatment of different musculoskeletal diseases&#44; although the risk of serious adverse events &#40;mainly gastrointestinal&#41; is also clearly increased&#46;</p>"
      ]
    ]
    "multimedia" => array:5 [
      0 => array:7 [
        "identificador" => "f0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 3933
            "Ancho" => 3110
            "Tamanyo" => 787416
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="sp0005" class="elsevierStyleSimplePara elsevierViewall">Flujo de la selecci&#243;n de los estudios&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "t0005"
        "etiqueta" => "Tabla 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="center" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Estrategia de b&#250;squeda&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="center" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Resultados&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Search elderly OR aged OR Oldest Old OR Centenarians OR Centenarian OR Nonagenarians OR Nonagenarian OR Octogenarians OR Octogenarian OR Frail Elders OR Elders&#44; Frail OR Frail Elder OR Frail Older Adults OR aging OR elder OR geriatric OR gerontology OR gerontological OR geriatrics&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#46;997&#46;247&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">NSAID OR Nonsteroidal Anti-Inflammatory Agents OR Nonsteroidal Antiinflammatory Agents OR Analgesics&#44;Anti Inflammatory OR Non-Steroidal Anti-Rheumatic Agents OR Non-Steroidal Antirheumatic Agents OR Aspirin-LikeAgents OR Agents&#44; Aspirin-Like OR naproxen&#42; OR ibuprofen&#42; OR dexibuprofen OR dexketoprofen OR flurbiprofenOR Ketoprofen OR Ketorola&#42; OR aceclofenac OR diclofenac OR lornoxicam OR meloxicam OR piroxicam OR tenoxicamOR indometacin OR sulindac OR tolmetin OR fenilbutazon OR Phenylbutazone OR nabumeton OR celecoxib OR etoricoxibOR parecoxib OR rofecoxib OR valdecoxib OR lumiracoxib OR salicylic acid OR acetylsalicylic acid OR diflunisalOR Cyclooxygenase 2 Inhibitors OR COX-2 Inhibitors OR COX2 Inhibitors&#44; OR Coxibs&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">154&#46;508&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Randomized &#91;All Fields&#93; OR random allocation&#8221;&#91;TIAB&#93; NOT Medline&#91;SB&#93;&#41; OR &#8220;random allocation&#8221;&#91;MeSH Terms&#93; OR randomized&#91;Text Word&#93; OR controlled&#91;All Fields&#93; AND &#40;&#8220;clinical trials as topic&#8221;&#91;MeSH Terms&#93; OR trial&#91;Text Word&#93;&#41; OR placebo OR blinded&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">819&#46;404&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 y 2 y 3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">10&#46;959&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#40;Musculoskeletal diseases OR Polymyalgia Rheumatica OR Lupus Erythematosus&#44; Systemic OR vasculitis OR polymyositis OR dermatomyositis&#41; OR &#40;musculoskeletal diseases &#91;tiab&#93; OR polymyalgia&#91;tiab&#93; OR &#8220;lupus erythematosus systemic&#8221;&#91;tiab&#93; OR vasculitis&#91;tiab&#93; OR polymyositis&#91;tiab&#93; OR dermatomyositis&#91;tiab&#93;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">731&#46;817&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4 y 5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3&#46;081&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">acute &#91;All Fields&#93; OR post-operative &#91;All Fields&#93; OR post-surgical&#91;All Fields&#93; OR postsurgical &#91;All Fields&#93; OR Postoperative Complications &#91;MeSH&#93; OR Intraoperative Complications &#91;MeSH&#93; dysmenorrhoea&#91;All Fields&#93; OR orthodontic &#91;All fields&#93; OR Cancer OR neoplasm OR cancers OR tumor OR tumors OR Benign Neoplasms OR metastasis OR metastases&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#46;248&#46;303&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6 NOT 7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#46;855&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8 Limits&#58; Humans&#44; Clinical Trial&#44; Meta-Analysis&#44; Randomized Controlled Trial&#44; Clinical Trial&#44; Phase I&#44; Clinical Trial&#44; Phase II&#44; Clinical Trial&#44; Phase III&#44; Clinical Trial&#44; Phase IV&#44; Comparative Study&#44; Controlled Clinical Trial&#44; English&#44; Spanish&#44; Aged&#58; 65<span class="elsevierStyleHsp" style=""></span>&#43; years&#44; 80 and over&#58; 80<span class="elsevierStyleHsp" style=""></span>&#43; years&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;549&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab211960.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="sp0010" class="elsevierStyleSimplePara elsevierViewall">Estrategia de b&#250;squeda y resultados en MEDLINE</p>"
        ]
      ]
      2 => array:7 [
        "identificador" => "t0010"
        "etiqueta" => "Tabla 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="center" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Estrategia de b&#250;squeda&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="center" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Resultados&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">aged&#46;mp&#46; or aged&#47; or aged hospital patient&#46;mp&#46; or aged hospital patient&#47; or frail elderly&#46;mp&#46; or frail elderly&#47;or very elderly&#46;mp&#46; or very elderly&#47; or elder&#46;mp&#46; or geriatrics&#46;mp&#46; or geriatrics&#47; or aging&#46;mp&#46; or aging&#47;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;090&#46;777&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">nsaid&#46;mp&#46; or Nonsteroid Antiinflammatory Agent&#47; or Nonsteroidal Anti-Inflammatory Agents&#46;mp&#46; or &#40;coxib or Cyclooxygenase 2 Inhibitor&#41;&#46;mp&#46; or Acetylsalicylic Acid&#47; or Aspirin-Like Agents&#46;mp&#46; or naproxen&#46;mp&#46; or NAPROXEN&#47;or ibuprofen&#46;mp&#46; or IBUPROFEN&#47; or dexibuprofen&#36;&#46;mp&#46; or DEXIBUPROFEN&#47; or dexketoprofen&#46;mp&#46; or DEXKETOPROFEN&#47; or flurbiprofen&#46;mp&#46; or FLURBIPROFEN&#47; or Ketoprofen&#46;mp&#46; or KETOPROFEN&#47; or KETOROLAC&#47; or Ketorolac&#46;mp&#46; or aceclofenac&#46;mp&#46; or ACECLOFENAC&#47; or diclofenac&#46;mp&#46; or DICLOFENAC&#47; or lornoxicam&#46;mp&#46; or LORNOXICAM&#47; or meloxicam&#46;mp&#46; or MELOXICAM&#47; or PIROXICAM&#47; or piroxicam&#46;mp&#46; or PIROXICAM&#47; or piroxicam&#46;mp&#46; or tenoxicam&#46;mp&#46; or TENOXICAM&#47; or INDOMETACIN&#47; or indometacin&#46;mp&#46; or sulindac&#46;mp&#46; or SULINDAC&#47; or tolmetin&#46;mp&#46; or TOLMETIN&#47; or Phenylbutazone&#46;mp&#46; or PHENYLBUTAZONE&#47; or nabumetone&#47; or nabumeton&#46;mp&#46; or celecoxib&#46;mp&#46; or CELECOXIB&#47; or etoricoxib&#46;mp&#46; or ETORICOXIB&#47; or parecoxib&#46;mp&#46; or PARECOXIB&#47; or rofecoxib&#46;mp&#46; or ROFECOXIB&#47; or salicylic acid&#46;mp&#46; or Salicylic Acid&#47; or acetylsalicylic acid&#46;mp&#46; or Acetylsalicylic Acid&#47; or diflunisal&#46;mp&#46; or DIFLUNISAL&#47; or valdecoxib&#46;mp&#46; or VALDECOXIB&#47; or lumiracoxib&#46;mp&#46; or LUMIRACOXIB&#47;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">207&#46;945&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">exp clinical trial&#47; or evidence based medicine&#47; or outcomes research&#47; or crossover procedure&#47; or double blind procedure&#47; or single blind procedure&#47; or prospective study&#47; or major clinical study&#47; or exp comparative study&#47; or placebo&#47; or &#8220;evaluation and follow up&#8221;&#47; or follow up&#47; or randomization&#47;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;964&#46;112&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">controlled study&#47; not case control study&#47;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#46;568&#46;695&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3 o 4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3&#46;774&#46;593&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#40;&#40;clinic&#36; adjs trial&#36;&#41; or &#40;&#40;singl&#36; or doubl&#36; or trebl&#36; or tripl&#36;&#41; adj &#40;blind&#36; or mask&#36;&#41;&#41; or random&#36; or placebo&#36;&#41;&#46;ti&#44;ab&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">489&#46;355&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">5 o 6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3&#46;890&#46;101&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">exp musculoskeletal disease&#47; or musculoskeletal disease&#46;mp&#46; or rheumatic polymyalgia&#46;mp&#46; or polymyalgia&#47; or lupus erythematosus systemic&#46;mp&#46; or systemic lupus erythematosus&#47; or vasculitis&#47; or vasculitis&#46;mp&#46; or polymyositis&#46;mp&#46; or polymyositis&#47; or dermatomyositis&#46;mp&#46; or dermatomyositis&#47;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">669&#46;390&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">perioperative period&#46;mp&#46; or PERIOPERATIVE PERIOD&#47; or perioperative care&#46;mp&#46; or SURGERY&#47; or surgery&#46;mp&#46; or SURGICAL TECHNIQUE&#47; or surgical procedures&#46;mp&#46; or PEROPERATIVE CARE&#47; or preoperative care&#46;mp&#46; or intraoperative care&#46;mp&#46; or PEROPERATIVE COMPLICATION&#47; or POSTOPERATIVE COMPLICATION&#47; or dysmenorrhoea&#46;mp&#46; or Dysmenorrhea&#47; or orthodontic&#46;mp&#46; or Orthodontics&#47; or exp malignant neoplastic disease&#47; or cancer&#47; or exp metastasis&#47; or exp mixed tumor&#47; or exp &#8220;neoplasms of uncertain behavior&#8221;&#47; or exp neoplasms subdivided by anatomical site&#47; or exp &#8220;oncogenesis and malignant transformation&#8221;&#47; or exp paraneoplastic syndrome&#47; or exp &#8220;precancer and cancer-in-situ&#8221;&#47; or adolescent&#46;mp&#46; or adolescent&#47; or hospitalized adolescent&#47; or juvenile&#46;mp&#46; or juvenile&#47; or child&#46;mp&#46; or child&#47; or boy&#46;mp&#46; or boy&#47; or gifted child&#47; or girl&#46;mp&#46; or girl&#47; or handicapped child&#47; or hospitalized child&#47; or preschool child&#47; or school child&#47; or infant&#46;mp&#46; or infant&#47; or baby&#46;mp&#46; or baby&#47; or high risk infant&#47; or hospitalized infant&#47; or newborn&#46;mp&#46; or newborn&#47; or suckling&#46;mp&#46; or suckling&#47; or pediatric&#46;mp&#46; or review&#47; or guideline&#46;mp&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3&#46;370&#46;213&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">10&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 y 2 y 7 y 8&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4&#46;449&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">11&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">10 no 9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#46;997&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">12&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Limit 11 to humans&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#46;965&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">13&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Limit 12 to abstracts&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#46;668&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab211963.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="sp0015" class="elsevierStyleSimplePara elsevierViewall">Estrategia de b&#250;squeda y resultados en EMBASE</p>"
        ]
      ]
      3 => array:7 [
        "identificador" => "t0015"
        "etiqueta" => "Tabla 3"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:2 [
          "leyenda" => "<p id="sp0025" class="elsevierStyleSimplePara elsevierViewall">AINE&#58; antiinflamatorios no esteroideos&#59; AR&#58; artritis reumatoide&#59; CE&#58; criterios de exclusi&#243;n&#59; CI&#58; criterios de inclusi&#243;n&#59; EC&#58; ensayo cl&#237;nico&#59; HTA&#58; hipertensi&#243;n arterial&#59; HZ&#58; <span class="elsevierStyleItalic">hazard ratio&#59;</span> IC&#58; intervalo de confianza&#59; OA&#58; osteoartrosis&#59; OR&#58; <span class="elsevierStyleItalic">odds ratio&#59;</span> PA&#58; presi&#243;n arterial&#59; PAD&#58; presi&#243;n arterial diast&#243;lica&#59; PAS&#58; presi&#243;n arterial sist&#243;lica&#59; RR&#58; riesgo relativo&#59; VGM&#58; valoraci&#243;n global del m&#233;dico&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Resultados&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Participantes e intervenci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Bakshi et al<a class="elsevierStyleCrossRef" href="#bb0065"><span class="elsevierStyleSup">13</span></a>&#44; EC a doble ciego controlado con placebo&#46; Seguimiento&#44; 4 meses&#46; Jadad 4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">314 OA cadera&#47;rodilla&#47;manos&#44; 186 &#40;60&#37;&#41; mujeres&#44; 60-80 a&#241;os&#44; duraci&#243;n media de la OA 6&#44;4 a&#241;os&#46; CE&#58; alergia a AINE&#44; &#250;lcera o sangrado digestivo previo&#44; enfermedad hem&#225;tica&#44; hep&#225;tica o insuficiencia card&#237;aca&#46; Diclofenaco 150<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; 4 semanas &#40;n &#61; 208&#41;&#46; Placebo&#44; 4 semanas &#40;n &#61; 106&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Eficacia&#58; en comparaci&#243;n con placebo el diclofenaco fue mejor en&#58; dolor en reposo &#40;p &#60; 0&#44;001&#41;&#44; dolor en movimiento &#40;p &#60; 0&#44;001&#41;&#44; dolor a la presi&#243;n local &#40;p &#61; 0&#44;040&#41;&#44; rigidez en reposo &#40;p &#61; 0&#44;008&#41;&#46; Sin diferencias en dolor en actividad diaria&#46; Seguridad&#58; eventos adversos leves-moderados&#58; diclofenaco &#40;n &#61; 30&#41;&#44; placebo &#40;n &#61; 18&#41; &#40;p &#61; 0&#44;551&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Chan et al<a class="elsevierStyleCrossRef" href="#bb0070"><span class="elsevierStyleSup">14</span></a>&#44; EC a doble ciego controlado con placebo&#46; Seguimiento&#44; 6 meses&#46; Jadad 5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">222 pacientes con artriris &#40;52&#37; mujeres&#59; media de edad&#44; 67&#44;1 a&#241;os&#41;&#46; CI&#58; ulcus sangrante previo curado&#44; <span class="elsevierStyleItalic">Helicobacter pilori</span> negativo&#46; CE&#58; esteroides&#44; anticoagulantes&#44; cirug&#237;a g&#225;strica o duodenal&#44; esofagitis erosiva&#44; obstrucci&#243;n g&#225;strica&#44; insuficiencia renal&#46; Celecoxib 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#43; placebo 6 meses &#40;n &#61; 116&#41;&#46; Diclofenaco 150<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#43; omeprazol 20<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 6 meses &#40;n &#61; 106&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Seguridad&#58; <span class="elsevierStyleItalic">a&#41;</span> sangrado gastrointestinal&#58; celecoxib &#40;n &#61; 7&#41;&#44; diclofenaco &#40;n &#61; 9&#41; &#40;p &#61; 0&#44;511&#41;&#59; <span class="elsevierStyleItalic">b&#41;</span> ulcus gastroduodenal recurrente&#58; celecoxib &#40;n &#61; 20&#41;&#44; diclofenaco &#40;n &#61; 26&#41; &#40;p &#61; 0&#44;180&#41;&#59; <span class="elsevierStyleItalic">c&#41;</span> sin dispepsia o m&#237;nima&#58; celecoxib &#40;n &#61; 100&#41;&#44; diclofenaco &#40;n &#61; 98&#41; &#40;p &#61; 0&#44;720&#41;&#59; <span class="elsevierStyleItalic">d&#41;</span> dispepsia significativa&#58; celecoxib &#40;n &#61; 16&#41;&#44; diclofenaco &#40;n &#61; 18&#41; &#40;p &#61; 0&#44;572&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Cheatum et al<a class="elsevierStyleCrossRef" href="#bb0125"><span class="elsevierStyleSup">25</span></a>&#44; estudio transversal&#44; calidad 2a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;826 pacientes &#40;1&#46;009 AR&#44; 817 OA&#41;&#44; 67&#44;3&#37; mujeres&#59; media de edad&#44; 54&#44;3 a&#241;os&#46; Consumo de AINE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Seguridad&#58; <span class="elsevierStyleItalic">a&#41;</span> prevalencia de &#250;lcera gastroduodenal&#58; 60-69 a&#241;os &#40;29&#37;&#41;&#44; 70-79 a&#241;os &#40;34&#37;&#41;&#44; &#62; 80 a&#241;os 32&#37;&#41;&#59; <span class="elsevierStyleItalic">b&#41;</span> prevalencia de &#250;lcera gastroduodenal en AR&#58; 60-69 a&#241;os &#40;24&#37;&#41;&#44; 70-79 a&#241;os &#40;27&#37;&#41;&#44; &#62; 80 a&#241;os &#40;14&#37;&#41;&#59; <span class="elsevierStyleItalic">c&#41;</span> prevalencia de &#250;lcera gastroduodenal en OA&#58; 60-69 a&#241;os &#40;35&#37;&#41;&#44; 70-79 a&#241;os &#40;41&#37;&#41;&#44; &#62; 80 a&#241;os &#40;37&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Detora et al<a class="elsevierStyleCrossRef" href="#bb0075"><span class="elsevierStyleSup">15</span></a>&#44; metaan&#225;lisis&#44; 3 EC &#40;Jadad 4&#41;&#44; seguimiento 6 semanas&#46; Calidad 1a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;491 OA &#40;73&#37; mujeres&#44; media de 62 a&#241;os&#41; Rofecoxib 12&#44;5<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 6 semanas &#40;n &#61; 288&#41;&#46; Rofecoxib 25<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 6 semanas &#40;n &#61; 607&#41;&#46; Placebo 6 semanas &#40;n &#61; 596&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Eficacia en comparaci&#243;n con placebo&#58; <span class="elsevierStyleItalic">a&#41;</span> valoraci&#243;n global del paciente &#40;VAS&#41;&#58; rofecoxib 12&#44;5<span class="elsevierStyleHsp" style=""></span>mg&#44; &#8211;1 &#40;&#8211;1&#44;3 a &#8211;1&#44;8&#41;&#59; rofecoxib 25<span class="elsevierStyleHsp" style=""></span>mg&#44; &#8211;1&#44;1 &#40;&#8211;1&#44;3 a &#8211;0&#44;9&#41;&#44; sin diferencias entre los 2 rofecoxib&#59; <span class="elsevierStyleItalic">b&#41;</span> dolor al caminar &#40;VAS&#41;&#58; Rofecoxib 12&#44;5<span class="elsevierStyleHsp" style=""></span>mg&#44; &#8211;16&#44;9 &#40;&#8211;21&#44;7 a &#8211;12&#44;1&#41;&#59; rofecoxib 25<span class="elsevierStyleHsp" style=""></span>mg&#44; &#8211;18&#44;1 &#40;&#8211;22&#44;8 a &#8211;13&#44;4&#41;&#59; sin diferencias entre los 2 rofecoxib&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Earl et al<a class="elsevierStyleCrossRef" href="#bb0075"><span class="elsevierStyleSup">15</span></a>&#44; EC a doble ciego&#44; seguimiento 4 semanas&#46; Jadad 5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">59 OA &#40;73&#37; mujeres&#44; media de edad&#44; 71 a&#241;os&#41;&#46; CI&#58; OA cadera&#47;rodilla&#44; capaces de andar y de autocuidado&#46; CE&#58; tratamientos para el dolor diferentes de AINE&#44; anemia&#44; ulcus&#44; alcohol&#44; disfunci&#243;n renal o hep&#225;tica&#46; Ibuprofeno 1&#46;600<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 4 semanas &#40;n &#61; 38&#41;&#46; Piroxicam 20<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 4 semanas &#40;n &#61; 21&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Eficacia&#58; s&#243;lo el ibuprofeno mejora la flexi&#243;n de cadera&#47;rodilla &#40;p &#60; 0&#44;050&#41;&#46; Ninguno&#58; rotaci&#243;n interna de cadera&#59; los 2&#58; dolor articular&#44; horas de sue&#241;o &#40;p &#62; 0&#44;050&#41;&#46; Seguridad&#58; eventos adversos&#58; ibuprofeno &#40;n &#61; 6&#41;&#44; piroxicam &#40;n &#61; 7&#41; &#40;p &#62; 0&#44;050&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Eisen et al<a class="elsevierStyleCrossRef" href="#bb0050"><span class="elsevierStyleSup">10</span></a> &#40;2005&#41;&#44; metaanalisis&#44; 5 EC &#40;Jadad 4-5&#41;&#44; seguimiento 12 semanas&#46; Calidad 1a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4&#46;394 AR&#47;OA &#40;28&#37; mujeres&#44; media de edad&#44; 59 a&#241;os&#41;&#46; CE&#58; enfermedad gastrointestinal grave&#44; malignidad&#46; Valdecoxib 10-40<span class="elsevierStyleHsp" style=""></span>mg&#47; d&#237;a 12 semanas &#40;n &#61; 2&#46;236&#41;&#46; Otros AINE 12 semanas &#40;n &#61; 1&#46;185&#41;&#58; naproxeno 1&#46;000<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; ibuprofeno 2&#46;400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; diclofenaco 150<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#46; Placebo 12 semanas &#40;n &#61; 973&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Seguridad&#58; comparado con grupo AINE riesgo de s&#237;ntoma gastroduodenal moderado&#47;severo&#59; valdecoxib &#40;cualquier dosis&#41;&#44; HR &#61; 0&#44;59 &#40;IC del 95&#37;&#44; 0&#44;47-0&#44;74&#41;&#59; valdecoxib 10<span class="elsevierStyleHsp" style=""></span>mg&#44; HR &#61; 0&#44;69 &#40;IC del 95&#37;&#44; 0&#44;53-0&#44;90&#41;&#59; valdecoxib 20<span class="elsevierStyleHsp" style=""></span>mg&#44; HR &#61; 0&#44;43 &#40;IC del 95&#37;&#44; 0&#44;32-0&#44;60&#41;&#59; valdecoxib 40<span class="elsevierStyleHsp" style=""></span>mg&#44; HR &#61; 0&#44;73 &#40;IC del 95&#37;&#44; 0&#44;49-1&#44;08&#41;&#59; placebo&#44; HR &#61; 0&#44;63 &#40;IC del 95&#37;&#44; 0&#44;47-0&#44;83&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Fries et al<a class="elsevierStyleCrossRef" href="#bb0115"><span class="elsevierStyleSup">23</span></a> &#40;1991&#41;&#44; cohorte prospectiva&#44; seguimiento medio 4 a&#241;os&#46; Calidad 2a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#46;747 AR &#40;76&#44;7&#37; mujeres&#44; media de edad 60 a&#241;os&#44; duraci&#243;n media de enfermedad 17 a&#241;os&#41;&#46; AINE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Seguridad&#58; <span class="elsevierStyleItalic">a&#41;</span> riesgo de hospitalizaci&#243;n&#47;muerte por evento adverso gastrointestinal&#58; &#62; 45 a&#241;os&#44; OR &#61; 7 &#40;2&#44;21-22&#44;4&#41;&#59; &#62; 50 a&#241;os&#44; OR &#61; 4&#44;4 &#40;2&#44;01-9&#44;52&#41;&#59; &#62; 60 a&#241;os&#44; OR &#61; 2&#44;7 &#40;1&#44;70-4&#44;30&#41;&#59; &#62; 65 a&#241;os&#44; OR &#61; 2&#44;4 &#40;1&#44;56-3&#44;55&#41;&#59; &#62; 70 a&#241;os&#44; OR &#61; 2 &#40;1&#44;30-3&#44;08&#41;&#59; &#62; 75 a&#241;os&#44; OR &#61; 2&#44;2 &#40;1&#44;28-3&#44;85&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hawkey et al<a class="elsevierStyleCrossRefs" href="#bb0080"><span class="elsevierStyleSup">16&#44;17</span></a>&#44; EC a doble ciego&#44; <span class="elsevierStyleItalic">doble-dummy</span>&#44; multic&#233;ntrico&#44; seguimiento 52 semanas&#46; Jadad 4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3&#46;959 OA&#44; &#62; 65 a&#241;os &#40;76&#37; mujeres&#41;&#46; CI&#58; dolor articular moderado&#46; CE&#58; protectores g&#225;stricos&#44; ulcus 30 d&#237;as previos&#44; sangrado&#47;perforaci&#243;n&#47; obstrucci&#243;n intestinal&#46; Lumiracoxib 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 3&#46;980&#41;&#46; Naproxeno 1&#46;000<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 2&#46;098&#41;&#46; Ibuprofeno 2&#46;400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 1&#46;861&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Seguridad&#58; riesgo de ulcus gastroduodenal&#58; AINE&#44; HR &#61; 1&#44;79 &#40;1&#44;33-2&#44;42&#41;&#59; lumiracoxib&#44; HR &#61; 1&#44;26 &#40;0&#44;82-1&#44;95&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Kaarela et al<a class="elsevierStyleCrossRef" href="#bb0090"><span class="elsevierStyleSup">18</span></a>&#44; EC a doble ciego&#44; seguimiento 14 d&#237;as&#46; Jadad 4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">31 AR &#40;84&#37; mujeres&#41;&#44; 18 &#62; 65 a&#241;os&#46; Indometacina 150<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 14 d&#237;as&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Eficacia&#58; mejor&#237;a de la rigidez matutina &#40;p &#61; 0&#44;001&#41;&#44; sin diferencias en comparaci&#243;n con los j&#243;venes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Koch et al<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a>&#44; EC a doble ciego controlado con placebo&#44; seguimiento 6 meses&#46; Jadad 4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8&#46;840 AR &#40;mujeres&#44; media de edad 68 a&#241;os&#41;&#46; CI&#58; &#62; 52 a&#241;os&#44; tomar AINE para 6 meses&#46; CE&#58; ulcus p&#233;ptico 30 d&#237;as antes&#44; otras enfermedades digestivas graves&#44; di&#225;tesis hemorr&#225;gica&#46; AINE &#43; misoprostol 6 meses n &#61; 4&#46;404&#41;&#46; AINE &#43; placebo 6 meses &#40;n &#61; 4&#46;404&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Seguridad&#58; riesgo de complicaci&#243;n gastrointestinal &#40;ulcus&#44; hemorragia&#44; obstrucci&#243;n&#41; &#62; 65 a&#241;os&#46; Grupo misoprostol&#44; RR &#61; 0&#44;70&#59; placebo&#44; RR &#61; 1&#44;16 &#40;reducci&#243;n del riesgo del 40&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Le Loet<a class="elsevierStyleCrossRef" href="#bb0120"><span class="elsevierStyleSup">24</span></a>&#44; cohorte prospectiva&#44; multic&#233;ntrica&#44; seguimiento 4 semanas&#46; Calidad 2a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">19&#46;880 pacientes &#62; 60 a&#241;os &#40;media&#44; 72 a&#241;os&#41;&#44; 66&#37; mujeres con enfermedad reum&#225;tica &#40;93&#37; enfermedad degenerativa&#41;&#46; CE&#58; contraindicaci&#243;n del uso de AINE&#44; enfermadad hep&#225;tica&#44; renal o hem&#225;tica severa&#46; Ketoprofeno 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 4 semanas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Eficacia&#58; <span class="elsevierStyleItalic">a&#41;</span> VGM buena&#47;excelente&#44; 74&#44;4&#37;&#59; <span class="elsevierStyleItalic">b&#41;</span> tolerabilidad seg&#250;n paciente buena&#47;excelente&#44; 85&#37;&#46; Seguridad&#58; <span class="elsevierStyleItalic">a&#41;</span> eventos adversos&#58; ketoprofeno&#44; 15&#44;3&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Lisse et al<a class="elsevierStyleCrossRef" href="#bb0055"><span class="elsevierStyleSup">11</span></a>&#44; metaan&#225;lisis&#44; 3 EC &#40;Jadad 3-4&#41;&#44; seguimiento 12 semanas&#46; Calidad 1b&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">786 OA de cadera o rodilla&#44; &#62; 70 a&#241;os&#44; 68&#37; mujeres&#46; Celecoxib 200<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 12 semanas &#40;n &#61; 191&#41;&#46; Celecoxib 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 183&#41;&#46; Naproxeno 1&#46;000<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 12 semanas &#40;n &#61; 206&#41;&#46; Placebo 12 semanas &#40;n &#61; 188&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Eficacia&#58; comparado con placebo los 3 AINE mejoraron m&#225;s el WOMAC &#40;p &#60; 0&#44;001&#41; y el SF-36 &#40;p &#60; 0&#44;010&#41;&#46; No hubo diferencias entre los 3 AINE&#46; Seguridad&#58; <span class="elsevierStyleItalic">a&#41;</span> al menos un evento adverso grave&#58; celecoxib 200<span class="elsevierStyleHsp" style=""></span>mg &#40;n &#61; 7&#41;&#44; celecoxib 400 &#40;n &#61; 9&#41;&#44; naproxeno 1&#46;000<span class="elsevierStyleHsp" style=""></span>mg &#40;n &#61; 4&#41;&#44; placebo &#40;n &#61; 8&#41; &#40;p &#62; 0&#44;050&#41;&#59; <span class="elsevierStyleItalic">b&#41;</span> evento adverso gastrointestinal&#58; celecoxib 200<span class="elsevierStyleHsp" style=""></span>mg &#40;n &#61; 49&#41;&#44; celecoxib 400<span class="elsevierStyleHsp" style=""></span>mg &#40;n &#61; 37&#41;&#44; naproxeno &#40;n &#61; 62&#41;&#44; placebo &#40;n &#61; 32&#41;&#46; Mayor en naproxeno comparado con placebo y celecoxib 200<span class="elsevierStyleHsp" style=""></span>mg&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Regula et al<a class="elsevierStyleCrossRef" href="#bb0100"><span class="elsevierStyleSup">20</span></a> &#40;2006&#41;&#44; EC a doble ciego&#44; seguimiento 6 meses&#46; Jadad&#58; 4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">595 AR&#44; OA&#44; espondilosis&#44; espondilitis &#40;71&#37; mujeres&#44; media de edad 66 a&#241;os&#41;&#46; CI&#58; &#8805; 1 factor de riesgo de toxicidad gastrointestinal&#46; CE&#58; ulcus activo&#47;complicado&#44; cirug&#237;a digestiva&#44; bridas esof&#225;gicas&#44; Zollinger-Ellison&#44; enfermedad grave&#46; AINE &#43; pantoprazol 20<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 6 meses &#40;n &#61; 196&#41;&#46; AINE &#43; pantoprazol 40<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 6 meses &#40;n &#61; 199&#41;&#46; AINE &#43; omeprazol 20<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 6 meses &#40;n &#61; 200&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Seguridad&#58; ulcus p&#233;ptico&#58; pantoprazol 20<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 7&#41;&#44; pantoprazol 40<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 3&#41;&#44; omeprazol 20<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 4&#41; &#40;p &#62; 0&#44;050&#41;&#59; sin diferencias&#58; s&#237;ntomas gastrointestinales&#44; esofagitis por reflujo&#44; 10 o m&#225;s erosiones o petequias&#44; eventos adversos graves&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Schiff et al<a class="elsevierStyleCrossRef" href="#bb0060"><span class="elsevierStyleSup">12</span></a>&#44; metaan&#225;lisis de 2 EC &#40;Jadad 4&#41;&#44; Seguimiento 1 semana&#46; Calidad 1b&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">198 OA de rodilla&#44; &#62; 65 a&#241;os&#44; 62&#37; mujeres&#46; CI&#58; OA activa con dolor al menos moderado&#46; CE&#58; protectores g&#225;stricos&#44; otras enfermedades reumatol&#243;gicas&#44; historia de ulcus p&#233;ptico en 9 meses previos&#44; cirug&#237;a digestiva&#44; trastornos en la absorci&#243;n&#46; Naproxeno 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 1 semana &#40;n &#61; 66&#41;&#46; Ibuprofeno 1&#46;200<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 1 semana &#40;n &#61; 66&#41;&#46; Placebo 1 semana &#40;n &#61; 66&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Eficacia&#58; naproxeno e ibuprofeno mejores que placebo en&#58; dolor en reposo&#44; movimientos pasivos nocturnos&#44; rigidez matutina&#44; tiempo en caminar 20<span class="elsevierStyleHsp" style=""></span>m &#40;p &#60; 0&#44;050&#41;&#44; dolor diario &#40;p &#60; 0&#44;010&#41;&#44; a la carga &#40;p &#61; 0&#44;064&#41;&#46; Seguridad&#58; <span class="elsevierStyleItalic">a&#41;</span> cualquier evento adverso&#58; naproxeno 440<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 14&#41;&#44; ibuprofeno 1&#46;200<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 14&#41;&#44; placebo &#40;n &#61; 17&#41; &#40;p &#61; 0&#44;538&#41;&#59; <span class="elsevierStyleItalic">b&#41;</span> eventos adversos graves&#58; naproxeno 440<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 3&#41;&#44; ibuprofeno 1&#46;200<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 4&#41;&#44; placebo &#40;n &#61; 8&#41; &#40;p &#61; 0&#44;115&#41;&#59; <span class="elsevierStyleItalic">c&#41;</span> evento adverso gastrointestinal&#58; naproxeno 440<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 11&#41;&#44; ibuprofeno 1&#46;200<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 10&#41;&#44; placebo &#40;n &#61; 9&#41; &#40;p &#61; 0&#44;627&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Silverstein et al<a class="elsevierStyleCrossRef" href="#bb0105"><span class="elsevierStyleSup">21</span></a>&#44; EC a doble ciego&#44; controlado con placebo&#44; seguimiento 6 meses&#46; Jadad 4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8&#46;840 AR &#40;mujeres&#44; media de edad 68 a&#241;os&#41;&#46; CI&#58; &#62; 52 a&#241;os&#44; tomar AINE para 6 meses&#46; CE&#58; ulcus 30 d&#237;as previos&#44; enfermedades digestivas graves&#44; protectores g&#225;stricos&#44; di&#225;tesis hemorr&#225;gica&#46; AINE &#43; misoprostol 6 meses &#40;n &#61; 4&#46;404&#41;&#46; AINE &#43; placebo 6 meses &#40;n &#61; 4&#46;404&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Seguridad&#58; asociaci&#243;n &#40;ajustada&#41; a complicaci&#243;n gastrointestinal &#40;&#250;lcera&#44; hemorragia&#44; obstrucci&#243;n&#41; en &#62; 75 a&#241;os en la cohorte &#40;OR &#61; 2&#44;48&#59; IC del 95&#37;&#44; 1&#44;48-4&#44;14&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Whelton et al<a class="elsevierStyleCrossRef" href="#bb0110"><span class="elsevierStyleSup">22</span></a>&#44; EC a doble ciego&#44; seguimiento 6 semanas&#46; Jadad 5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;092 OA &#40;62&#37; mujeres&#44; media de edad 73 a&#241;os&#41;&#46; CI&#58; &#62; 65 a&#241;os&#44; OA clase funcional I-III&#44; HTA estable con dosis fija de antihipertensivos en 3 meses previos&#44; beneficio del uso de AINE&#46; CE&#58; protectores g&#225;stricos&#44; enfermedades severas&#46; Celecoxib 200<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 6 semanas &#40;n &#61; 543&#41;&#46; Rofecoxib 25<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 6 semanas &#40;n &#61; 549&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Seguridad&#58; <span class="elsevierStyleItalic">a&#41;</span> &#8593; en PAS &#62; 20 y PAS &#62; 140<span class="elsevierStyleHsp" style=""></span>mmHg&#58; celecoxib &#40;n &#61; 38&#41;&#44; rofecoxib &#40;n &#61; 81&#41; &#40;p &#60; 0&#44;001&#41;&#59; <span class="elsevierStyleItalic">b&#41;</span> &#8593; en PAD &#62; 15 y PAD &#62; 90<span class="elsevierStyleHsp" style=""></span>mmHg&#58; celecoxib &#40;n &#61; 7&#41;&#44; rofecoxib &#40;n &#61; 12&#41; &#40;p &#61; 0&#44;257&#41;&#59; <span class="elsevierStyleItalic">c&#41;</span> edema cl&#237;nicamente significativo&#58; celecoxib &#40;n &#61; 26&#41;&#44; rofecoxib &#40;n &#61; 42&#41; &#40;p &#61; 0&#44;045&#41;&#59; <span class="elsevierStyleItalic">d&#41;</span> insuficiencia card&#237;aca congestiva &#40;primer episodio&#41;&#58; celecoxib &#40;n &#61; 2&#41;&#44; rofecoxib &#40;n &#61; 3&#41; &#40;p &#61; 0&#44;663&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab211961.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="sp0020" class="elsevierStyleSimplePara elsevierViewall">Caracter&#237;sticas de los estudios incluidos</p>"
        ]
      ]
      4 => array:7 [
        "identificador" => "t0020"
        "etiqueta" => "Tabla 4"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Causas de exclusi&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Admani et al<a class="elsevierStyleCrossRef" href="#bb0130"><span class="elsevierStyleSup">26</span></a> &#40;1983&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Ahern et al<a class="elsevierStyleCrossRef" href="#bb0135"><span class="elsevierStyleSup">27</span></a> &#40;1992&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Arone<a class="elsevierStyleCrossRef" href="#bb0140"><span class="elsevierStyleSup">28</span></a> &#40;1989&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Bacon<a class="elsevierStyleCrossRef" href="#bb0145"><span class="elsevierStyleSup">29</span></a> &#40;1994&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Bauer et al<a class="elsevierStyleCrossRef" href="#bb0150"><span class="elsevierStyleSup">30</span></a> &#40;1996&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Blardi et al<a class="elsevierStyleCrossRef" href="#bb0155"><span class="elsevierStyleSup">31</span></a> &#40;1992&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Browning et al<a class="elsevierStyleCrossRef" href="#bb0160"><span class="elsevierStyleSup">32</span></a> &#40;1994&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Busson<a class="elsevierStyleCrossRef" href="#bb0165"><span class="elsevierStyleSup">33</span></a> &#40;1986a&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Busson<a class="elsevierStyleCrossRef" href="#bb0170"><span class="elsevierStyleSup">34</span></a> &#40;1986b&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Calin<a class="elsevierStyleCrossRef" href="#bb0175"><span class="elsevierStyleSup">35</span></a> &#40;1993&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Caughey et al<a class="elsevierStyleCrossRef" href="#bb0180"><span class="elsevierStyleSup">36</span></a> &#40;1989&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Cordaro et al<a class="elsevierStyleCrossRef" href="#bb0185"><span class="elsevierStyleSup">37</span></a> &#40;1988&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No hay datos de pacientes mayores de 60 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Cummings et al<a class="elsevierStyleCrossRef" href="#bb0190"><span class="elsevierStyleSup">38</span></a> &#40;1988&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Currie et al<a class="elsevierStyleCrossRef" href="#bb0195"><span class="elsevierStyleSup">39</span></a> &#40;1984&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Davis et al<a class="elsevierStyleCrossRef" href="#bb0200"><span class="elsevierStyleSup">40</span></a> &#40;1987&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Dominick et al<a class="elsevierStyleCrossRef" href="#bb0205"><span class="elsevierStyleSup">41</span></a> &#40;2003&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No relacionado con la pregunta de investigaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Dreiser et al<a class="elsevierStyleCrossRef" href="#bb0210"><span class="elsevierStyleSup">42</span></a> &#40;1993&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Famaey et al<a class="elsevierStyleCrossRef" href="#bb0215"><span class="elsevierStyleSup">43</span></a> &#40;1976&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Fossaluzza et al<a class="elsevierStyleCrossRef" href="#bb0220"><span class="elsevierStyleSup">44</span></a> &#40;1989&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Fries<a class="elsevierStyleCrossRef" href="#bb0225"><span class="elsevierStyleSup">45</span></a> &#40;1992&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No hace un an&#225;lisis estrictamente de mayores de 60 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Fries et al<a class="elsevierStyleCrossRef" href="#bb0230"><span class="elsevierStyleSup">46</span></a> &#40;2004&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No relacionado con la pregunta de investigaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Fullerton et al<a class="elsevierStyleCrossRef" href="#bb0235"><span class="elsevierStyleSup">47</span></a> &#40;1993&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Gabriel et al<a class="elsevierStyleCrossRef" href="#bb0240"><span class="elsevierStyleSup">48</span></a> &#40;1997&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Geczy et al<a class="elsevierStyleCrossRef" href="#bb0245"><span class="elsevierStyleSup">49</span></a> &#40;1987&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Girawan et al<a class="elsevierStyleCrossRef" href="#bb0250"><span class="elsevierStyleSup">50</span></a> &#40;2004&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Goldstein et al<a class="elsevierStyleCrossRef" href="#bb0015"><span class="elsevierStyleSup">3</span></a> &#40;2003&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Sujetos sanos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Grace et al<a class="elsevierStyleCrossRef" href="#bb0255"><span class="elsevierStyleSup">51</span></a> &#40;1987&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Grigor et al<a class="elsevierStyleCrossRef" href="#bb0260"><span class="elsevierStyleSup">52</span></a> &#40;1987&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No se sabe si el AAS se utiliza a dosis de antiagregante&#44; analg&#233;sico o antiinflamatorio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Halici et al<a class="elsevierStyleCrossRef" href="#bb0265"><span class="elsevierStyleSup">53</span></a> &#40;2002&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hart et al<a class="elsevierStyleCrossRef" href="#bb0270"><span class="elsevierStyleSup">54</span></a> &#40;1965&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hart et al<a class="elsevierStyleCrossRef" href="#bb0275"><span class="elsevierStyleSup">55</span></a> &#40;1983&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hawkey et al<a class="elsevierStyleCrossRef" href="#bb0280"><span class="elsevierStyleSup">56</span></a> &#40;2001&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No aporta datos suficientes de mayores de 60 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Henry et al<a class="elsevierStyleCrossRef" href="#bb0285"><span class="elsevierStyleSup">57</span></a> &#40;1997&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hochain et al<a class="elsevierStyleCrossRef" href="#bb0290"><span class="elsevierStyleSup">58</span></a> &#40;1995&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Horackova et al<a class="elsevierStyleCrossRef" href="#bb0295"><span class="elsevierStyleSup">59</span></a> &#40;2005&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Innes<a class="elsevierStyleCrossRef" href="#bb0300"><span class="elsevierStyleSup">60</span></a> &#40;1977&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Jackson et al<a class="elsevierStyleCrossRef" href="#bb0305"><span class="elsevierStyleSup">61</span></a> &#40;1987&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No aporta datos concretos en mayores de 60 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Janke et al<a class="elsevierStyleCrossRef" href="#bb0310"><span class="elsevierStyleSup">62</span></a> &#40;1984&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Johnson et al<a class="elsevierStyleCrossRef" href="#bb0315"><span class="elsevierStyleSup">63</span></a> &#40;1993&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Laine et al<a class="elsevierStyleCrossRef" href="#bb0320"><span class="elsevierStyleSup">64</span></a> &#40;2002&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Lai et al<a class="elsevierStyleCrossRef" href="#bb0325"><span class="elsevierStyleSup">65</span></a> &#40;2005&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Lane et al<a class="elsevierStyleCrossRef" href="#bb0330"><span class="elsevierStyleSup">66</span></a> &#40;1997&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Layton et al<a class="elsevierStyleCrossRef" href="#bb0335"><span class="elsevierStyleSup">67</span></a> &#40;2003&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Le Loet et al<a class="elsevierStyleCrossRef" href="#bb0340"><span class="elsevierStyleSup">68</span></a> &#40;1997&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Littman et al<a class="elsevierStyleCrossRef" href="#bb0345"><span class="elsevierStyleSup">69</span></a> &#40;1995&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Mamdani et al<a class="elsevierStyleCrossRef" href="#bb0350"><span class="elsevierStyleSup">70</span></a> &#40;2002&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Mann et al<a class="elsevierStyleCrossRef" href="#bb0355"><span class="elsevierStyleSup">71</span></a> &#40;2004&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">La poblaci&#243;n de estudio es general&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">McNeil<a class="elsevierStyleCrossRef" href="#bb0360"><span class="elsevierStyleSup">72</span></a> &#40;1993&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Meurice<a class="elsevierStyleCrossRef" href="#bb0365"><span class="elsevierStyleSup">73</span></a> &#40;1983&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Montrone et al<a class="elsevierStyleCrossRef" href="#bb0370"><span class="elsevierStyleSup">74</span></a> &#40;1990&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Morgan et al<a class="elsevierStyleCrossRef" href="#bb0375"><span class="elsevierStyleSup">75</span></a> &#40;1993&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Morgan et al<a class="elsevierStyleCrossRef" href="#bb0010"><span class="elsevierStyleSup">2</span></a> &#40;2001&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Morton et al<a class="elsevierStyleCrossRef" href="#bb0380"><span class="elsevierStyleSup">76</span></a> &#40;1998&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No hay datos concretos de pacientes mayores de 60 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Motsko et al<a class="elsevierStyleCrossRef" href="#bb0385"><span class="elsevierStyleSup">77</span></a> &#40;2006&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&#46; Poblaci&#243;n general&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Nesher et al<a class="elsevierStyleCrossRef" href="#bb0390"><span class="elsevierStyleSup">78</span></a> &#40;1995&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Niccoli et al<a class="elsevierStyleCrossRef" href="#bb0035"><span class="elsevierStyleSup">7</span></a> &#40;2002&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Nietert et al<a class="elsevierStyleCrossRef" href="#bb0395"><span class="elsevierStyleSup">79</span></a> &#40;2003&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">O&#39;Brien<a class="elsevierStyleCrossRef" href="#bb0400"><span class="elsevierStyleSup">80</span></a> &#40;1983&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Perpignano et al<a class="elsevierStyleCrossRef" href="#bb0405"><span class="elsevierStyleSup">81</span></a> &#40;1994&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Puccetti et al<a class="elsevierStyleCrossRef" href="#bb0410"><span class="elsevierStyleSup">82</span></a> &#40;1991&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Rabenda et al<a class="elsevierStyleCrossRef" href="#bb0415"><span class="elsevierStyleSup">83</span></a> &#40;2005&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">La poblaci&#243;n de estudio es general&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Rabenda et al<a class="elsevierStyleCrossRef" href="#bb0420"><span class="elsevierStyleSup">84</span></a> &#40;2006&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No hay datos concretos de pacientes mayores de 60 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Rahme et al<a class="elsevierStyleCrossRef" href="#bb0425"><span class="elsevierStyleSup">85</span></a> &#40;2002&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Rahme et al<a class="elsevierStyleCrossRef" href="#bb0430"><span class="elsevierStyleSup">86</span></a> &#40;2007a&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Rahme et al<a class="elsevierStyleCrossRef" href="#bb0435"><span class="elsevierStyleSup">87</span></a> &#40;2007b&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Roth et al<a class="elsevierStyleCrossRef" href="#bb0440"><span class="elsevierStyleSup">88</span></a> &#40;1993&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Roth et al<a class="elsevierStyleCrossRef" href="#bb0445"><span class="elsevierStyleSup">89</span></a> &#40;1995&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Scharf et al<a class="elsevierStyleCrossRef" href="#bb0450"><span class="elsevierStyleSup">90</span></a> &#40;1998&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Schattenkirchner<a class="elsevierStyleCrossRef" href="#bb0455"><span class="elsevierStyleSup">91</span></a> &#40;1991&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Schattenkirchner<a class="elsevierStyleCrossRef" href="#bb0460"><span class="elsevierStyleSup">92</span></a> &#40;1993&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Sheldon et al<a class="elsevierStyleCrossRef" href="#bb0465"><span class="elsevierStyleSup">93</span></a> &#40;2005&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No hay datos concretos de pacientes mayores de 60 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Sheridan et al<a class="elsevierStyleCrossRef" href="#bb0470"><span class="elsevierStyleSup">94</span></a> &#40;2005&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Smalley et al<a class="elsevierStyleCrossRef" href="#bb0475"><span class="elsevierStyleSup">95</span></a> &#40;1995&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&#46;Poblaci&#243;n general&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Sontag et al<a class="elsevierStyleCrossRef" href="#bb0480"><span class="elsevierStyleSup">96</span></a> &#40;1994&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No hace un an&#225;lisis estrictamente de mayores de 60 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Stewart et al<a class="elsevierStyleCrossRef" href="#bb0485"><span class="elsevierStyleSup">97</span></a> &#40;1988&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Theiler et al<a class="elsevierStyleCrossRef" href="#bb0490"><span class="elsevierStyleSup">98</span></a> &#40;2002&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Todesco et al<a class="elsevierStyleCrossRef" href="#bb0495"><span class="elsevierStyleSup">99</span></a> &#40;1994&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Truitt et al<a class="elsevierStyleCrossRef" href="#bb0500"><span class="elsevierStyleSup">100</span></a> &#40;2001&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Vetter<a class="elsevierStyleCrossRef" href="#bb0505"><span class="elsevierStyleSup">101</span></a> &#40;1985&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Vonkeman et al<a class="elsevierStyleCrossRef" href="#bb0510"><span class="elsevierStyleSup">102</span></a> &#40;2007&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Whelton et al<a class="elsevierStyleCrossRef" href="#bb0515"><span class="elsevierStyleSup">103</span></a> &#40;2006&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No hace un an&#225;lisis estrictamente de mayores de 60 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Williams<a class="elsevierStyleCrossRef" href="#bb0520"><span class="elsevierStyleSup">104</span></a> &#40;1985&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Williams et al<a class="elsevierStyleCrossRef" href="#bb0525"><span class="elsevierStyleSup">105</span></a> &#40;1989&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Yajima et al<a class="elsevierStyleCrossRef" href="#bb0530"><span class="elsevierStyleSup">106</span></a> &#40;2007&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab211962.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="sp0030" class="elsevierStyleSimplePara elsevierViewall">Estudios excluidos y causas de exclusi&#243;n</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bs0005"
          "bibliografiaReferencia" => array:106 [
            0 => array:3 [
              "identificador" => "bb0005"
              "etiqueta" => "1&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs&#46; A meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [ …3]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Intern Med"
                        "fecha" => "1991"
                        "volumen" => "115"
                        "paginaInicial" => "787"
                        "paginaFinal" => "796"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bb0010"
              "etiqueta" => "2&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment of elderly patients with nabumetone or diclofenac&#58; gastrointestinal safety profile"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Gastroenterol"
                        "fecha" => "2001"
                        "volumen" => "32"
                        "paginaInicial" => "310"
                        "paginaFinal" => "314"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bb0015"
              "etiqueta" => "3&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A comparison of the upper gastrointestinal mucosal effects of valdecoxib&#44; naproxen and placebo in healthy elderly subjects"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Aliment Pharmacol Ther"
                        "fecha" => "2003"
                        "volumen" => "18"
                        "paginaInicial" => "125"
                        "paginaFinal" => "132"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bb0020"
              "etiqueta" => "4&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2165/00003088-198712020-00002"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Pharmacokinet"
                        "fecha" => "1987"
                        "volumen" => "12"
                        "paginaInicial" => "111"
                        "paginaFinal" => "122"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bb0025"
              "etiqueta" => "5&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Renal complications of nonsteroidal anti-inflammatory drugs"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Kidney Int"
                        "fecha" => "1993"
                        "volumen" => "44"
                        "paginaInicial" => "643"
                        "paginaFinal" => "653"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bb0030"
              "etiqueta" => "6&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Consumption of NSAIDs and the development of congestive heart failure in elderly patients&#58; an underrecognized public health problem"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Intern Med"
                        "fecha" => "2000"
                        "volumen" => "160"
                        "paginaInicial" => "777"
                        "paginaFinal" => "784"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bb0035"
              "etiqueta" => "7&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Renal tolerability of three commonly employed non-steroidal anti-inflammatory drugs in elderly patients with osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [ …3]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Exp Rheumatol"
                        "fecha" => "2002"
                        "volumen" => "20"
                        "paginaInicial" => "201"
                        "paginaFinal" => "207"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bb0040"
              "etiqueta" => "8&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Assessing the quality of reports of randomized clinical trials&#58; is blinding necessary"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Control Clin Trials"
                        "fecha" => "1996"
                        "volumen" => "17"
                        "paginaInicial" => "1"
                        "paginaFinal" => "12"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bb0045"
              "etiqueta" => "9&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Rofecoxib shows consistent efficacy in osteoarthritis clinical trials&#44; regardless of specific patient demographic and disease factors"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [ …5]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Rheumatol"
                        "fecha" => "2001"
                        "volumen" => "28"
                        "paginaInicial" => "2494"
                        "paginaFinal" => "2503"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bb0050"
              "etiqueta" => "10&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Meta-analysis&#58; upper gastrointestinal tolerability of valdecoxib&#44; a cyclooxygenase-2-specific inhibitor&#44; compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1365-2036.2005.02383.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Aliment Pharmacol Ther"
                        "fecha" => "2005"
                        "volumen" => "21"
                        "paginaInicial" => "591"
                        "paginaFinal" => "598"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bb0055"
              "etiqueta" => "11&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Functional status and health-related quality of life of elderly osteoarthritic patients treated with celecoxib"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [ …5]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Gerontol A Biol Sci Med Sci"
                        "fecha" => "2001"
                        "volumen" => "56"
                        "paginaInicial" => "M167"
                        "paginaFinal" => "M175"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bb0060"
              "etiqueta" => "12&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Comparison of the analgesic efficacy and safety of nonprescription doses of naproxen sodium and Ibuprofen in the treatment of osteoarthritis of the knee"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Rheumatol"
                        "fecha" => "2004"
                        "volumen" => "31"
                        "paginaInicial" => "1373"
                        "paginaFinal" => "1383"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bb0065"
              "etiqueta" => "13&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and tolerability of diclofenac dispersible in elderly patients with osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1185/03007999109111517"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Med Res Opin"
                        "fecha" => "1991"
                        "volumen" => "12"
                        "paginaInicial" => "459"
                        "paginaFinal" => "465"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bb0070"
              "etiqueta" => "14&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients&#58; results of a randomized double-blind trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Gastroenterology"
                        "fecha" => "2004"
                        "volumen" => "127"
                        "paginaInicial" => "1038"
                        "paginaFinal" => "1043"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bb0075"
              "etiqueta" => "15&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A double-masked comparison of the efficacy of once-daily sustained-release ibuprofen and once-daily piroxicam for 24-hour control of arthralgia due to osteoarthritis in the elderly"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [ …3]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Curr Ther Res Clin Exp"
                        "fecha" => "1996"
                        "volumen" => "57"
                        "paginaInicial" => "811"
                        "paginaFinal" => "821"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bb0080"
              "etiqueta" => "16&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effect of risk factors on complicated and uncomplicated ulcers in the TARGET lumiracoxib outcomes study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1053/j.gastro.2007.04.045"
                      "Revista" => array:6 [
                        "tituloSerie" => "Gastroenterology"
                        "fecha" => "2007"
                        "volumen" => "133"
                        "paginaInicial" => "57"
                        "paginaFinal" => "64"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bb0085"
              "etiqueta" => "17&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Therapeutic arthritis research and gastrointestinal event trial of lumiracoxib &#8211; study design and patient demographics"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1365-2036.2004.02026.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Aliment Pharmacol Ther"
                        "fecha" => "2004"
                        "volumen" => "20"
                        "paginaInicial" => "51"
                        "paginaFinal" => "63"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bb0090"
              "etiqueta" => "18&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The effect of different indomethacin formulations in young and elderly patients&#58; a comparative controlled clinical trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1185/03007998909115929"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Med Res Opin"
                        "fecha" => "1989"
                        "volumen" => "11"
                        "paginaInicial" => "427"
                        "paginaFinal" => "431"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bb0095"
              "etiqueta" => "19&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal mucosal injury&#58; risk factors for serious complications"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Dig Liver Dis"
                        "fecha" => "2000"
                        "volumen" => "32"
                        "paginaInicial" => "138"
                        "paginaFinal" => "151"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bb0100"
              "etiqueta" => "20&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevention of nsaid-associated gastrointestinal lesions&#58; a comparison study pantoprazole versus omeprazole"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1572-0241.2006.00686.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Gastroenterol"
                        "fecha" => "2006"
                        "volumen" => "101"
                        "paginaInicial" => "1747"
                        "paginaFinal" => "1755"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bb0105"
              "etiqueta" => "21&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs&#46; A randomized&#44; double-blind&#44; placebo-controlled trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Intern Med"
                        "fecha" => "1995"
                        "volumen" => "123"
                        "paginaInicial" => "241"
                        "paginaFinal" => "249"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bb0110"
              "etiqueta" => "22&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "SUCCESS-VII Investigators Effects of celecoxib and rofecoxib on blood pressure and edema in patients &#62; or &#61;65 years of age with systemic hypertension and osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [ …5]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Cardiol"
                        "fecha" => "2002"
                        "volumen" => "90"
                        "paginaInicial" => "959"
                        "paginaFinal" => "963"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bb0115"
              "etiqueta" => "23&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Nonsteroidal anti-inflammatory drug-associated gastropathy&#58; incidence and risk factor models"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Med"
                        "fecha" => "1991"
                        "volumen" => "91"
                        "paginaInicial" => "213"
                        "paginaFinal" => "222"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bb0120"
              "etiqueta" => "24&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety of ketoprofen in the elderly&#58; a prospective study on 20&#44;000 patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Scand J Rheumatol Suppl"
                        "fecha" => "1989"
                        "volumen" => "83"
                        "paginaInicial" => "21"
                        "paginaFinal" => "27"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bb0125"
              "etiqueta" => "25&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [ …5]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Ther"
                        "fecha" => "1999"
                        "volumen" => "21"
                        "paginaInicial" => "992"
                        "paginaFinal" => "1003"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bb0130"
              "etiqueta" => "26&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A study of sulindac versus ibuprofen in elderly patients with osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1185/03007998309112390"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Med Res Opin"
                        "fecha" => "1983"
                        "volumen" => "8"
                        "paginaInicial" => "315"
                        "paginaFinal" => "320"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bb0135"
              "etiqueta" => "27&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A comparison of ketoprofen SR and sulindac in the elderly with rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Clin Pract"
                        "fecha" => "1992"
                        "volumen" => "46"
                        "paginaInicial" => "229"
                        "paginaFinal" => "233"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bb0140"
              "etiqueta" => "28&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Long term study of ketoprofen sr in elderly patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Scand J Rheumatol Suppl"
                        "fecha" => "1989"
                        "volumen" => "83"
                        "paginaInicial" => "15"
                        "paginaFinal" => "19"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bb0145"
              "etiqueta" => "29&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety profile of etodolac in the elderly population"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur J Rheumatol Inflamm"
                        "fecha" => "1994"
                        "volumen" => "14"
                        "paginaInicial" => "19"
                        "paginaFinal" => "22"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            29 => array:3 [
              "identificador" => "bb0150"
              "etiqueta" => "30&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Aspirin and nsaid use in older women&#58; effect on bone mineral density and fracture risk"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/jbmr.5650110106"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Bone Miner Res"
                        "fecha" => "1996"
                        "volumen" => "11"
                        "paginaInicial" => "29"
                        "paginaFinal" => "35"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            30 => array:3 [
              "identificador" => "bb0155"
              "etiqueta" => "31&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effectiveness and tolerability of nimesulide in the treatment of osteoarthritic elderly patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Tissue React"
                        "fecha" => "1992"
                        "volumen" => "14"
                        "paginaInicial" => "263"
                        "paginaFinal" => "268"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            31 => array:3 [
              "identificador" => "bb0160"
              "etiqueta" => "32&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Reducing the dose of oral NSAIDs by use of Feldene Gel&#58; an open study in elderly patients with osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Adv Ther"
                        "fecha" => "1994"
                        "volumen" => "11"
                        "paginaInicial" => "198"
                        "paginaFinal" => "207"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            32 => array:3 [
              "identificador" => "bb0165"
              "etiqueta" => "33&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A long-term study of flurbiprofen in rheumatological disorders&#58; I&#46; Rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Int Med Res"
                        "fecha" => "1986"
                        "volumen" => "14"
                        "paginaInicial" => "1"
                        "paginaFinal" => "6"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            33 => array:3 [
              "identificador" => "bb0170"
              "etiqueta" => "34&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A long-term study of flurbiprofen in rheumatological disorders&#58; II&#46; Osteoarthrosis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Int Med Res"
                        "fecha" => "1986"
                        "volumen" => "14"
                        "paginaInicial" => "13"
                        "paginaFinal" => "18"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            34 => array:3 [
              "identificador" => "bb0175"
              "etiqueta" => "35&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety profile of a sustained release formulation of etodolac in patients with rheumatoid arthritis and osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Adv Ther"
                        "fecha" => "1993"
                        "volumen" => "10"
                        "paginaInicial" => "1"
                        "paginaFinal" => "8"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            35 => array:3 [
              "identificador" => "bb0180"
              "etiqueta" => "36&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A study of the safety of tenoxicam in general practice"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "N Z Med J"
                        "fecha" => "1989"
                        "volumen" => "102"
                        "paginaInicial" => "582"
                        "paginaFinal" => "583"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            36 => array:3 [
              "identificador" => "bb0185"
              "etiqueta" => "37&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and tolerance of naproxen instant suspension formulation&#58; a post-marketing survey"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [ …3]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Int Med Res"
                        "fecha" => "1988"
                        "volumen" => "16"
                        "paginaInicial" => "157"
                        "paginaFinal" => "165"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            37 => array:3 [
              "identificador" => "bb0190"
              "etiqueta" => "38&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Office-based evaluation of renal function in elderly patients receiving nonsteroidal anti-inflammatory drugs"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Board Fam Pract"
                        "fecha" => "1988"
                        "volumen" => "1"
                        "paginaInicial" => "77"
                        "paginaFinal" => "80"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            38 => array:3 [
              "identificador" => "bb0195"
              "etiqueta" => "39&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Symptomatic osteoarthritis in the elderly&#58; multicentre comparative study of sulindac and ibuprofen"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Clin Pract"
                        "fecha" => "1984"
                        "volumen" => "38"
                        "paginaInicial" => "176"
                        "paginaFinal" => "181"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            39 => array:3 [
              "identificador" => "bb0200"
              "etiqueta" => "40&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Multicenter comparative study of tiaprofenic acid in the treatment of patients with rheumatic diseases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Curr Ther Res Clin Exp"
                        "fecha" => "1987"
                        "volumen" => "42"
                        "paginaInicial" => "916"
                        "paginaFinal" => "921"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            40 => array:3 [
              "identificador" => "bb0205"
              "etiqueta" => "41&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Gender differences in nsaid use among older adults with osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1345/aph.1C418"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Pharmacother"
                        "fecha" => "2003"
                        "volumen" => "37"
                        "paginaInicial" => "1566"
                        "paginaFinal" => "1571"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            41 => array:3 [
              "identificador" => "bb0210"
              "etiqueta" => "42&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Long term tolerability profile of nimesulide in the treatment of osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:7 [
                        "tituloSerie" => "Drugs"
                        "fecha" => "1993"
                        "volumen" => "46"
                        "numero" => "Suppl 1"
                        "paginaInicial" => "270"
                        "paginaFinal" => "274"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            42 => array:3 [
              "identificador" => "bb0215"
              "etiqueta" => "43&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A double-blind trial of ketoprofen in the treatment of osteoarthritis of the hip"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Scand J Rheumatol Suppl"
                        "fecha" => "1976"
                        "volumen" => "1976"
                        "paginaInicial" => "129"
                        "paginaFinal" => "132"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            43 => array:3 [
              "identificador" => "bb0220"
              "etiqueta" => "44&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and tolerability of nimesulide in elderly patients with osteoarthritis&#58; double-blind trial versus naproxen"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Int Med Res"
                        "fecha" => "1989"
                        "volumen" => "17"
                        "paginaInicial" => "295"
                        "paginaFinal" => "303"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            44 => array:3 [
              "identificador" => "bb0225"
              "etiqueta" => "45&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Assessing and understanding patient risk"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Scand J Rheumatol Suppl"
                        "fecha" => "1992"
                        "volumen" => "92"
                        "paginaInicial" => "21"
                        "paginaFinal" => "24"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            45 => array:3 [
              "identificador" => "bb0230"
              "etiqueta" => "46&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.20440"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2004"
                        "volumen" => "50"
                        "paginaInicial" => "2433"
                        "paginaFinal" => "2440"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            46 => array:3 [
              "identificador" => "bb0235"
              "etiqueta" => "47&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Evaluation of the renal protective effect of misoprostol in elderly&#44; osteoarthritic patients at risk for nonsteroidal anti-inflammatory drug-induced renal dysfunction"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Pharmacol"
                        "fecha" => "1993"
                        "volumen" => "33"
                        "paginaInicial" => "1225"
                        "paginaFinal" => "1232"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            47 => array:3 [
              "identificador" => "bb0240"
              "etiqueta" => "48&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/1529-0131(199710)40:10&lt;1873::AID-ART22&gt;3.0.CO;2-V"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "1997"
                        "volumen" => "40"
                        "paginaInicial" => "1873"
                        "paginaFinal" => "1878"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            48 => array:3 [
              "identificador" => "bb0245"
              "etiqueta" => "49&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Naproxen tolerability in the elderly&#58; a summary report"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Rheumatol"
                        "fecha" => "1987"
                        "volumen" => "14"
                        "paginaInicial" => "348"
                        "paginaFinal" => "354"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            49 => array:3 [
              "identificador" => "bb0250"
              "etiqueta" => "50&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Comparison of endoscopic gastric mucosa features after administration of piroxicam to meloxicam and their correlation with dyspepsia symptoms in elderly patient with knee osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Acta Med Indones"
                        "fecha" => "2004"
                        "volumen" => "36"
                        "paginaInicial" => "202"
                        "paginaFinal" => "206"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            50 => array:3 [
              "identificador" => "bb0255"
              "etiqueta" => "51&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The pharmacokinetics of isoxicam in elderly patients with rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1185/03007998709112411"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Med Res Opin"
                        "fecha" => "1987"
                        "volumen" => "10"
                        "paginaInicial" => "580"
                        "paginaFinal" => "591"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            51 => array:3 [
              "identificador" => "bb0260"
              "etiqueta" => "52&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Salicylate toxicity in elderly patients with rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Journal J Rheumatol"
                        "fecha" => "1987"
                        "volumen" => "14"
                        "paginaInicial" => "60"
                        "paginaFinal" => "66"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            52 => array:3 [
              "identificador" => "bb0265"
              "etiqueta" => "53&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Elderly patients with osteoarthritis&#58; treatment with nonselective&#44; nonsteroidial&#44; antiinflammatory drugs&#44; and the gastrointestinal consequences"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Gerontol Geriatr Suppl"
                        "fecha" => "2002"
                        "volumen" => "8"
                        "paginaInicial" => "165"
                        "paginaFinal" => "170"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            53 => array:3 [
              "identificador" => "bb0270"
              "etiqueta" => "54&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Indomethacin and phenylbutazone&#58; a comparison"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Br Med J"
                        "fecha" => "1965"
                        "volumen" => "2"
                        "paginaInicial" => "1281"
                        "paginaFinal" => "1284"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            54 => array:3 [
              "identificador" => "bb0275"
              "etiqueta" => "55&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "&#8216;Osmosin&#8217; &#40;sodium indomethacin trihydrate&#41; in the treatment of elderly patients with osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1185/03007998309109826"
                      "Revista" => array:7 [
                        "tituloSerie" => "Curr Med Res Opin"
                        "fecha" => "1983"
                        "volumen" => "8"
                        "numero" => "Suppl 2"
                        "paginaInicial" => "72"
                        "paginaFinal" => "82"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            55 => array:3 [
              "identificador" => "bb0280"
              "etiqueta" => "56&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Influence of risk factors on endoscopic and clinical ulcers in patients taking rofecoxib or ibuprofen in two randomized controlled trials"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Aliment Pharmacol Ther"
                        "fecha" => "2001"
                        "volumen" => "15"
                        "paginaInicial" => "1593"
                        "paginaFinal" => "1601"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            56 => array:3 [
              "identificador" => "bb0285"
              "etiqueta" => "57&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Consumption of non-steroidal anti-inflammatory drugs and the development of functional renal impairment in elderly subjects&#46; Results of a case-control study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Clin Pharmacol"
                        "fecha" => "1997"
                        "volumen" => "44"
                        "paginaInicial" => "85"
                        "paginaFinal" => "90"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            57 => array:3 [
              "identificador" => "bb0290"
              "etiqueta" => "58&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Which patients taking non-aspirin non-steroidal anti-inflammatory drugs bleed&#63; A case-control study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur J Gastroenterol Hepatol"
                        "fecha" => "1995"
                        "volumen" => "7"
                        "paginaInicial" => "419"
                        "paginaFinal" => "426"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            58 => array:3 [
              "identificador" => "bb0295"
              "etiqueta" => "59&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effect of rofecoxib on the glomerular filtration rate&#44; proteinuria and the renin-angiotensin-aldosterone system in elderly subjects with chronic renal impairment"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Clin Pharmacol Ther"
                        "fecha" => "2005"
                        "volumen" => "43"
                        "paginaInicial" => "413"
                        "paginaFinal" => "419"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            59 => array:3 [
              "identificador" => "bb0300"
              "etiqueta" => "60&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and tolerance of flurbiprofen in the elderly using liquid and tablet formulations"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1185/03007997709108988"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Med Res Opin"
                        "fecha" => "1977"
                        "volumen" => "5"
                        "paginaInicial" => "122"
                        "paginaFinal" => "126"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            60 => array:3 [
              "identificador" => "bb0305"
              "etiqueta" => "61&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety evaluation of nabumetone in United States clinical trials"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Med"
                        "fecha" => "1987"
                        "volumen" => "83"
                        "paginaInicial" => "115"
                        "paginaFinal" => "120"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            61 => array:3 [
              "identificador" => "bb0310"
              "etiqueta" => "62&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A multi-centre study of sulindac versus naproxen in the treatment of elderly osteoarthritic patients"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Pharmatherapeutica"
                        "fecha" => "1984"
                        "volumen" => "3"
                        "paginaInicial" => "663"
                        "paginaFinal" => "667"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            62 => array:3 [
              "identificador" => "bb0315"
              "etiqueta" => "63&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Nonsteroidal anti-inflammatory drugs and hypertension in the elderly&#58; a community-based cross-sectional study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Clin Pharmacol"
                        "fecha" => "1993"
                        "volumen" => "35"
                        "paginaInicial" => "455"
                        "paginaFinal" => "459"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            63 => array:3 [
              "identificador" => "bb0320"
              "etiqueta" => "64&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Stratifying the risk of NSAID-related upper gastrointestinal clinical events&#58; results of a double-blind outcomes study in patients with rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Gastroenterology"
                        "fecha" => "2002"
                        "volumen" => "123"
                        "paginaInicial" => "1006"
                        "paginaFinal" => "1012"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            64 => array:3 [
              "identificador" => "bb0325"
              "etiqueta" => "65&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.amjmed.2005.04.031"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Med"
                        "fecha" => "2005"
                        "volumen" => "118"
                        "paginaInicial" => "1271"
                        "paginaFinal" => "1278"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            65 => array:3 [
              "identificador" => "bb0330"
              "etiqueta" => "66&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Aspirin and nonsteroidal antiinflammatory drug use in elderly women&#58; effects on a marker of bone resorption"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Rheumatol"
                        "fecha" => "1997"
                        "volumen" => "24"
                        "paginaInicial" => "1132"
                        "paginaFinal" => "1136"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            66 => array:3 [
              "identificador" => "bb0335"
              "etiqueta" => "67&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety profile of rofecoxib as used in general practice in england&#58; results of a prescription-event monitoring study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Clin Pharmacol"
                        "fecha" => "2003"
                        "volumen" => "55"
                        "paginaInicial" => "166"
                        "paginaFinal" => "174"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            67 => array:3 [
              "identificador" => "bb0340"
              "etiqueta" => "68&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Therapeutic equivalence of diclofenac sustained-released 75 mg tablets and diclofenac enteric-coated 50 mg tablets in the treatment of painful osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Clin Pract"
                        "fecha" => "1997"
                        "volumen" => "51"
                        "paginaInicial" => "389"
                        "paginaFinal" => "393"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            68 => array:3 [
              "identificador" => "bb0345"
              "etiqueta" => "69&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Steroid sparing activity of tenidap in patients with polymyalgia rheumatica&#58; a multicenter double blind randomized placebo controlled study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Rheumatol"
                        "fecha" => "1995"
                        "volumen" => "22"
                        "paginaInicial" => "1097"
                        "paginaFinal" => "1103"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            69 => array:3 [
              "identificador" => "bb0350"
              "etiqueta" => "70&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "BMJ"
                        "fecha" => "2002"
                        "volumen" => "325"
                        "paginaInicial" => "624"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            70 => array:3 [
              "identificador" => "bb0355"
              "etiqueta" => "71&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Gastrointestinal-related complications in a longterm care population taking nsaids versus cox-2 inhibitor therapy"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Consult Pharm"
                        "fecha" => "2004"
                        "volumen" => "19"
                        "paginaInicial" => "602"
                        "paginaFinal" => "613"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            71 => array:3 [
              "identificador" => "bb0360"
              "etiqueta" => "72&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Nsaids &#8211; a double-edged sword"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Hospital Pharmacy"
                        "fecha" => "1993"
                        "volumen" => "28"
                        "numero" => "50"
                        "paginaInicial" => "53"
                        "paginaFinal" => "55"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            72 => array:3 [
              "identificador" => "bb0365"
              "etiqueta" => "73&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment of osteoarthritis&#58; a 3-month comparison between tiaprofenic acid and indomethacin"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1185/03007998309112387"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Med Res Opin"
                        "fecha" => "1983"
                        "volumen" => "8"
                        "paginaInicial" => "295"
                        "paginaFinal" => "301"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            73 => array:3 [
              "identificador" => "bb0370"
              "etiqueta" => "74&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Imidazole salicylate versus piroxicam in the treatment of arthrosis in elderly patients&#46; A double-blind clinical and endoscopic trial"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Geriatr Soc"
                        "fecha" => "1990"
                        "volumen" => "38"
                        "paginaInicial" => "985"
                        "paginaFinal" => "988"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            74 => array:3 [
              "identificador" => "bb0375"
              "etiqueta" => "75&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of nabumetone versus diclofenac&#44; naproxen&#44; ibuprofen&#44; and piroxicam in the elderly"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Am J Med"
                        "fecha" => "1993"
                        "volumen" => "95"
                        "paginaInicial" => "S19"
                        "paginaFinal" => "27"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            75 => array:3 [
              "identificador" => "bb0380"
              "etiqueta" => "76&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Nonsteroidal anti-inflammatory drugs and bone mineral density in older women&#58; the Rancho Bernardo study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1359/jbmr.1998.13.12.1924"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Bone Miner Res"
                        "fecha" => "1998"
                        "volumen" => "13"
                        "paginaInicial" => "1924"
                        "paginaFinal" => "1931"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            76 => array:3 [
              "identificador" => "bb0385"
              "etiqueta" => "77&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Temporal relationship between use of nsaids&#44; including selective cox- 2 inhibitors&#44; and cardiovascular risk"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Drug Saf"
                        "fecha" => "2006"
                        "volumen" => "29"
                        "paginaInicial" => "621"
                        "paginaFinal" => "632"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            77 => array:3 [
              "identificador" => "bb0390"
              "etiqueta" => "78&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Protective effect of misoprostol on indomethacin induced renal dysfunction in elderly patients"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Rheumatol"
                        "fecha" => "1995"
                        "volumen" => "22"
                        "paginaInicial" => "713"
                        "paginaFinal" => "716"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            78 => array:3 [
              "identificador" => "bb0395"
              "etiqueta" => "79&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Comparison of changes in blood pressure measurements and antihypertensive therapy in older&#44; hypertensive&#44; ambulatory care patients prescribed celecoxib or rofecoxib"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Pharmacotherapy"
                        "fecha" => "2003"
                        "volumen" => "23"
                        "paginaInicial" => "1416"
                        "paginaFinal" => "1423"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            79 => array:3 [
              "identificador" => "bb0400"
              "etiqueta" => "80&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Long-term efficacy and safety of tolmetin sodium in treatment of geriatric patients with rheumatoid arthritis and osteoarthritis&#58; a retrospective study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Pharmacol"
                        "fecha" => "1983"
                        "volumen" => "23"
                        "paginaInicial" => "309"
                        "paginaFinal" => "323"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            80 => array:3 [
              "identificador" => "bb0405"
              "etiqueta" => "81&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Double-blind comparison of the efficacy and safety of etodolac SR 600 mg u&#46;i&#46;d&#46; and of tenoxicam 20 mg u&#46;i&#46;d&#46; in elderly patients with osteoarthritis of the hip and of the knee"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Clin Pharmacol Res"
                        "fecha" => "1994"
                        "volumen" => "14"
                        "paginaInicial" => "203"
                        "paginaFinal" => "216"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            81 => array:3 [
              "identificador" => "bb0410"
              "etiqueta" => "82&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Evaluation of the effectiveness and safety of etodolac in prolonged treatment of active osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Clin Pharmacol Res"
                        "fecha" => "1991"
                        "volumen" => "11"
                        "paginaInicial" => "143"
                        "paginaFinal" => "158"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            82 => array:3 [
              "identificador" => "bb0415"
              "etiqueta" => "83&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A naturalistic study of the determinants of health related quality of life improvement in osteoarthritic patients treated with non-specific non-steroidal anti-inflammatory drugs"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/ard.2004.026658"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Rheum Dis"
                        "fecha" => "2005"
                        "volumen" => "64"
                        "paginaInicial" => "688"
                        "paginaFinal" => "693"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            83 => array:3 [
              "identificador" => "bb0420"
              "etiqueta" => "84&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Determinants of gastro-protective drugs co-prescription during treatment with nonselective nsaids&#58; a prospective survey of 2197 patients recruited in primary care"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.joca.2006.01.002"
                      "Revista" => array:6 [
                        "tituloSerie" => "Osteoarthritis Cartilage"
                        "fecha" => "2006"
                        "volumen" => "14"
                        "paginaInicial" => "625"
                        "paginaFinal" => "630"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            84 => array:3 [
              "identificador" => "bb0425"
              "etiqueta" => "85&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Use of nsaids&#44; cox-2 inhibitors&#44; and acetaminophen and associated coprescriptions of gastroprotective agents in an elderly population"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.10796"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2002"
                        "volumen" => "47"
                        "paginaInicial" => "595"
                        "paginaFinal" => "602"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            85 => array:3 [
              "identificador" => "bb0430"
              "etiqueta" => "86&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risks and benefits of cox-2 inhibitors vs non-selective nsaids&#58; does their cardiovascular risk exceed their gastrointestinal benefit&#63; A retrospective cohort study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/rheumatology/kel428"
                      "Revista" => array:6 [
                        "tituloSerie" => "Rheumatology"
                        "fecha" => "2007"
                        "volumen" => "46"
                        "paginaInicial" => "435"
                        "paginaFinal" => "438"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            86 => array:3 [
              "identificador" => "bb0435"
              "etiqueta" => "87&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Do proton-pump inhibitors confer additional gastrointestinal protection in patients given celecoxib&#63;"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.22764"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2007"
                        "volumen" => "57"
                        "paginaInicial" => "748"
                        "paginaFinal" => "755"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            87 => array:3 [
              "identificador" => "bb0440"
              "etiqueta" => "88&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A controlled study comparing the effects of nabumetone&#44; ibuprofen&#44; and ibuprofen plus misoprostol on the upper gastrointestinal tract mucosa"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Intern Med"
                        "fecha" => "1993"
                        "volumen" => "153"
                        "paginaInicial" => "2565"
                        "paginaFinal" => "2571"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            88 => array:3 [
              "identificador" => "bb0445"
              "etiqueta" => "89&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Endoscopic evaluation of the long term effects of diclofenac sodium and naproxen in elderly patients with arthritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Clin Drug Investig"
                        "fecha" => "1995"
                        "volumen" => "9"
                        "paginaInicial" => "171"
                        "paginaFinal" => "179"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            89 => array:3 [
              "identificador" => "bb0450"
              "etiqueta" => "90&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "NSAIDs and faecal blood loss in elderly patients with osteoarthritis&#58; is plasma half-life relevant&#63;"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Aust N Z J Med"
                        "fecha" => "1998"
                        "volumen" => "28"
                        "paginaInicial" => "436"
                        "paginaFinal" => "439"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            90 => array:3 [
              "identificador" => "bb0455"
              "etiqueta" => "91&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Long-term safety of ketoprofen in an elderly population of arthritic patients"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Scand J Rheumatol Suppl"
                        "fecha" => "1991"
                        "volumen" => "91"
                        "paginaInicial" => "27"
                        "paginaFinal" => "36"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            91 => array:3 [
              "identificador" => "bb0460"
              "etiqueta" => "92&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The safety profile of sustained-release etodolac"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:7 [
                        "tituloSerie" => "Rheumatol Int"
                        "fecha" => "1993"
                        "volumen" => "13"
                        "numero" => "Suppl 2"
                        "paginaInicial" => "S31"
                        "paginaFinal" => "S35"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            92 => array:3 [
              "identificador" => "bb0465"
              "etiqueta" => "93&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee&#58; a 13-week&#44; randomized&#44; double-blind comparison with celecoxib and placebo"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.clinthera.2005.01.002"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Ther"
                        "fecha" => "2005"
                        "volumen" => "27"
                        "paginaInicial" => "64"
                        "paginaFinal" => "77"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            93 => array:3 [
              "identificador" => "bb0470"
              "etiqueta" => "94&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Nsaid use and bp in treated hypertensives&#58; a retrospective controlled observational study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/sj.jhh.1001839"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Hum Hypertens"
                        "fecha" => "2005"
                        "volumen" => "19"
                        "paginaInicial" => "445"
                        "paginaFinal" => "450"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            94 => array:3 [
              "identificador" => "bb0475"
              "etiqueta" => "95&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Epidemiol"
                        "fecha" => "1995"
                        "volumen" => "141"
                        "paginaInicial" => "539"
                        "paginaFinal" => "545"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            95 => array:3 [
              "identificador" => "bb0480"
              "etiqueta" => "96&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Healing of NSAID-induced gastric ulcers with a synthetic prostaglandin analog &#40;enprostil&#41;"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Gastroenterol"
                        "fecha" => "1994"
                        "volumen" => "89"
                        "paginaInicial" => "1014"
                        "paginaFinal" => "1020"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            96 => array:3 [
              "identificador" => "bb0485"
              "etiqueta" => "97&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mefenamic acid compared with diclofenac sodium in elderly patients with osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Clin Pract"
                        "fecha" => "1988"
                        "volumen" => "42"
                        "paginaInicial" => "316"
                        "paginaFinal" => "320"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            97 => array:3 [
              "identificador" => "bb0490"
              "etiqueta" => "98&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Rofecoxib improves quality of life in patients with hip or knee osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "2002/39/smw-10075"
                      "Revista" => array:6 [
                        "tituloSerie" => "Swiss Med Wkly"
                        "fecha" => "2002"
                        "volumen" => "132"
                        "paginaInicial" => "566"
                        "paginaFinal" => "573"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            98 => array:3 [
              "identificador" => "bb0495"
              "etiqueta" => "99&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and tolerability of etodolac in aged patients affected by degenerative joint disease &#40;osteoarthritis&#41; in its active phase"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Clin Pharmacol Res"
                        "fecha" => "1994"
                        "volumen" => "14"
                        "paginaInicial" => "11"
                        "paginaFinal" => "26"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            99 => array:3 [
              "identificador" => "bb0500"
              "etiqueta" => "100&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A multicenter&#44; randomized&#44; controlled trial to evaluate the safety profile&#44; tolerability&#44; and efficacy of rofecoxib in advanced elderly patients with osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Aging &#40;Milano&#41;"
                        "fecha" => "2001"
                        "volumen" => "13"
                        "paginaInicial" => "112"
                        "paginaFinal" => "121"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            100 => array:3 [
              "identificador" => "bb0505"
              "etiqueta" => "101&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A comparison of naproxen and diclofenac sodium in the treatment of osteoarthritis in elderly patients"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Clin Pract"
                        "fecha" => "1985"
                        "volumen" => "39"
                        "paginaInicial" => "276"
                        "paginaFinal" => "281"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            101 => array:3 [
              "identificador" => "bb0510"
              "etiqueta" => "102&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to nonsteroidal anti-inflammatory drugs&#58; a nested case-control study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1186/ar2207"
                      "Revista" => array:5 [
                        "tituloSerie" => "Arthritis Res Ther"
                        "fecha" => "2007"
                        "volumen" => "9"
                        "paginaInicial" => "R52"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            102 => array:3 [
              "identificador" => "bb0515"
              "etiqueta" => "103&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/sj.ki.5001766"
                      "Revista" => array:6 [
                        "tituloSerie" => "Kidney Int"
                        "fecha" => "2006"
                        "volumen" => "70"
                        "paginaInicial" => "1495"
                        "paginaFinal" => "1502"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            103 => array:3 [
              "identificador" => "bb0520"
              "etiqueta" => "104&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Adverse effects of isoxicam in relation to age"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Med"
                        "fecha" => "1985"
                        "volumen" => "79"
                        "paginaInicial" => "38"
                        "paginaFinal" => "40"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            104 => array:3 [
              "identificador" => "bb0525"
              "etiqueta" => "105&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Etodolac therapy for osteoarthritis&#58; a double-blind&#44; placebo-controlled trial"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1185/03007998909115933"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Med Res Opin"
                        "fecha" => "1989"
                        "volumen" => "11"
                        "paginaInicial" => "463"
                        "paginaFinal" => "470"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            105 => array:3 [
              "identificador" => "bb0530"
              "etiqueta" => "106&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Up-to-date information on gastric mucosal lesions from long-term NSAID therapy in orthopedic outpatients&#58; a study using logistic regression analysis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s00776-007-1139-9"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Orthop Sci"
                        "fecha" => "2007"
                        "volumen" => "12"
                        "paginaInicial" => "341"
                        "paginaFinal" => "346"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/1699258X/0000000400000005/v1_201305061804/S1699258X08724616/v1_201305061804/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "17499"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Originales"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/1699258X/0000000400000005/v1_201305061804/S1699258X08724616/v1_201305061804/es/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X08724616?idApp=UINPBA00004M"
]
Compartir
Información de la revista

Estadísticas

Siga este enlace para acceder al texto completo del artículo

Originales
Revisión sistemática: ¿es eficaz y seguro el uso de AINE para los ancianos?
Systematic Review: Is the Use of NSAIDs Effective and Safe in the Elderly?
Estíbaliz Loza
Autor para correspondencia
eloza.hcsc@salud.madrid.org

Dra. E. Loza. Servicio de Reumatología. Hospital Clínico San Carlos. Profesor Martin Lagos, s/n. 28015 Madrid. España.
Servicio de Reumatología. Hospital Clínico San Carlos. Madrid. España
Leído
28718
Veces
se ha leído el artículo
4282
Total PDF
24436
Total HTML
Compartir estadísticas
 array:23 [
  "pii" => "S1699258X08724616"
  "issn" => "1699258X"
  "doi" => "10.1016/S1699-258X(08)72461-6"
  "estado" => "S300"
  "fechaPublicacion" => "2008-09-01"
  "aid" => "72461"
  "copyright" => "Elsevier Espa&#241;a S&#46;L Barcelona"
  "copyrightAnyo" => "2008"
  "documento" => "article"
  "crossmark" => 0
  "subdocumento" => "fla"
  "cita" => "Reumatol Clin. 2008;4:172-82"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 8762
    "formatos" => array:3 [
      "EPUB" => 143
      "HTML" => 7205
      "PDF" => 1414
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S1699258X08724628"
    "issn" => "1699258X"
    "doi" => "10.1016/S1699-258X(08)72462-8"
    "estado" => "S300"
    "fechaPublicacion" => "2008-09-01"
    "aid" => "72462"
    "copyright" => "Elsevier Espa&#241;a S&#46;L Barcelona"
    "documento" => "article"
    "crossmark" => 0
    "subdocumento" => "fla"
    "cita" => "Reumatol Clin. 2008;4:183-90"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 64979
      "formatos" => array:3 [
        "EPUB" => 181
        "HTML" => 51568
        "PDF" => 13230
      ]
    ]
    "es" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Originales</span>"
      "titulo" => "&#191;Es la puntuaci&#243;n DAS28 el m&#233;todo m&#225;s adecuado para estimar la actividad de la artritis reumatoide&#63; Consideracionens clinim&#233;tricas y escenarios de simulaci&#243;n"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "183"
          "paginaFinal" => "190"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "Is the DAS28 Score the Most Adequate Method to Estimate Activity in Rheumatoid Arthritis&#63; Clinimetric Considerations and Simulations Scenarios"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "f0015"
          "etiqueta" => "Figura 3"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr3.jpeg"
              "Alto" => 733
              "Ancho" => 934
              "Tamanyo" => 53194
            ]
          ]
          "descripcion" => array:1 [
            "es" => "<p id="sp0015" class="elsevierStyleSimplePara elsevierViewall">Participaci&#243;n m&#225;xima de cada uno de los componentes en el valor combinado del DAS28&#46; GH&#58; valoraci&#243;n global del paciente&#59; NAD&#58; recuento de articulaciones dolorosas&#59; NAT&#58; recuento de articulaciones tumefactas&#59; VSG&#58; velocidad de sedimentaci&#243;n globular&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Miguel &#193;ngel Belmonte Serrano"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "Miguel &#193;ngel"
              "apellidos" => "Belmonte Serrano"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X08724628?idApp=UINPBA00004M"
    "url" => "/1699258X/0000000400000005/v1_201305061804/S1699258X08724628/v1_201305061804/es/main.assets"
  ]
  "itemAnterior" => array:18 [
    "pii" => "S1699258X08724604"
    "issn" => "1699258X"
    "doi" => "10.1016/S1699-258X(08)72460-4"
    "estado" => "S300"
    "fechaPublicacion" => "2008-09-01"
    "aid" => "72460"
    "copyright" => "Elsevier Espa&#241;a S&#46;L Barcelona"
    "documento" => "simple-article"
    "crossmark" => 0
    "subdocumento" => "edi"
    "cita" => "Reumatol Clin. 2008;4:169-71"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 6055
      "formatos" => array:3 [
        "EPUB" => 155
        "HTML" => 4763
        "PDF" => 1137
      ]
    ]
    "es" => array:9 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
      "titulo" => "Perspectivas sobre la osteoporosis en los pa&#237;ses en desarrollo&#58; problema creciente&#44; recursos escasos"
      "tienePdf" => "es"
      "tieneTextoCompleto" => "es"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "169"
          "paginaFinal" => "171"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "es" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Jorge Morales-Torres"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "Jorge"
              "apellidos" => "Morales-Torres"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X08724604?idApp=UINPBA00004M"
    "url" => "/1699258X/0000000400000005/v1_201305061804/S1699258X08724604/v1_201305061804/es/main.assets"
  ]
  "es" => array:19 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Originales</span>"
    "titulo" => "Revisi&#243;n sistem&#225;tica&#58; &#191;es eficaz y seguro el uso de AINE para los ancianos&#63;"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "172"
        "paginaFinal" => "182"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Est&#237;baliz Loza"
        "autores" => array:1 [
          0 => array:4 [
            "nombre" => "Est&#237;baliz"
            "apellidos" => "Loza"
            "email" => array:1 [
              0 => "eloza&#46;hcsc&#64;salud&#46;madrid&#46;org"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "&#42;"
                "identificador" => "cor1"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:1 [
            "entidad" => "Servicio de Reumatolog&#237;a&#46; Hospital Cl&#237;nico San Carlos&#46; Madrid&#46; Espa&#241;a"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor1"
            "etiqueta" => "&#42;"
            "correspondencia" => "Dra&#46; E&#46; Loza&#46; Servicio de Reumatolog&#237;a&#46; Hospital Cl&#237;nico San Carlos&#46; Profesor Martin Lagos&#44; s&#47;n&#46; 28015 Madrid&#46; Espa&#241;a&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "Systematic Review&#58; Is the Use of NSAIDs Effective and Safe in the Elderly&#63;"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "f0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 3933
            "Ancho" => 3110
            "Tamanyo" => 787416
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="sp0005" class="elsevierStyleSimplePara elsevierViewall">Flujo de la selecci&#243;n de los estudios&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="s0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0005">Introducci&#243;n</span><p id="p0005" class="elsevierStylePara elsevierViewall">El uso de antiinflamatorios no esteroideos &#40;AINE&#41; es muy frecuente en pacientes con enfermedades reum&#225;ticas&#44; especialmente en procesos degenerativos como la artrosis&#44; y en enfermedades inflamatorias como la artritis reumatoide&#46;</p><p id="p0010" class="elsevierStylePara elsevierViewall">De acuerdo con estudios en poblaci&#243;n general&#44; los ancianos parecen ser m&#225;s susceptibles a desarrollar eventos adversos relacionados con el uso de AINE&#44; especialmente de origen digestivo&#44; de hecho&#44; algunos estudios han puesto de manifiesto que los ancianos tienen un riesgo 5 veces mayor de toxicidad gastrointestinal por estos f&#225;rmacos<a class="elsevierStyleCrossRefs" href="#bb0005"><span class="elsevierStyleSup">1&#8211;3</span></a>&#46; M&#250;ltiples factores parecen estar implicados en el desarrollo de la toxicidad gastrointestinal inducida por los AINE en ancianos&#46; Entre &#233;stos destacan el da&#241;o directo en la mucosa digestiva&#44; la inhibici&#243;n de prostaglandinas protectoras end&#243;genas&#44; el aumento del tiempo de hemorragia y la posible disminuci&#243;n de la capacidad de eliminaci&#243;n de estos f&#225;rmacos que producir&#237;a mayores concentraciones sangu&#237;neas<a class="elsevierStyleCrossRefs" href="#bb0020"><span class="elsevierStyleSup">4&#44;5</span></a>&#46;</p><p id="p0015" class="elsevierStylePara elsevierViewall">Pero adem&#225;s&#44; y en probable relaci&#243;n con la inhibici&#243;n de prostaglandinas&#44; en pacientes ancianos se han descrito alteraciones en la funci&#243;n renal relacionadas con los AINE&#44; que pueden causar importantes cambios en el filtrado glomerular y en la presi&#243;n arterial&#44; y en pacientes con disfunci&#243;n ventricular&#44; un mayor riesgo de desarrollar insuficiencia card&#237;aca congestiva<a class="elsevierStyleCrossRefs" href="#bb0030"><span class="elsevierStyleSup">6&#44;7</span></a>&#46;</p><p id="p0020" class="elsevierStylePara elsevierViewall">A todo lo previamente comentado hay que a&#241;adir el hecho de que en los ancianos es muy frecuente la asociaci&#243;n de otras enfermedades y medicamentos que pueden influir en la toxicidad inducida por los AINE&#46; Por todo ello&#44; el uso de AINE en poblaciones de alto riesgo&#44; como los ancianos&#44; es de m&#225;ximo inter&#233;s y prioridad en nuestro medio&#44; y &#233;ste es el objetivo de la presente revisi&#243;n sistem&#225;tica&#46;</p></span><span id="s0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0010">Material y m&#233;todos</span><p id="p0025" class="elsevierStylePara elsevierViewall">Se realiz&#243; una revisi&#243;n sistem&#225;tica para analizar la seguridad del uso de AINE en ancianos&#46; Los criterios de selecci&#243;n de estudios fueron&#58;<ul class="elsevierStyleList" id="l0005"><li class="elsevierStyleListItem" id="o0005"><span class="elsevierStyleLabel">1&#46;</span><p id="p0030" class="elsevierStylePara elsevierViewall">Estudios que incluyeran ancianos con dolor de origen reum&#225;tico de m&#225;s de 1 mes de duraci&#243;n&#46; Se defini&#243; anciano como persona con edad o media de edad &#62; 60 a&#241;os&#46;</p></li><li class="elsevierStyleListItem" id="o0010"><span class="elsevierStyleLabel">2&#46;</span><p id="p0035" class="elsevierStylePara elsevierViewall">Estudios en que los pacientes tomaran alg&#250;n AINE&#46; No hubo restricci&#243;n en cuanto al tipo y la dosis del f&#225;rmaco&#44; pero se excluyeron los estudios en que los sujetos tomaran AINE a dosis antiagregantes y no analg&#233;sica&#47;antiinflamatoria&#44; as&#237; como los tratamientos t&#243;picos&#46;</p></li><li class="elsevierStyleListItem" id="o0015"><span class="elsevierStyleLabel">3&#46;</span><p id="p0040" class="elsevierStylePara elsevierViewall">Para evaluar la eficacia de los AINE&#44; se buscaron art&#237;culos que analizaran el dolor&#44; la funci&#243;n o la calidad de vida de los ancianos &#40;no se puso restricci&#243;n en cuanto al tipo de variable empleada para medir estos par&#225;metros&#41;&#46; A continuaci&#243;n&#44; y para valorar la seguridad del AINE&#44; se incluyeron estudios en los que analizaran algunas de las siguientes variables&#58; toxicidad gastrointestinal&#44; renal o cardiovascular &#40;tampoco se puso restricci&#243;n en cuanto al tipo de variable empleada en la medici&#243;n&#41;&#46;</p></li><li class="elsevierStyleListItem" id="o0020"><span class="elsevierStyleLabel">4&#46;</span><p id="p0045" class="elsevierStylePara elsevierViewall">En relaci&#243;n con el dise&#241;o de los estudios&#44; se incluyeron ensayos cl&#237;nicos &#40;EC&#41; Jadad 4&#8211;5 y estudios de cohortes de m&#225;xima calidad&#46; Se excluyeron los estudios en sujetos sanos voluntarios&#44; as&#237; como estudios en animales&#46; Finalmente&#44; en relaci&#243;n con el idioma&#44; se seleccionaron art&#237;culos en ingl&#233;s y espa&#241;ol&#46;</p></li></ul></p><p id="p0050" class="elsevierStylePara elsevierViewall">Se busc&#243; en las siguientes bases de datos electr&#243;nicas hasta diciembre de 2007&#58; MEDLINE &#40;desde 1960&#41;&#44; EMBASE &#40;desde 1980&#41; y Cochrane Library &#40;Central&#41;&#46; Se buscaron tanto t&#233;rminos MeSH como en formato texto libre&#46; No se pusieron l&#237;mites en cuanto a la fecha de publicaci&#243;n&#46; La estrategia de b&#250;squeda espec&#237;fica se detalla en las <a class="elsevierStyleCrossRefs" href="#t0005">tablas 1 y 2</a>&#46; No se realiz&#243; b&#250;squeda manual en lo publicado en congresos nacionales &#40;SER&#41; o internacionales &#40;ACR&#44; EULAR&#41; dado el gran volumen de art&#237;culos rescatados en las bases de datos electr&#243;nicas&#46; Un &#250;nico revisor analiz&#243; los art&#237;culos resultantes de la estrategia de b&#250;squeda&#44; as&#237; como el an&#225;lisis en detalle de los art&#237;culos incluidos&#46; El resultado de la b&#250;squeda primeramente se depur&#243; por t&#237;tulo y resumen o por art&#237;culo entero en caso de que no tuviera resumen&#44; mediante sesiones de 20<span class="elsevierStyleHsp" style=""></span>min de duraci&#243;n m&#225;xima&#46; Tras este proceso&#44; los art&#237;culos restantes se analizaron en detalle&#46; Finalmente&#44; se realiz&#243; una b&#250;squeda manual con las referencias de los art&#237;culos seleccionados para su an&#225;lisis en detalle&#46; Todas las referencias se recuperaron de internet y se introdujeron en el programa Procite 5&#46;1 para facilitar su gesti&#243;n&#46;</p><elsevierMultimedia ident="t0005"></elsevierMultimedia><elsevierMultimedia ident="t0010"></elsevierMultimedia><p id="p0055" class="elsevierStylePara elsevierViewall">Para evaluar la calidad metodol&#243;gica de los estudios incluidos&#44; se utiliz&#243;&#58; <span class="elsevierStyleItalic">a&#41;</span> para los EC&#44; la escala de Jadad<a class="elsevierStyleCrossRef" href="#bb0040"><span class="elsevierStyleSup">8</span></a> &#40;1 a 5&#59; se consider&#243; de buena calidad los estudios con Jadad de 3&#8211;5&#41;&#44; y <span class="elsevierStyleItalic">b&#41;</span> para los estudios de cohortes&#44; la escala de calidad de Oxford&#46;</p></span><span id="s0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0015">Resultados</span><p id="p0060" class="elsevierStylePara elsevierViewall">Los resultados de la b&#250;squeda se detallan en la <a class="elsevierStyleCrossRef" href="#f0005">figura 1</a>&#46; Finalmente se incluyeron 16 estudios que incluyeron a m&#225;s de 50&#46;000 ancianos&#44; con un seguimiento que vari&#243; desde 1 semana a 4 a&#241;os&#46; Destaca la gran diversidad en cuanto al tipo de AINE y las medidas de desenlace&#46; Se incluyeron 4 metaan&#225;lisis &#40;calidad 1a-b&#41;&#44; 9 EC &#40;Jadad 4&#41;&#44; 2 estudios de cohortes &#40;calidad 2a&#41; y un estudio de prevalencia &#40;calidad 2a&#41;&#46; La mayor&#237;a de estos estudios incluy&#243; a pacientes con osteoartrosis &#40;OA&#41; o artritis reumatoide &#40;AR&#41;&#46; En muchos de los estudios no estaba permitido el uso de protectores g&#225;stricos o no consta que los tomaran&#46; Los principales resultados de los estudios incluidos est&#225;n descritos en la <a class="elsevierStyleCrossRef" href="#t0015">tabla 3</a><a class="elsevierStyleCrossRefs" href="#bb0045"><span class="elsevierStyleSup">9&#8211;25</span></a>&#44; los art&#237;culos excluidos y el motivo de su exclusi&#243;n&#44; en la <a class="elsevierStyleCrossRef" href="#t0020">tabla 4</a><a class="elsevierStyleCrossRefs" href="#bb0130"><span class="elsevierStyleSup">26&#8211;106</span></a>&#46;</p><elsevierMultimedia ident="f0005"></elsevierMultimedia><elsevierMultimedia ident="t0015"></elsevierMultimedia><elsevierMultimedia ident="t0020"></elsevierMultimedia><p id="p0065" class="elsevierStylePara elsevierViewall">Seg&#250;n la evidencia de la presente revisi&#243;n sistem&#225;tica&#44; generalmente&#44; los AINE se han mostrado eficaces en el anciano para el control del dolor de origen reum&#225;tico &#40;en reposo&#44; con el movimiento&#44; nocturno&#41;&#44; la rigidez y la funci&#243;n articular<a class="elsevierStyleCrossRefs" href="#bb0045"><span class="elsevierStyleSup">9&#44;11&#8211;13&#44;15&#44;18&#44;24</span></a>&#44; sin poder precisarse qu&#233; AINE tiene un efecto mayor que otro&#46; En cuanto a los eventos adversos&#44; cabe destacar que presentan riesgo aumentado de cualquier evento gastrointestinal grave de cualquier origen<a class="elsevierStyleCrossRefs" href="#bb0055"><span class="elsevierStyleSup">11&#44;12</span></a>&#44; en especial los de origen gastrointestinal&#58; muerte u hospitalizaci&#243;n<a class="elsevierStyleCrossRef" href="#bb0115"><span class="elsevierStyleSup">23</span></a>&#44; hemorragia digestiva<a class="elsevierStyleCrossRefs" href="#bb0070"><span class="elsevierStyleSup">14&#44;19&#44;21</span></a>&#44; ulcus<a class="elsevierStyleCrossRefs" href="#bb0080"><span class="elsevierStyleSup">16&#44;17&#44;19&#8211;21&#44;25</span></a> u obstrucci&#243;n digestiva<a class="elsevierStyleCrossRefs" href="#bb0095"><span class="elsevierStyleSup">19&#44;21</span></a>&#59; sin poder realizar comparaciones entre todos los AINE&#46; Este riesgo disminuye al asociarse un protector g&#225;strico<a class="elsevierStyleCrossRefs" href="#bb0070"><span class="elsevierStyleSup">14&#44;19&#8211;21</span></a>&#46; En cuanto a los efectos cardiovasculares&#44; &#250;nicamente se pudo objetivar que el uso de rofecoxib se asoci&#243; a edema cl&#237;nicamente significativo y aumento en la presi&#243;n arterial &#40;PA&#41; sist&#243;lica&#46;</p><span id="s0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0020">Principales resultados de los metaan&#225;lisis</span><p id="p0070" class="elsevierStylePara elsevierViewall">Seg&#250;n Detora et al<a class="elsevierStyleCrossRef" href="#bb0045"><span class="elsevierStyleSup">9</span></a>&#44; en ancianos con OA&#47;AR&#44; el uso de rofecoxib &#40;12&#44;5&#47;25<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#41; fue m&#225;s eficaz que el placebo para mejorar su valoraci&#243;n global y el dolor al caminar&#46;</p><p id="p0075" class="elsevierStylePara elsevierViewall">Eisen et al<a class="elsevierStyleCrossRef" href="#bb0050"><span class="elsevierStyleSup">10</span></a> analizaron a ancianos con AR&#47;OA&#44; en los que valdecoxib &#40;10&#44; 20 o 40<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#41;&#44; en comparaci&#243;n con naproxeno 1&#46;000<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; ibuprofeno 2&#46;400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a y diclofenaco 150<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; se asoci&#243; a menor riesgo de s&#237;ntomas gastrointestinales moderados-severos&#46;</p><p id="p0080" class="elsevierStylePara elsevierViewall">Lisse et al<a class="elsevierStyleCrossRef" href="#bb0055"><span class="elsevierStyleSup">11</span></a> objetivaron que en ancianos con OA&#44; el celecoxib &#40;200 o 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#41; o el naproxeno 1&#46;000<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a mejoraron m&#225;s el &#237;ndice WOMAC que el placebo&#44; sin diferencias entre ellos&#46; No hubo diferencias en el n&#250;mero de eventos adversos graves&#46; El naproxeno tuvo mayor n&#250;mero de eventos adversos gastrointestinales que el placebo y que el celecoxib 200<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#46;</p><p id="p0085" class="elsevierStylePara elsevierViewall">En el metaan&#225;lisis de Schiff et al<a class="elsevierStyleCrossRef" href="#bb0060"><span class="elsevierStyleSup">12</span></a>&#44; en ancianos con OA&#44; el naproxeno 1&#46;000<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a o el ibuprofeno 1&#46;200<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a mejoraron el dolor en reposo o con los movimientos pasivos&#44; el nocturno&#44; el tiempo empleado para caminar 20<span class="elsevierStyleHsp" style=""></span>m y la rigidez matutina m&#225;s que el placebo&#46; No hubo diferencias en el n&#250;mero&#44; el tipo o la severidad de los eventos adversos&#46;</p></span><span id="s0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0025">Principales resultados de los EC &#40;no incluidos en los metaan&#225;lisis&#41;</span><p id="p0090" class="elsevierStylePara elsevierViewall">Bakshi et al<a class="elsevierStyleCrossRef" href="#bb0065"><span class="elsevierStyleSup">13</span></a> analizaron a ancianos con OA&#44; en los que diclofenaco 150<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a fue superior en cuanto a la mejor&#237;a del dolor en reposo&#44; dolor con el movimiento&#44; dolor a la presi&#243;n y la rigidez en reposo que el placebo&#46; No hubo diferencias en cuanto al dolor en la actividad diaria ni en el n&#250;mero de eventos adversos &#40;leves-moderados&#41;&#46;</p><p id="p0095" class="elsevierStylePara elsevierViewall">Chan et al<a class="elsevierStyleCrossRef" href="#bb0070"><span class="elsevierStyleSup">14</span></a>&#44; en pacientes ancianos con artritis y episodio de ulcus previo&#44; no objetivaron diferencias entre el celecoxib 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a y el diclofenaco 150<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#43; omeprazol 20<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a en sangrado gastrointestinal&#44; ulcus recurrente o dispepsia&#46;</p><p id="p0100" class="elsevierStylePara elsevierViewall">Por otro lado&#44; Earl et al<a class="elsevierStyleCrossRef" href="#bb0075"><span class="elsevierStyleSup">15</span></a>&#44; en pacientes con OA&#44; observarn que ibuprofeno 1&#46;600<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a o piroxicam 20<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a mejoraron el dolor articular y las horas de sue&#241;o&#46; S&#243;lo el ibuprofeno mejor&#243; la flexi&#243;n de la cadera y la rodilla&#44; y ninguno la rotaci&#243;n interna de la cadera&#46; No hubo diferencias en el n&#250;mero de eventos adversos y abandonos en el grupo con AINE&#46;</p><p id="p0105" class="elsevierStylePara elsevierViewall">Seg&#250;n Hawkey et al<a class="elsevierStyleCrossRefs" href="#bb0080"><span class="elsevierStyleSup">16&#44;17</span></a>&#44; en ancianos con OA&#44; el lumiracoxib 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a no se asoci&#243; con el ulcus gastroduodenal&#44; pero s&#237; el naproxeno 1&#46;000<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a y el ibuprofeno 2&#46;400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#46;</p><p id="p0110" class="elsevierStylePara elsevierViewall">En el estudio de Kareela et al<a class="elsevierStyleCrossRef" href="#bb0090"><span class="elsevierStyleSup">18</span></a>&#44; ancianos con AR e indometacina 150<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a mejoraron su rigidez matutina&#46; No hubo diferencias en comparaci&#243;n con los pacientes menores de 65 a&#241;os&#46;</p><p id="p0115" class="elsevierStylePara elsevierViewall">Seg&#250;n Koch et al<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a>&#44; en ancianos con AR el uso de AINE con misoprostol disminuye en un 40&#37; el riesgo de complicaci&#243;n gastrointestinal grave en comparaci&#243;n con el AINE solo&#46;</p><p id="p0120" class="elsevierStylePara elsevierViewall">Regula et al<a class="elsevierStyleCrossRef" href="#bb0100"><span class="elsevierStyleSup">20</span></a> estudiaron a ancianos con AR&#47;OA con AINE y pantoprazol 20 o 40<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a u omeprazol 20<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; sin objetivar diferencias en la aparici&#243;n de eventos adversos gastrointestinales leves o graves&#46;</p><p id="p0125" class="elsevierStylePara elsevierViewall">En el EC de Silverstein et al<a class="elsevierStyleCrossRef" href="#bb0105"><span class="elsevierStyleSup">21</span></a>&#44; en ancianos con AR&#44; el uso de AINE se asoci&#243; a mayor riesgo de evento adverso grave &#40;ulcus&#44; hemorragia&#44; obstrucci&#243;n&#41;&#44; <span class="elsevierStyleItalic">odds ratio</span> &#91;OR&#93; &#61; 2&#44;48 &#40;intervalo&#44; 1&#44;48-4&#44;14&#41;&#46;</p><p id="p0130" class="elsevierStylePara elsevierViewall">Whelton et al<a class="elsevierStyleCrossRef" href="#bb0110"><span class="elsevierStyleSup">22</span></a>&#44; en ancianos con OA&#44; no encontraron diferencias en el aumento de PA diast&#243;lica ni en la aparici&#243;n de insuficiencia card&#237;aca &#40;primer episodio&#41; entre los que tomaron celecoxib 200<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a o rofecoxib 25<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#46; S&#237; hubo m&#225;s pacientes con edema cl&#237;nicamente significativo y aumento de la PA sist&#243;lica en el grupo rofecoxib&#46;</p></span><span id="s0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0030">Principales resultados de los estudios de cohortes</span><p id="p0135" class="elsevierStylePara elsevierViewall">En el estudio de Fries et al<a class="elsevierStyleCrossRef" href="#bb0115"><span class="elsevierStyleSup">23</span></a> el riesgo de hospitalizaci&#243;n o muerte por evento gastrointestinal de los AINE de los pacientes con AR fue&#58; en mayores de 60 a&#241;os&#44; OR &#61; 2&#44;7&#59; en mayores de 65 a&#241;os&#44; OR &#61; 2&#44;4&#59; en mayores de 70 a&#241;os&#44; OR &#61; 2&#44;0&#44; y en mayores de 75 a&#241;os&#44; OR &#61; 2&#44;2 &#40;todos los resultados son estad&#237;sticamente significativos&#41;&#46;</p><p id="p0140" class="elsevierStylePara elsevierViewall">En la cohorte de Le Loet<a class="elsevierStyleCrossRef" href="#bb0120"><span class="elsevierStyleSup">24</span></a>&#44; en ancianos con enfermedad reum&#225;tica que hab&#237;an tomado ketoprofeno 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; la valoraci&#243;n global del m&#233;dico fue buena&#47;excelente en un 74&#44;4&#37;&#44; y seg&#250;n los pacientes&#44; la tolerabilidad del f&#225;rmaco fue buena&#47;excelente en un 85&#37;&#46; Hubo eventos adversos relacionados con el f&#225;rmaco en el 15&#44;3&#37; de los pacientes&#46;</p></span><span id="s0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0035">Estudio de prevalencia</span><p id="p0145" class="elsevierStylePara elsevierViewall">Seg&#250;n Cheatum et al<a class="elsevierStyleCrossRef" href="#bb0125"><span class="elsevierStyleSup">25</span></a>&#44; en pacientes con AR&#47;OA en tratamiento con AINE&#44; la prevalencia de ulcus gastroduodenal fue&#58; en el grupo de 60&#8211;69 a&#241;os&#44; del 29&#37;&#59; en el de 70&#8211;79 a&#241;os&#44; del 34&#37;&#44; y en los mayores de 80 a&#241;os&#44; del 32&#37;&#46;</p></span></span><span id="s0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0040">Discusi&#243;n</span><p id="p0150" class="elsevierStylePara elsevierViewall">Hemos analizado los resultados de eficacia cl&#237;nica &#40;en el tratamiento del dolor y funci&#243;n y calidad de vida&#41; y de seguridad &#40;gastrointestinal&#44; cardiovascular&#44; renal&#41; de los AINE en el tratamiento de enfermedades reum&#225;ticas en ancianos&#44; mediante la revisi&#243;n sistem&#225;tica de la literatura&#46; El objetivo es contribuir con la evidencia cient&#237;fica publicada a la hora de generar un consenso sobre el uso de AINE en ancianos&#46;</p><p id="p0155" class="elsevierStylePara elsevierViewall">En cuanto a la eficacia&#44; seg&#250;n los resultados obtenidos&#44; hay datos que apoyan el uso de los AINE para el dolor y otros s&#237;ntomas de origen reum&#225;tico en ancianos<a class="elsevierStyleCrossRefs" href="#bb0045"><span class="elsevierStyleSup">9&#44;11&#8211;13&#44;15&#44;18&#44;24</span></a>&#46; Pero&#44; dada la diversidad de AINE empleados en los estudios y las distintas variables utilizadas para medir la eficacia&#44; es dif&#237;cil definir si un AINE es claramente m&#225;s eficaz que otro en los ancianos con dolor reum&#225;tico&#46; Tampoco queda muy clara la magnitud de sus efectos que&#44; en general&#44; seg&#250;n lo publicado&#44; no parece muy llamativa&#44; aunque hay que tener en cuenta el contexto en el que se utilizan &#40;b&#225;sicamente ancianos con artritis reumatoide y artrosis&#41;&#46;</p><p id="p0160" class="elsevierStylePara elsevierViewall">En cuanto a su seguridad&#44; en primer lugar es de destacar que&#44; seg&#250;n un estudio transversal<a class="elsevierStyleCrossRef" href="#bb0125"><span class="elsevierStyleSup">25</span></a>&#44; la prevalencia de ulcus gastroduodenal en ancianos con enfermedad reum&#225;tica en tratamiento con AINE es considerable&#44; mayor en el grupo de 70&#8211;79 a&#241;os de edad&#46; Este hecho se complementa con los datos que se desprenden de un estudio de cohortes y de otros EC&#44; en que se evidencia un riesgo aumentado de cualquier tipo de evento adverso grave&#44; especialmente los de origen gastrointestinal &#40;hospitalizaci&#243;n o muerte<a class="elsevierStyleCrossRef" href="#bb0115"><span class="elsevierStyleSup">23</span></a>&#44; hemorragia digestiva<a class="elsevierStyleCrossRefs" href="#bb0070"><span class="elsevierStyleSup">14&#44;19&#44;21</span></a>&#44; ulcus<a class="elsevierStyleCrossRefs" href="#bb0080"><span class="elsevierStyleSup">16&#44;17&#44;19&#8211;21&#44;25</span></a> u obstrucci&#243;n digestiva<a class="elsevierStyleCrossRefs" href="#bb0095"><span class="elsevierStyleSup">19&#44;21</span></a>&#41;&#46; En estudios de poblaci&#243;n general&#44; el riesgo descrito de evento gastrointestinal grave es incluso mayor<a class="elsevierStyleCrossRef" href="#bb0015"><span class="elsevierStyleSup">3</span></a>&#46; Esto pudiera deberse a que actualmente en reumatolog&#237;a se prescribe AINE a los ancianos en momentos de dolor agudo y no tanto como tratamiento continuo y cr&#243;nico&#46; S&#243;lo un art&#237;culo de los incluidos analiz&#243; eventos adversos cardiovasculares<a class="elsevierStyleCrossRef" href="#bb0110"><span class="elsevierStyleSup">22</span></a>&#44; donde no hubo diferencia significativa de aumento de PA diast&#243;lica ni en la aparici&#243;n de insuficiencia card&#237;aca &#40;primer episodio&#41; entre celecoxib y rofecoxib&#46; Pero hubo m&#225;s pacientes con edema cl&#237;nicamente significativo y aumento en la PA sist&#243;lica en el grupo rofecoxib&#46; De nuevo es dif&#237;cil establecer qu&#233; AINE presenta un mejor perfil de seguridad&#46;</p><p id="p0165" class="elsevierStylePara elsevierViewall">Por &#250;ltimo&#44; cabe se&#241;alar que en los art&#237;culos seleccionados el uso de protectores g&#225;stricos se asoci&#243; a reducci&#243;n del riesgo de ulcus gastroduodenal en ancianos<a class="elsevierStyleCrossRefs" href="#bb0095"><span class="elsevierStyleSup">19&#8211;21</span></a>&#46; Aunque al igual que con la eficacia y la seguridad&#44; es dif&#237;cil establecer cu&#225;les son mejores que otros&#46;</p><p id="p0170" class="elsevierStylePara elsevierViewall">Pero todos estos resultados hay que tomarlos con cautela por los siguientes motivos&#58; una de las principales dificultades de la revisi&#243;n ha sido la falta de definici&#243;n homog&#233;nea del concepto anciano&#44; es decir&#44; actualmente a qu&#233; edad y&#47;o qu&#233; condiciones consideramos las propias de un ser humano anciano&#46; Otra dificultad a&#241;adida es que&#44; en general&#44; en los EC y en otros estudios&#44; suele ser muy escaso el n&#250;mero de ancianos incluidos&#44; lo que hace que se muestren pocos datos de ellos&#44; por lo que puede que no se est&#233; describiendo correctamente lo que sucede en la pr&#225;ctica diaria con este grupo de poblaci&#243;n&#46; En la presente revisi&#243;n&#44; se puso un corte en los 60 a&#241;os&#44; cuando es posible que sea diferente &#40;en t&#233;rminos de eficacia y seguridad de los AINE&#41; tener 60 o 79 a&#241;os&#46; Y como se ha visto&#44; hay pocos an&#225;lisis de subgrupos de edad entre ancianos que puedan estudiar este fen&#243;meno&#46; Otra posible limitaci&#243;n es que la dificultad para ajustar por todas las variables que en el anciano con enfermedad reum&#225;tica puedan influir en las variables de resultado estudiadas&#44; que pueden potencialmente modificar los resultados expuestos &#40;uso concomitante de otras medicaciones&#44; enfermedades&#44; etc&#46;&#41;&#46; Por &#250;ltimo&#44; comentar tambi&#233;n la falta de estudios de calidad que confirmen el efecto en las funciones renal y card&#237;aca en ancianos que toman AINE&#44; en art&#237;culos ya publicados en otro tipo de poblaciones&#46;</p><p id="p0175" class="elsevierStylePara elsevierViewall">En conclusi&#243;n&#44; los AINE son eficaces en los ancianos para el tratamiento del dolor de origen reum&#225;tico&#44; si bien el riesgo de evento adverso grave es mayor&#44; por lo que ser&#237;a recomendable&#44; por un lado&#44; el uso de gastroprotectores siempre que se utilicen&#44; adem&#225;s de individualizar en cada caso el uso de los AINE&#44; ya que hay otras alternativas de tratamiento del dolor de origen reum&#225;tico que se han demostrado muy seguras y eficaces en los ancianos&#44; como los analg&#233;sicos o los esteroides a dosis bajas&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:7 [
        0 => array:2 [
          "identificador" => "xpalclavsec112552"
          "titulo" => "Palabras clave"
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec112553"
          "titulo" => "Key words"
        ]
        2 => array:2 [
          "identificador" => "s0005"
          "titulo" => "Introducci&#243;n"
        ]
        3 => array:2 [
          "identificador" => "s0010"
          "titulo" => "Material y m&#233;todos"
        ]
        4 => array:3 [
          "identificador" => "s0015"
          "titulo" => "Resultados"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "s0020"
              "titulo" => "Principales resultados de los metaan&#225;lisis"
            ]
            1 => array:2 [
              "identificador" => "s0025"
              "titulo" => "Principales resultados de los EC &#40;no incluidos en los metaan&#225;lisis&#41;"
            ]
            2 => array:2 [
              "identificador" => "s0030"
              "titulo" => "Principales resultados de los estudios de cohortes"
            ]
            3 => array:2 [
              "identificador" => "s0035"
              "titulo" => "Estudio de prevalencia"
            ]
          ]
        ]
        5 => array:2 [
          "identificador" => "s0040"
          "titulo" => "Discusi&#243;n"
        ]
        6 => array:1 [
          "titulo" => "Bibliograf&#237;a"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2008-02-15"
    "fechaAceptado" => "2008-05-16"
    "PalabrasClave" => array:2 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec112552"
          "palabras" => array:4 [
            0 => "Antiinflamatorios no esteroideos"
            1 => "Ancianos"
            2 => "Eficacia"
            3 => "Seguridad"
          ]
        ]
      ]
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Key words"
          "identificador" => "xpalclavsec112553"
          "palabras" => array:4 [
            0 => "Non-steroidal anti-inflammatory drugs"
            1 => "Elderly"
            2 => "Efficacy"
            3 => "Safety"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "es" => array:1 [
        "resumen" => "<span class="elsevierStyleSectionTitle">Objetivo</span><p id="sp0035" class="elsevierStyleSimplePara elsevierViewall">Analizar la eficacia y la seguridad de los antiinflamatorios no esteroideos &#40;AINE&#41; en ancianos&#46;</p> <span class="elsevierStyleSectionTitle">M&#233;todos</span><p id="sp0040" class="elsevierStyleSimplePara elsevierViewall">Revisi&#243;n sistem&#225;tica&#46; Se defini&#243; una estrategia de b&#250;squeda bibliogr&#225;fica sensible en MEDLINE &#40;desde 1961&#41;&#44; EMBASE &#40;desde 1980&#41; y Cochrane Library &#40;hasta diciembre de 2007&#41;&#59; se defini&#243; la poblaci&#243;n &#40;ancianos&#58; sujetos mayores de 60 a&#241;os&#44; con enfermedades reum&#225;ticas&#41;&#44; la intervenci&#243;n &#40;AINE&#41; y los resultados&#59; variables de eficacia &#40;dolor&#44; funci&#243;n&#44; calidad de vida&#41; y de seguridad &#40;toxicidad gastrointestinal&#44; renal y cardiovascular&#41;&#46; Se incluyeron ensayos cl&#237;nicos &#40;EC&#41; de 4-5 en la escala de Jadad y estudios de cohortes de m&#225;xima calidad&#46;</p> <span class="elsevierStyleSectionTitle">Resultados</span><p id="sp0045" class="elsevierStyleSimplePara elsevierViewall">Se seleccionaron 101 art&#237;culos para lectura en detalle&#44; de los que se incluyeron 16&#44; que analizaron m&#225;s de 50&#46;000 ancianos&#44; con un seguimiento que vari&#243; desde 1 semana a 4 a&#241;os&#46; Destaca la gran diversidad en cuanto al tipo de AINE y las medidas de desenlace&#46; Se incluyeron 4 metaan&#225;lisis&#44; 9 EC&#44; 2 estudios de cohortes y un estudio de prevalencia&#46; La mayor&#237;a de estos estudios analizaron a pacientes con osteoartrosis o artritis reumatoide&#46; Los AINE en el anciano se han mostrado eficaces para el control del dolor de origen reum&#225;tico&#44; la rigidez y la funci&#243;n articular&#44; pero presentan un riesgo aumentado de cualquier evento grave&#44; especialmente gastrointestinal &#40;muerte&#44; hospitalizaci&#243;n&#44; hemorragia&#44; ulcus u obstrucci&#243;n digestiva&#41;&#46; Este riesgo disminuye al asociarse un protector g&#225;strico&#46;</p> <span class="elsevierStyleSectionTitle">Conclusiones</span><p id="sp0050" class="elsevierStyleSimplePara elsevierViewall">De acuerdo con la evidencia recogida&#44; el uso de AINE es eficaz para el tratamiento de ancianos con enfermedades reum&#225;ticas&#44; aunque tambi&#233;n presenta un riesgo aumentado de evento adverso grave&#44; sobre todo de origen gastrointestinal&#46;</p>"
      ]
      "en" => array:1 [
        "resumen" => "<span class="elsevierStyleSectionTitle">Objective</span><p id="sp0055" class="elsevierStyleSimplePara elsevierViewall">To analyze the efficacy and safety of nonsteroidal anti-inflammatory drugs &#40;NSAID&#41; in the elderly&#46;</p> <span class="elsevierStyleSectionTitle">Methods</span><p id="sp0060" class="elsevierStyleSimplePara elsevierViewall">We performed a systematic review using a sensitive search strategy&#46; All studies published in MEDLINE &#40;since 1961&#41;&#44; EMBASE &#40;since 1961&#41; and Cochrane Library &#40;up to December 2007&#41; were selected&#46; We defined the population &#40;elderly as subjects aged 60 years or above with musculoskeletal diseases&#41;&#44; the intervention &#40;use of NSAID&#41;&#44; and the results related to efficacy &#40;pain&#44; function and quality of life&#41; and safety &#40;gastrointestinal&#44; cardiovascular or renal toxicity&#41;&#46;</p><p id="sp0065" class="elsevierStyleSimplePara elsevierViewall">Randomized clinical trials &#40;RCT&#41;&#44; &#40;Jadad 4 or 5&#41; and high quality cohort studies were included&#46;</p> <span class="elsevierStyleSectionTitle">Results</span><p id="sp0070" class="elsevierStyleSimplePara elsevierViewall">A total of 101 studies were analyzed in detail&#44; and 16 were included&#46; More than 50&#44;000 patients aged 60 years or above were analyzed from 1 week&#44; up to 4 years&#46; Different NSAID were included as well as different outcomes&#46; Four meta-analyses&#44; 9 RCT&#44; 2 cohort studies&#44; and one cross-sectional study were included&#46; NSAID are effective for the treatment of musculoskeletal pain&#44; stiffness or joint function&#46; However&#44; NSAID are associated with an increased risk of any serious adverse events&#44; especially serious gastrointestinal adverse events &#40;death&#44; hospitalization&#44; bleeding&#44; ulcers&#44; obstruction&#41;&#46; This risk decreased with the use of proton pump inhibitors&#46;</p> <span class="elsevierStyleSectionTitle">Conclusions</span><p id="sp0075" class="elsevierStyleSimplePara elsevierViewall">Based on the evidence&#44; NSAID in the elderly are effective for the treatment of different musculoskeletal diseases&#44; although the risk of serious adverse events &#40;mainly gastrointestinal&#41; is also clearly increased&#46;</p>"
      ]
    ]
    "multimedia" => array:5 [
      0 => array:7 [
        "identificador" => "f0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 3933
            "Ancho" => 3110
            "Tamanyo" => 787416
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="sp0005" class="elsevierStyleSimplePara elsevierViewall">Flujo de la selecci&#243;n de los estudios&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "t0005"
        "etiqueta" => "Tabla 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="center" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Estrategia de b&#250;squeda&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="center" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Resultados&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Search elderly OR aged OR Oldest Old OR Centenarians OR Centenarian OR Nonagenarians OR Nonagenarian OR Octogenarians OR Octogenarian OR Frail Elders OR Elders&#44; Frail OR Frail Elder OR Frail Older Adults OR aging OR elder OR geriatric OR gerontology OR gerontological OR geriatrics&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#46;997&#46;247&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">NSAID OR Nonsteroidal Anti-Inflammatory Agents OR Nonsteroidal Antiinflammatory Agents OR Analgesics&#44;Anti Inflammatory OR Non-Steroidal Anti-Rheumatic Agents OR Non-Steroidal Antirheumatic Agents OR Aspirin-LikeAgents OR Agents&#44; Aspirin-Like OR naproxen&#42; OR ibuprofen&#42; OR dexibuprofen OR dexketoprofen OR flurbiprofenOR Ketoprofen OR Ketorola&#42; OR aceclofenac OR diclofenac OR lornoxicam OR meloxicam OR piroxicam OR tenoxicamOR indometacin OR sulindac OR tolmetin OR fenilbutazon OR Phenylbutazone OR nabumeton OR celecoxib OR etoricoxibOR parecoxib OR rofecoxib OR valdecoxib OR lumiracoxib OR salicylic acid OR acetylsalicylic acid OR diflunisalOR Cyclooxygenase 2 Inhibitors OR COX-2 Inhibitors OR COX2 Inhibitors&#44; OR Coxibs&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">154&#46;508&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Randomized &#91;All Fields&#93; OR random allocation&#8221;&#91;TIAB&#93; NOT Medline&#91;SB&#93;&#41; OR &#8220;random allocation&#8221;&#91;MeSH Terms&#93; OR randomized&#91;Text Word&#93; OR controlled&#91;All Fields&#93; AND &#40;&#8220;clinical trials as topic&#8221;&#91;MeSH Terms&#93; OR trial&#91;Text Word&#93;&#41; OR placebo OR blinded&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">819&#46;404&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 y 2 y 3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">10&#46;959&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#40;Musculoskeletal diseases OR Polymyalgia Rheumatica OR Lupus Erythematosus&#44; Systemic OR vasculitis OR polymyositis OR dermatomyositis&#41; OR &#40;musculoskeletal diseases &#91;tiab&#93; OR polymyalgia&#91;tiab&#93; OR &#8220;lupus erythematosus systemic&#8221;&#91;tiab&#93; OR vasculitis&#91;tiab&#93; OR polymyositis&#91;tiab&#93; OR dermatomyositis&#91;tiab&#93;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">731&#46;817&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4 y 5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3&#46;081&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">acute &#91;All Fields&#93; OR post-operative &#91;All Fields&#93; OR post-surgical&#91;All Fields&#93; OR postsurgical &#91;All Fields&#93; OR Postoperative Complications &#91;MeSH&#93; OR Intraoperative Complications &#91;MeSH&#93; dysmenorrhoea&#91;All Fields&#93; OR orthodontic &#91;All fields&#93; OR Cancer OR neoplasm OR cancers OR tumor OR tumors OR Benign Neoplasms OR metastasis OR metastases&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#46;248&#46;303&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6 NOT 7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#46;855&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8 Limits&#58; Humans&#44; Clinical Trial&#44; Meta-Analysis&#44; Randomized Controlled Trial&#44; Clinical Trial&#44; Phase I&#44; Clinical Trial&#44; Phase II&#44; Clinical Trial&#44; Phase III&#44; Clinical Trial&#44; Phase IV&#44; Comparative Study&#44; Controlled Clinical Trial&#44; English&#44; Spanish&#44; Aged&#58; 65<span class="elsevierStyleHsp" style=""></span>&#43; years&#44; 80 and over&#58; 80<span class="elsevierStyleHsp" style=""></span>&#43; years&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;549&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab211960.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="sp0010" class="elsevierStyleSimplePara elsevierViewall">Estrategia de b&#250;squeda y resultados en MEDLINE</p>"
        ]
      ]
      2 => array:7 [
        "identificador" => "t0010"
        "etiqueta" => "Tabla 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="center" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Estrategia de b&#250;squeda&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="center" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Resultados&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">aged&#46;mp&#46; or aged&#47; or aged hospital patient&#46;mp&#46; or aged hospital patient&#47; or frail elderly&#46;mp&#46; or frail elderly&#47;or very elderly&#46;mp&#46; or very elderly&#47; or elder&#46;mp&#46; or geriatrics&#46;mp&#46; or geriatrics&#47; or aging&#46;mp&#46; or aging&#47;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;090&#46;777&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">nsaid&#46;mp&#46; or Nonsteroid Antiinflammatory Agent&#47; or Nonsteroidal Anti-Inflammatory Agents&#46;mp&#46; or &#40;coxib or Cyclooxygenase 2 Inhibitor&#41;&#46;mp&#46; or Acetylsalicylic Acid&#47; or Aspirin-Like Agents&#46;mp&#46; or naproxen&#46;mp&#46; or NAPROXEN&#47;or ibuprofen&#46;mp&#46; or IBUPROFEN&#47; or dexibuprofen&#36;&#46;mp&#46; or DEXIBUPROFEN&#47; or dexketoprofen&#46;mp&#46; or DEXKETOPROFEN&#47; or flurbiprofen&#46;mp&#46; or FLURBIPROFEN&#47; or Ketoprofen&#46;mp&#46; or KETOPROFEN&#47; or KETOROLAC&#47; or Ketorolac&#46;mp&#46; or aceclofenac&#46;mp&#46; or ACECLOFENAC&#47; or diclofenac&#46;mp&#46; or DICLOFENAC&#47; or lornoxicam&#46;mp&#46; or LORNOXICAM&#47; or meloxicam&#46;mp&#46; or MELOXICAM&#47; or PIROXICAM&#47; or piroxicam&#46;mp&#46; or PIROXICAM&#47; or piroxicam&#46;mp&#46; or tenoxicam&#46;mp&#46; or TENOXICAM&#47; or INDOMETACIN&#47; or indometacin&#46;mp&#46; or sulindac&#46;mp&#46; or SULINDAC&#47; or tolmetin&#46;mp&#46; or TOLMETIN&#47; or Phenylbutazone&#46;mp&#46; or PHENYLBUTAZONE&#47; or nabumetone&#47; or nabumeton&#46;mp&#46; or celecoxib&#46;mp&#46; or CELECOXIB&#47; or etoricoxib&#46;mp&#46; or ETORICOXIB&#47; or parecoxib&#46;mp&#46; or PARECOXIB&#47; or rofecoxib&#46;mp&#46; or ROFECOXIB&#47; or salicylic acid&#46;mp&#46; or Salicylic Acid&#47; or acetylsalicylic acid&#46;mp&#46; or Acetylsalicylic Acid&#47; or diflunisal&#46;mp&#46; or DIFLUNISAL&#47; or valdecoxib&#46;mp&#46; or VALDECOXIB&#47; or lumiracoxib&#46;mp&#46; or LUMIRACOXIB&#47;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">207&#46;945&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">exp clinical trial&#47; or evidence based medicine&#47; or outcomes research&#47; or crossover procedure&#47; or double blind procedure&#47; or single blind procedure&#47; or prospective study&#47; or major clinical study&#47; or exp comparative study&#47; or placebo&#47; or &#8220;evaluation and follow up&#8221;&#47; or follow up&#47; or randomization&#47;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;964&#46;112&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">controlled study&#47; not case control study&#47;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#46;568&#46;695&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3 o 4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3&#46;774&#46;593&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">&#40;&#40;clinic&#36; adjs trial&#36;&#41; or &#40;&#40;singl&#36; or doubl&#36; or trebl&#36; or tripl&#36;&#41; adj &#40;blind&#36; or mask&#36;&#41;&#41; or random&#36; or placebo&#36;&#41;&#46;ti&#44;ab&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">489&#46;355&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">5 o 6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3&#46;890&#46;101&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">exp musculoskeletal disease&#47; or musculoskeletal disease&#46;mp&#46; or rheumatic polymyalgia&#46;mp&#46; or polymyalgia&#47; or lupus erythematosus systemic&#46;mp&#46; or systemic lupus erythematosus&#47; or vasculitis&#47; or vasculitis&#46;mp&#46; or polymyositis&#46;mp&#46; or polymyositis&#47; or dermatomyositis&#46;mp&#46; or dermatomyositis&#47;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">669&#46;390&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">perioperative period&#46;mp&#46; or PERIOPERATIVE PERIOD&#47; or perioperative care&#46;mp&#46; or SURGERY&#47; or surgery&#46;mp&#46; or SURGICAL TECHNIQUE&#47; or surgical procedures&#46;mp&#46; or PEROPERATIVE CARE&#47; or preoperative care&#46;mp&#46; or intraoperative care&#46;mp&#46; or PEROPERATIVE COMPLICATION&#47; or POSTOPERATIVE COMPLICATION&#47; or dysmenorrhoea&#46;mp&#46; or Dysmenorrhea&#47; or orthodontic&#46;mp&#46; or Orthodontics&#47; or exp malignant neoplastic disease&#47; or cancer&#47; or exp metastasis&#47; or exp mixed tumor&#47; or exp &#8220;neoplasms of uncertain behavior&#8221;&#47; or exp neoplasms subdivided by anatomical site&#47; or exp &#8220;oncogenesis and malignant transformation&#8221;&#47; or exp paraneoplastic syndrome&#47; or exp &#8220;precancer and cancer-in-situ&#8221;&#47; or adolescent&#46;mp&#46; or adolescent&#47; or hospitalized adolescent&#47; or juvenile&#46;mp&#46; or juvenile&#47; or child&#46;mp&#46; or child&#47; or boy&#46;mp&#46; or boy&#47; or gifted child&#47; or girl&#46;mp&#46; or girl&#47; or handicapped child&#47; or hospitalized child&#47; or preschool child&#47; or school child&#47; or infant&#46;mp&#46; or infant&#47; or baby&#46;mp&#46; or baby&#47; or high risk infant&#47; or hospitalized infant&#47; or newborn&#46;mp&#46; or newborn&#47; or suckling&#46;mp&#46; or suckling&#47; or pediatric&#46;mp&#46; or review&#47; or guideline&#46;mp&#46;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3&#46;370&#46;213&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">10&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 y 2 y 7 y 8&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4&#46;449&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">11&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">10 no 9&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#46;997&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">12&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Limit 11 to humans&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#46;965&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">13&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Limit 12 to abstracts&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="right" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#46;668&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab211963.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="sp0015" class="elsevierStyleSimplePara elsevierViewall">Estrategia de b&#250;squeda y resultados en EMBASE</p>"
        ]
      ]
      3 => array:7 [
        "identificador" => "t0015"
        "etiqueta" => "Tabla 3"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:2 [
          "leyenda" => "<p id="sp0025" class="elsevierStyleSimplePara elsevierViewall">AINE&#58; antiinflamatorios no esteroideos&#59; AR&#58; artritis reumatoide&#59; CE&#58; criterios de exclusi&#243;n&#59; CI&#58; criterios de inclusi&#243;n&#59; EC&#58; ensayo cl&#237;nico&#59; HTA&#58; hipertensi&#243;n arterial&#59; HZ&#58; <span class="elsevierStyleItalic">hazard ratio&#59;</span> IC&#58; intervalo de confianza&#59; OA&#58; osteoartrosis&#59; OR&#58; <span class="elsevierStyleItalic">odds ratio&#59;</span> PA&#58; presi&#243;n arterial&#59; PAD&#58; presi&#243;n arterial diast&#243;lica&#59; PAS&#58; presi&#243;n arterial sist&#243;lica&#59; RR&#58; riesgo relativo&#59; VGM&#58; valoraci&#243;n global del m&#233;dico&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Resultados&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Participantes e intervenci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Bakshi et al<a class="elsevierStyleCrossRef" href="#bb0065"><span class="elsevierStyleSup">13</span></a>&#44; EC a doble ciego controlado con placebo&#46; Seguimiento&#44; 4 meses&#46; Jadad 4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">314 OA cadera&#47;rodilla&#47;manos&#44; 186 &#40;60&#37;&#41; mujeres&#44; 60-80 a&#241;os&#44; duraci&#243;n media de la OA 6&#44;4 a&#241;os&#46; CE&#58; alergia a AINE&#44; &#250;lcera o sangrado digestivo previo&#44; enfermedad hem&#225;tica&#44; hep&#225;tica o insuficiencia card&#237;aca&#46; Diclofenaco 150<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; 4 semanas &#40;n &#61; 208&#41;&#46; Placebo&#44; 4 semanas &#40;n &#61; 106&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Eficacia&#58; en comparaci&#243;n con placebo el diclofenaco fue mejor en&#58; dolor en reposo &#40;p &#60; 0&#44;001&#41;&#44; dolor en movimiento &#40;p &#60; 0&#44;001&#41;&#44; dolor a la presi&#243;n local &#40;p &#61; 0&#44;040&#41;&#44; rigidez en reposo &#40;p &#61; 0&#44;008&#41;&#46; Sin diferencias en dolor en actividad diaria&#46; Seguridad&#58; eventos adversos leves-moderados&#58; diclofenaco &#40;n &#61; 30&#41;&#44; placebo &#40;n &#61; 18&#41; &#40;p &#61; 0&#44;551&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Chan et al<a class="elsevierStyleCrossRef" href="#bb0070"><span class="elsevierStyleSup">14</span></a>&#44; EC a doble ciego controlado con placebo&#46; Seguimiento&#44; 6 meses&#46; Jadad 5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">222 pacientes con artriris &#40;52&#37; mujeres&#59; media de edad&#44; 67&#44;1 a&#241;os&#41;&#46; CI&#58; ulcus sangrante previo curado&#44; <span class="elsevierStyleItalic">Helicobacter pilori</span> negativo&#46; CE&#58; esteroides&#44; anticoagulantes&#44; cirug&#237;a g&#225;strica o duodenal&#44; esofagitis erosiva&#44; obstrucci&#243;n g&#225;strica&#44; insuficiencia renal&#46; Celecoxib 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#43; placebo 6 meses &#40;n &#61; 116&#41;&#46; Diclofenaco 150<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#43; omeprazol 20<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 6 meses &#40;n &#61; 106&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Seguridad&#58; <span class="elsevierStyleItalic">a&#41;</span> sangrado gastrointestinal&#58; celecoxib &#40;n &#61; 7&#41;&#44; diclofenaco &#40;n &#61; 9&#41; &#40;p &#61; 0&#44;511&#41;&#59; <span class="elsevierStyleItalic">b&#41;</span> ulcus gastroduodenal recurrente&#58; celecoxib &#40;n &#61; 20&#41;&#44; diclofenaco &#40;n &#61; 26&#41; &#40;p &#61; 0&#44;180&#41;&#59; <span class="elsevierStyleItalic">c&#41;</span> sin dispepsia o m&#237;nima&#58; celecoxib &#40;n &#61; 100&#41;&#44; diclofenaco &#40;n &#61; 98&#41; &#40;p &#61; 0&#44;720&#41;&#59; <span class="elsevierStyleItalic">d&#41;</span> dispepsia significativa&#58; celecoxib &#40;n &#61; 16&#41;&#44; diclofenaco &#40;n &#61; 18&#41; &#40;p &#61; 0&#44;572&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Cheatum et al<a class="elsevierStyleCrossRef" href="#bb0125"><span class="elsevierStyleSup">25</span></a>&#44; estudio transversal&#44; calidad 2a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;826 pacientes &#40;1&#46;009 AR&#44; 817 OA&#41;&#44; 67&#44;3&#37; mujeres&#59; media de edad&#44; 54&#44;3 a&#241;os&#46; Consumo de AINE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Seguridad&#58; <span class="elsevierStyleItalic">a&#41;</span> prevalencia de &#250;lcera gastroduodenal&#58; 60-69 a&#241;os &#40;29&#37;&#41;&#44; 70-79 a&#241;os &#40;34&#37;&#41;&#44; &#62; 80 a&#241;os 32&#37;&#41;&#59; <span class="elsevierStyleItalic">b&#41;</span> prevalencia de &#250;lcera gastroduodenal en AR&#58; 60-69 a&#241;os &#40;24&#37;&#41;&#44; 70-79 a&#241;os &#40;27&#37;&#41;&#44; &#62; 80 a&#241;os &#40;14&#37;&#41;&#59; <span class="elsevierStyleItalic">c&#41;</span> prevalencia de &#250;lcera gastroduodenal en OA&#58; 60-69 a&#241;os &#40;35&#37;&#41;&#44; 70-79 a&#241;os &#40;41&#37;&#41;&#44; &#62; 80 a&#241;os &#40;37&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Detora et al<a class="elsevierStyleCrossRef" href="#bb0075"><span class="elsevierStyleSup">15</span></a>&#44; metaan&#225;lisis&#44; 3 EC &#40;Jadad 4&#41;&#44; seguimiento 6 semanas&#46; Calidad 1a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;491 OA &#40;73&#37; mujeres&#44; media de 62 a&#241;os&#41; Rofecoxib 12&#44;5<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 6 semanas &#40;n &#61; 288&#41;&#46; Rofecoxib 25<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 6 semanas &#40;n &#61; 607&#41;&#46; Placebo 6 semanas &#40;n &#61; 596&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Eficacia en comparaci&#243;n con placebo&#58; <span class="elsevierStyleItalic">a&#41;</span> valoraci&#243;n global del paciente &#40;VAS&#41;&#58; rofecoxib 12&#44;5<span class="elsevierStyleHsp" style=""></span>mg&#44; &#8211;1 &#40;&#8211;1&#44;3 a &#8211;1&#44;8&#41;&#59; rofecoxib 25<span class="elsevierStyleHsp" style=""></span>mg&#44; &#8211;1&#44;1 &#40;&#8211;1&#44;3 a &#8211;0&#44;9&#41;&#44; sin diferencias entre los 2 rofecoxib&#59; <span class="elsevierStyleItalic">b&#41;</span> dolor al caminar &#40;VAS&#41;&#58; Rofecoxib 12&#44;5<span class="elsevierStyleHsp" style=""></span>mg&#44; &#8211;16&#44;9 &#40;&#8211;21&#44;7 a &#8211;12&#44;1&#41;&#59; rofecoxib 25<span class="elsevierStyleHsp" style=""></span>mg&#44; &#8211;18&#44;1 &#40;&#8211;22&#44;8 a &#8211;13&#44;4&#41;&#59; sin diferencias entre los 2 rofecoxib&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Earl et al<a class="elsevierStyleCrossRef" href="#bb0075"><span class="elsevierStyleSup">15</span></a>&#44; EC a doble ciego&#44; seguimiento 4 semanas&#46; Jadad 5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">59 OA &#40;73&#37; mujeres&#44; media de edad&#44; 71 a&#241;os&#41;&#46; CI&#58; OA cadera&#47;rodilla&#44; capaces de andar y de autocuidado&#46; CE&#58; tratamientos para el dolor diferentes de AINE&#44; anemia&#44; ulcus&#44; alcohol&#44; disfunci&#243;n renal o hep&#225;tica&#46; Ibuprofeno 1&#46;600<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 4 semanas &#40;n &#61; 38&#41;&#46; Piroxicam 20<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 4 semanas &#40;n &#61; 21&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Eficacia&#58; s&#243;lo el ibuprofeno mejora la flexi&#243;n de cadera&#47;rodilla &#40;p &#60; 0&#44;050&#41;&#46; Ninguno&#58; rotaci&#243;n interna de cadera&#59; los 2&#58; dolor articular&#44; horas de sue&#241;o &#40;p &#62; 0&#44;050&#41;&#46; Seguridad&#58; eventos adversos&#58; ibuprofeno &#40;n &#61; 6&#41;&#44; piroxicam &#40;n &#61; 7&#41; &#40;p &#62; 0&#44;050&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Eisen et al<a class="elsevierStyleCrossRef" href="#bb0050"><span class="elsevierStyleSup">10</span></a> &#40;2005&#41;&#44; metaanalisis&#44; 5 EC &#40;Jadad 4-5&#41;&#44; seguimiento 12 semanas&#46; Calidad 1a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4&#46;394 AR&#47;OA &#40;28&#37; mujeres&#44; media de edad&#44; 59 a&#241;os&#41;&#46; CE&#58; enfermedad gastrointestinal grave&#44; malignidad&#46; Valdecoxib 10-40<span class="elsevierStyleHsp" style=""></span>mg&#47; d&#237;a 12 semanas &#40;n &#61; 2&#46;236&#41;&#46; Otros AINE 12 semanas &#40;n &#61; 1&#46;185&#41;&#58; naproxeno 1&#46;000<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; ibuprofeno 2&#46;400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#44; diclofenaco 150<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a&#46; Placebo 12 semanas &#40;n &#61; 973&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Seguridad&#58; comparado con grupo AINE riesgo de s&#237;ntoma gastroduodenal moderado&#47;severo&#59; valdecoxib &#40;cualquier dosis&#41;&#44; HR &#61; 0&#44;59 &#40;IC del 95&#37;&#44; 0&#44;47-0&#44;74&#41;&#59; valdecoxib 10<span class="elsevierStyleHsp" style=""></span>mg&#44; HR &#61; 0&#44;69 &#40;IC del 95&#37;&#44; 0&#44;53-0&#44;90&#41;&#59; valdecoxib 20<span class="elsevierStyleHsp" style=""></span>mg&#44; HR &#61; 0&#44;43 &#40;IC del 95&#37;&#44; 0&#44;32-0&#44;60&#41;&#59; valdecoxib 40<span class="elsevierStyleHsp" style=""></span>mg&#44; HR &#61; 0&#44;73 &#40;IC del 95&#37;&#44; 0&#44;49-1&#44;08&#41;&#59; placebo&#44; HR &#61; 0&#44;63 &#40;IC del 95&#37;&#44; 0&#44;47-0&#44;83&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Fries et al<a class="elsevierStyleCrossRef" href="#bb0115"><span class="elsevierStyleSup">23</span></a> &#40;1991&#41;&#44; cohorte prospectiva&#44; seguimiento medio 4 a&#241;os&#46; Calidad 2a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2&#46;747 AR &#40;76&#44;7&#37; mujeres&#44; media de edad 60 a&#241;os&#44; duraci&#243;n media de enfermedad 17 a&#241;os&#41;&#46; AINE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Seguridad&#58; <span class="elsevierStyleItalic">a&#41;</span> riesgo de hospitalizaci&#243;n&#47;muerte por evento adverso gastrointestinal&#58; &#62; 45 a&#241;os&#44; OR &#61; 7 &#40;2&#44;21-22&#44;4&#41;&#59; &#62; 50 a&#241;os&#44; OR &#61; 4&#44;4 &#40;2&#44;01-9&#44;52&#41;&#59; &#62; 60 a&#241;os&#44; OR &#61; 2&#44;7 &#40;1&#44;70-4&#44;30&#41;&#59; &#62; 65 a&#241;os&#44; OR &#61; 2&#44;4 &#40;1&#44;56-3&#44;55&#41;&#59; &#62; 70 a&#241;os&#44; OR &#61; 2 &#40;1&#44;30-3&#44;08&#41;&#59; &#62; 75 a&#241;os&#44; OR &#61; 2&#44;2 &#40;1&#44;28-3&#44;85&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hawkey et al<a class="elsevierStyleCrossRefs" href="#bb0080"><span class="elsevierStyleSup">16&#44;17</span></a>&#44; EC a doble ciego&#44; <span class="elsevierStyleItalic">doble-dummy</span>&#44; multic&#233;ntrico&#44; seguimiento 52 semanas&#46; Jadad 4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3&#46;959 OA&#44; &#62; 65 a&#241;os &#40;76&#37; mujeres&#41;&#46; CI&#58; dolor articular moderado&#46; CE&#58; protectores g&#225;stricos&#44; ulcus 30 d&#237;as previos&#44; sangrado&#47;perforaci&#243;n&#47; obstrucci&#243;n intestinal&#46; Lumiracoxib 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 3&#46;980&#41;&#46; Naproxeno 1&#46;000<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 2&#46;098&#41;&#46; Ibuprofeno 2&#46;400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 1&#46;861&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Seguridad&#58; riesgo de ulcus gastroduodenal&#58; AINE&#44; HR &#61; 1&#44;79 &#40;1&#44;33-2&#44;42&#41;&#59; lumiracoxib&#44; HR &#61; 1&#44;26 &#40;0&#44;82-1&#44;95&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Kaarela et al<a class="elsevierStyleCrossRef" href="#bb0090"><span class="elsevierStyleSup">18</span></a>&#44; EC a doble ciego&#44; seguimiento 14 d&#237;as&#46; Jadad 4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">31 AR &#40;84&#37; mujeres&#41;&#44; 18 &#62; 65 a&#241;os&#46; Indometacina 150<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 14 d&#237;as&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Eficacia&#58; mejor&#237;a de la rigidez matutina &#40;p &#61; 0&#44;001&#41;&#44; sin diferencias en comparaci&#243;n con los j&#243;venes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Koch et al<a class="elsevierStyleCrossRef" href="#bb0095"><span class="elsevierStyleSup">19</span></a>&#44; EC a doble ciego controlado con placebo&#44; seguimiento 6 meses&#46; Jadad 4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8&#46;840 AR &#40;mujeres&#44; media de edad 68 a&#241;os&#41;&#46; CI&#58; &#62; 52 a&#241;os&#44; tomar AINE para 6 meses&#46; CE&#58; ulcus p&#233;ptico 30 d&#237;as antes&#44; otras enfermedades digestivas graves&#44; di&#225;tesis hemorr&#225;gica&#46; AINE &#43; misoprostol 6 meses n &#61; 4&#46;404&#41;&#46; AINE &#43; placebo 6 meses &#40;n &#61; 4&#46;404&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Seguridad&#58; riesgo de complicaci&#243;n gastrointestinal &#40;ulcus&#44; hemorragia&#44; obstrucci&#243;n&#41; &#62; 65 a&#241;os&#46; Grupo misoprostol&#44; RR &#61; 0&#44;70&#59; placebo&#44; RR &#61; 1&#44;16 &#40;reducci&#243;n del riesgo del 40&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Le Loet<a class="elsevierStyleCrossRef" href="#bb0120"><span class="elsevierStyleSup">24</span></a>&#44; cohorte prospectiva&#44; multic&#233;ntrica&#44; seguimiento 4 semanas&#46; Calidad 2a&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">19&#46;880 pacientes &#62; 60 a&#241;os &#40;media&#44; 72 a&#241;os&#41;&#44; 66&#37; mujeres con enfermedad reum&#225;tica &#40;93&#37; enfermedad degenerativa&#41;&#46; CE&#58; contraindicaci&#243;n del uso de AINE&#44; enfermadad hep&#225;tica&#44; renal o hem&#225;tica severa&#46; Ketoprofeno 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 4 semanas&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Eficacia&#58; <span class="elsevierStyleItalic">a&#41;</span> VGM buena&#47;excelente&#44; 74&#44;4&#37;&#59; <span class="elsevierStyleItalic">b&#41;</span> tolerabilidad seg&#250;n paciente buena&#47;excelente&#44; 85&#37;&#46; Seguridad&#58; <span class="elsevierStyleItalic">a&#41;</span> eventos adversos&#58; ketoprofeno&#44; 15&#44;3&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Lisse et al<a class="elsevierStyleCrossRef" href="#bb0055"><span class="elsevierStyleSup">11</span></a>&#44; metaan&#225;lisis&#44; 3 EC &#40;Jadad 3-4&#41;&#44; seguimiento 12 semanas&#46; Calidad 1b&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">786 OA de cadera o rodilla&#44; &#62; 70 a&#241;os&#44; 68&#37; mujeres&#46; Celecoxib 200<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 12 semanas &#40;n &#61; 191&#41;&#46; Celecoxib 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 183&#41;&#46; Naproxeno 1&#46;000<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 12 semanas &#40;n &#61; 206&#41;&#46; Placebo 12 semanas &#40;n &#61; 188&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Eficacia&#58; comparado con placebo los 3 AINE mejoraron m&#225;s el WOMAC &#40;p &#60; 0&#44;001&#41; y el SF-36 &#40;p &#60; 0&#44;010&#41;&#46; No hubo diferencias entre los 3 AINE&#46; Seguridad&#58; <span class="elsevierStyleItalic">a&#41;</span> al menos un evento adverso grave&#58; celecoxib 200<span class="elsevierStyleHsp" style=""></span>mg &#40;n &#61; 7&#41;&#44; celecoxib 400 &#40;n &#61; 9&#41;&#44; naproxeno 1&#46;000<span class="elsevierStyleHsp" style=""></span>mg &#40;n &#61; 4&#41;&#44; placebo &#40;n &#61; 8&#41; &#40;p &#62; 0&#44;050&#41;&#59; <span class="elsevierStyleItalic">b&#41;</span> evento adverso gastrointestinal&#58; celecoxib 200<span class="elsevierStyleHsp" style=""></span>mg &#40;n &#61; 49&#41;&#44; celecoxib 400<span class="elsevierStyleHsp" style=""></span>mg &#40;n &#61; 37&#41;&#44; naproxeno &#40;n &#61; 62&#41;&#44; placebo &#40;n &#61; 32&#41;&#46; Mayor en naproxeno comparado con placebo y celecoxib 200<span class="elsevierStyleHsp" style=""></span>mg&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Regula et al<a class="elsevierStyleCrossRef" href="#bb0100"><span class="elsevierStyleSup">20</span></a> &#40;2006&#41;&#44; EC a doble ciego&#44; seguimiento 6 meses&#46; Jadad&#58; 4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">595 AR&#44; OA&#44; espondilosis&#44; espondilitis &#40;71&#37; mujeres&#44; media de edad 66 a&#241;os&#41;&#46; CI&#58; &#8805; 1 factor de riesgo de toxicidad gastrointestinal&#46; CE&#58; ulcus activo&#47;complicado&#44; cirug&#237;a digestiva&#44; bridas esof&#225;gicas&#44; Zollinger-Ellison&#44; enfermedad grave&#46; AINE &#43; pantoprazol 20<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 6 meses &#40;n &#61; 196&#41;&#46; AINE &#43; pantoprazol 40<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 6 meses &#40;n &#61; 199&#41;&#46; AINE &#43; omeprazol 20<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 6 meses &#40;n &#61; 200&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Seguridad&#58; ulcus p&#233;ptico&#58; pantoprazol 20<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 7&#41;&#44; pantoprazol 40<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 3&#41;&#44; omeprazol 20<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 4&#41; &#40;p &#62; 0&#44;050&#41;&#59; sin diferencias&#58; s&#237;ntomas gastrointestinales&#44; esofagitis por reflujo&#44; 10 o m&#225;s erosiones o petequias&#44; eventos adversos graves&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Schiff et al<a class="elsevierStyleCrossRef" href="#bb0060"><span class="elsevierStyleSup">12</span></a>&#44; metaan&#225;lisis de 2 EC &#40;Jadad 4&#41;&#44; Seguimiento 1 semana&#46; Calidad 1b&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">198 OA de rodilla&#44; &#62; 65 a&#241;os&#44; 62&#37; mujeres&#46; CI&#58; OA activa con dolor al menos moderado&#46; CE&#58; protectores g&#225;stricos&#44; otras enfermedades reumatol&#243;gicas&#44; historia de ulcus p&#233;ptico en 9 meses previos&#44; cirug&#237;a digestiva&#44; trastornos en la absorci&#243;n&#46; Naproxeno 400<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 1 semana &#40;n &#61; 66&#41;&#46; Ibuprofeno 1&#46;200<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 1 semana &#40;n &#61; 66&#41;&#46; Placebo 1 semana &#40;n &#61; 66&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Eficacia&#58; naproxeno e ibuprofeno mejores que placebo en&#58; dolor en reposo&#44; movimientos pasivos nocturnos&#44; rigidez matutina&#44; tiempo en caminar 20<span class="elsevierStyleHsp" style=""></span>m &#40;p &#60; 0&#44;050&#41;&#44; dolor diario &#40;p &#60; 0&#44;010&#41;&#44; a la carga &#40;p &#61; 0&#44;064&#41;&#46; Seguridad&#58; <span class="elsevierStyleItalic">a&#41;</span> cualquier evento adverso&#58; naproxeno 440<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 14&#41;&#44; ibuprofeno 1&#46;200<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 14&#41;&#44; placebo &#40;n &#61; 17&#41; &#40;p &#61; 0&#44;538&#41;&#59; <span class="elsevierStyleItalic">b&#41;</span> eventos adversos graves&#58; naproxeno 440<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 3&#41;&#44; ibuprofeno 1&#46;200<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 4&#41;&#44; placebo &#40;n &#61; 8&#41; &#40;p &#61; 0&#44;115&#41;&#59; <span class="elsevierStyleItalic">c&#41;</span> evento adverso gastrointestinal&#58; naproxeno 440<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 11&#41;&#44; ibuprofeno 1&#46;200<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a &#40;n &#61; 10&#41;&#44; placebo &#40;n &#61; 9&#41; &#40;p &#61; 0&#44;627&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Silverstein et al<a class="elsevierStyleCrossRef" href="#bb0105"><span class="elsevierStyleSup">21</span></a>&#44; EC a doble ciego&#44; controlado con placebo&#44; seguimiento 6 meses&#46; Jadad 4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8&#46;840 AR &#40;mujeres&#44; media de edad 68 a&#241;os&#41;&#46; CI&#58; &#62; 52 a&#241;os&#44; tomar AINE para 6 meses&#46; CE&#58; ulcus 30 d&#237;as previos&#44; enfermedades digestivas graves&#44; protectores g&#225;stricos&#44; di&#225;tesis hemorr&#225;gica&#46; AINE &#43; misoprostol 6 meses &#40;n &#61; 4&#46;404&#41;&#46; AINE &#43; placebo 6 meses &#40;n &#61; 4&#46;404&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Seguridad&#58; asociaci&#243;n &#40;ajustada&#41; a complicaci&#243;n gastrointestinal &#40;&#250;lcera&#44; hemorragia&#44; obstrucci&#243;n&#41; en &#62; 75 a&#241;os en la cohorte &#40;OR &#61; 2&#44;48&#59; IC del 95&#37;&#44; 1&#44;48-4&#44;14&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Whelton et al<a class="elsevierStyleCrossRef" href="#bb0110"><span class="elsevierStyleSup">22</span></a>&#44; EC a doble ciego&#44; seguimiento 6 semanas&#46; Jadad 5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#46;092 OA &#40;62&#37; mujeres&#44; media de edad 73 a&#241;os&#41;&#46; CI&#58; &#62; 65 a&#241;os&#44; OA clase funcional I-III&#44; HTA estable con dosis fija de antihipertensivos en 3 meses previos&#44; beneficio del uso de AINE&#46; CE&#58; protectores g&#225;stricos&#44; enfermedades severas&#46; Celecoxib 200<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 6 semanas &#40;n &#61; 543&#41;&#46; Rofecoxib 25<span class="elsevierStyleHsp" style=""></span>mg&#47;d&#237;a 6 semanas &#40;n &#61; 549&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Seguridad&#58; <span class="elsevierStyleItalic">a&#41;</span> &#8593; en PAS &#62; 20 y PAS &#62; 140<span class="elsevierStyleHsp" style=""></span>mmHg&#58; celecoxib &#40;n &#61; 38&#41;&#44; rofecoxib &#40;n &#61; 81&#41; &#40;p &#60; 0&#44;001&#41;&#59; <span class="elsevierStyleItalic">b&#41;</span> &#8593; en PAD &#62; 15 y PAD &#62; 90<span class="elsevierStyleHsp" style=""></span>mmHg&#58; celecoxib &#40;n &#61; 7&#41;&#44; rofecoxib &#40;n &#61; 12&#41; &#40;p &#61; 0&#44;257&#41;&#59; <span class="elsevierStyleItalic">c&#41;</span> edema cl&#237;nicamente significativo&#58; celecoxib &#40;n &#61; 26&#41;&#44; rofecoxib &#40;n &#61; 42&#41; &#40;p &#61; 0&#44;045&#41;&#59; <span class="elsevierStyleItalic">d&#41;</span> insuficiencia card&#237;aca congestiva &#40;primer episodio&#41;&#58; celecoxib &#40;n &#61; 2&#41;&#44; rofecoxib &#40;n &#61; 3&#41; &#40;p &#61; 0&#44;663&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab211961.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="sp0020" class="elsevierStyleSimplePara elsevierViewall">Caracter&#237;sticas de los estudios incluidos</p>"
        ]
      ]
      4 => array:7 [
        "identificador" => "t0020"
        "etiqueta" => "Tabla 4"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Causas de exclusi&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Admani et al<a class="elsevierStyleCrossRef" href="#bb0130"><span class="elsevierStyleSup">26</span></a> &#40;1983&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Ahern et al<a class="elsevierStyleCrossRef" href="#bb0135"><span class="elsevierStyleSup">27</span></a> &#40;1992&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Arone<a class="elsevierStyleCrossRef" href="#bb0140"><span class="elsevierStyleSup">28</span></a> &#40;1989&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Bacon<a class="elsevierStyleCrossRef" href="#bb0145"><span class="elsevierStyleSup">29</span></a> &#40;1994&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Bauer et al<a class="elsevierStyleCrossRef" href="#bb0150"><span class="elsevierStyleSup">30</span></a> &#40;1996&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Blardi et al<a class="elsevierStyleCrossRef" href="#bb0155"><span class="elsevierStyleSup">31</span></a> &#40;1992&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Browning et al<a class="elsevierStyleCrossRef" href="#bb0160"><span class="elsevierStyleSup">32</span></a> &#40;1994&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Busson<a class="elsevierStyleCrossRef" href="#bb0165"><span class="elsevierStyleSup">33</span></a> &#40;1986a&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Busson<a class="elsevierStyleCrossRef" href="#bb0170"><span class="elsevierStyleSup">34</span></a> &#40;1986b&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Calin<a class="elsevierStyleCrossRef" href="#bb0175"><span class="elsevierStyleSup">35</span></a> &#40;1993&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Caughey et al<a class="elsevierStyleCrossRef" href="#bb0180"><span class="elsevierStyleSup">36</span></a> &#40;1989&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Cordaro et al<a class="elsevierStyleCrossRef" href="#bb0185"><span class="elsevierStyleSup">37</span></a> &#40;1988&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No hay datos de pacientes mayores de 60 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Cummings et al<a class="elsevierStyleCrossRef" href="#bb0190"><span class="elsevierStyleSup">38</span></a> &#40;1988&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Currie et al<a class="elsevierStyleCrossRef" href="#bb0195"><span class="elsevierStyleSup">39</span></a> &#40;1984&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Davis et al<a class="elsevierStyleCrossRef" href="#bb0200"><span class="elsevierStyleSup">40</span></a> &#40;1987&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Dominick et al<a class="elsevierStyleCrossRef" href="#bb0205"><span class="elsevierStyleSup">41</span></a> &#40;2003&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No relacionado con la pregunta de investigaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Dreiser et al<a class="elsevierStyleCrossRef" href="#bb0210"><span class="elsevierStyleSup">42</span></a> &#40;1993&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Famaey et al<a class="elsevierStyleCrossRef" href="#bb0215"><span class="elsevierStyleSup">43</span></a> &#40;1976&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Fossaluzza et al<a class="elsevierStyleCrossRef" href="#bb0220"><span class="elsevierStyleSup">44</span></a> &#40;1989&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Fries<a class="elsevierStyleCrossRef" href="#bb0225"><span class="elsevierStyleSup">45</span></a> &#40;1992&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No hace un an&#225;lisis estrictamente de mayores de 60 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Fries et al<a class="elsevierStyleCrossRef" href="#bb0230"><span class="elsevierStyleSup">46</span></a> &#40;2004&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No relacionado con la pregunta de investigaci&#243;n&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Fullerton et al<a class="elsevierStyleCrossRef" href="#bb0235"><span class="elsevierStyleSup">47</span></a> &#40;1993&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Gabriel et al<a class="elsevierStyleCrossRef" href="#bb0240"><span class="elsevierStyleSup">48</span></a> &#40;1997&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Geczy et al<a class="elsevierStyleCrossRef" href="#bb0245"><span class="elsevierStyleSup">49</span></a> &#40;1987&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Girawan et al<a class="elsevierStyleCrossRef" href="#bb0250"><span class="elsevierStyleSup">50</span></a> &#40;2004&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Goldstein et al<a class="elsevierStyleCrossRef" href="#bb0015"><span class="elsevierStyleSup">3</span></a> &#40;2003&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Sujetos sanos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Grace et al<a class="elsevierStyleCrossRef" href="#bb0255"><span class="elsevierStyleSup">51</span></a> &#40;1987&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Grigor et al<a class="elsevierStyleCrossRef" href="#bb0260"><span class="elsevierStyleSup">52</span></a> &#40;1987&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No se sabe si el AAS se utiliza a dosis de antiagregante&#44; analg&#233;sico o antiinflamatorio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Halici et al<a class="elsevierStyleCrossRef" href="#bb0265"><span class="elsevierStyleSup">53</span></a> &#40;2002&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hart et al<a class="elsevierStyleCrossRef" href="#bb0270"><span class="elsevierStyleSup">54</span></a> &#40;1965&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hart et al<a class="elsevierStyleCrossRef" href="#bb0275"><span class="elsevierStyleSup">55</span></a> &#40;1983&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hawkey et al<a class="elsevierStyleCrossRef" href="#bb0280"><span class="elsevierStyleSup">56</span></a> &#40;2001&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No aporta datos suficientes de mayores de 60 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Henry et al<a class="elsevierStyleCrossRef" href="#bb0285"><span class="elsevierStyleSup">57</span></a> &#40;1997&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Hochain et al<a class="elsevierStyleCrossRef" href="#bb0290"><span class="elsevierStyleSup">58</span></a> &#40;1995&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Horackova et al<a class="elsevierStyleCrossRef" href="#bb0295"><span class="elsevierStyleSup">59</span></a> &#40;2005&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Innes<a class="elsevierStyleCrossRef" href="#bb0300"><span class="elsevierStyleSup">60</span></a> &#40;1977&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Jackson et al<a class="elsevierStyleCrossRef" href="#bb0305"><span class="elsevierStyleSup">61</span></a> &#40;1987&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No aporta datos concretos en mayores de 60 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Janke et al<a class="elsevierStyleCrossRef" href="#bb0310"><span class="elsevierStyleSup">62</span></a> &#40;1984&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Johnson et al<a class="elsevierStyleCrossRef" href="#bb0315"><span class="elsevierStyleSup">63</span></a> &#40;1993&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Laine et al<a class="elsevierStyleCrossRef" href="#bb0320"><span class="elsevierStyleSup">64</span></a> &#40;2002&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Lai et al<a class="elsevierStyleCrossRef" href="#bb0325"><span class="elsevierStyleSup">65</span></a> &#40;2005&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Lane et al<a class="elsevierStyleCrossRef" href="#bb0330"><span class="elsevierStyleSup">66</span></a> &#40;1997&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Layton et al<a class="elsevierStyleCrossRef" href="#bb0335"><span class="elsevierStyleSup">67</span></a> &#40;2003&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Le Loet et al<a class="elsevierStyleCrossRef" href="#bb0340"><span class="elsevierStyleSup">68</span></a> &#40;1997&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Littman et al<a class="elsevierStyleCrossRef" href="#bb0345"><span class="elsevierStyleSup">69</span></a> &#40;1995&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Mamdani et al<a class="elsevierStyleCrossRef" href="#bb0350"><span class="elsevierStyleSup">70</span></a> &#40;2002&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Mann et al<a class="elsevierStyleCrossRef" href="#bb0355"><span class="elsevierStyleSup">71</span></a> &#40;2004&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">La poblaci&#243;n de estudio es general&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">McNeil<a class="elsevierStyleCrossRef" href="#bb0360"><span class="elsevierStyleSup">72</span></a> &#40;1993&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Meurice<a class="elsevierStyleCrossRef" href="#bb0365"><span class="elsevierStyleSup">73</span></a> &#40;1983&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Montrone et al<a class="elsevierStyleCrossRef" href="#bb0370"><span class="elsevierStyleSup">74</span></a> &#40;1990&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Morgan et al<a class="elsevierStyleCrossRef" href="#bb0375"><span class="elsevierStyleSup">75</span></a> &#40;1993&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Morgan et al<a class="elsevierStyleCrossRef" href="#bb0010"><span class="elsevierStyleSup">2</span></a> &#40;2001&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Morton et al<a class="elsevierStyleCrossRef" href="#bb0380"><span class="elsevierStyleSup">76</span></a> &#40;1998&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No hay datos concretos de pacientes mayores de 60 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Motsko et al<a class="elsevierStyleCrossRef" href="#bb0385"><span class="elsevierStyleSup">77</span></a> &#40;2006&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&#46; Poblaci&#243;n general&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Nesher et al<a class="elsevierStyleCrossRef" href="#bb0390"><span class="elsevierStyleSup">78</span></a> &#40;1995&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Niccoli et al<a class="elsevierStyleCrossRef" href="#bb0035"><span class="elsevierStyleSup">7</span></a> &#40;2002&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Nietert et al<a class="elsevierStyleCrossRef" href="#bb0395"><span class="elsevierStyleSup">79</span></a> &#40;2003&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">O&#39;Brien<a class="elsevierStyleCrossRef" href="#bb0400"><span class="elsevierStyleSup">80</span></a> &#40;1983&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Perpignano et al<a class="elsevierStyleCrossRef" href="#bb0405"><span class="elsevierStyleSup">81</span></a> &#40;1994&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Puccetti et al<a class="elsevierStyleCrossRef" href="#bb0410"><span class="elsevierStyleSup">82</span></a> &#40;1991&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Rabenda et al<a class="elsevierStyleCrossRef" href="#bb0415"><span class="elsevierStyleSup">83</span></a> &#40;2005&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">La poblaci&#243;n de estudio es general&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Rabenda et al<a class="elsevierStyleCrossRef" href="#bb0420"><span class="elsevierStyleSup">84</span></a> &#40;2006&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No hay datos concretos de pacientes mayores de 60 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Rahme et al<a class="elsevierStyleCrossRef" href="#bb0425"><span class="elsevierStyleSup">85</span></a> &#40;2002&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Rahme et al<a class="elsevierStyleCrossRef" href="#bb0430"><span class="elsevierStyleSup">86</span></a> &#40;2007a&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Rahme et al<a class="elsevierStyleCrossRef" href="#bb0435"><span class="elsevierStyleSup">87</span></a> &#40;2007b&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Roth et al<a class="elsevierStyleCrossRef" href="#bb0440"><span class="elsevierStyleSup">88</span></a> &#40;1993&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Roth et al<a class="elsevierStyleCrossRef" href="#bb0445"><span class="elsevierStyleSup">89</span></a> &#40;1995&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Scharf et al<a class="elsevierStyleCrossRef" href="#bb0450"><span class="elsevierStyleSup">90</span></a> &#40;1998&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Schattenkirchner<a class="elsevierStyleCrossRef" href="#bb0455"><span class="elsevierStyleSup">91</span></a> &#40;1991&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Schattenkirchner<a class="elsevierStyleCrossRef" href="#bb0460"><span class="elsevierStyleSup">92</span></a> &#40;1993&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Sheldon et al<a class="elsevierStyleCrossRef" href="#bb0465"><span class="elsevierStyleSup">93</span></a> &#40;2005&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No hay datos concretos de pacientes mayores de 60 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Sheridan et al<a class="elsevierStyleCrossRef" href="#bb0470"><span class="elsevierStyleSup">94</span></a> &#40;2005&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Smalley et al<a class="elsevierStyleCrossRef" href="#bb0475"><span class="elsevierStyleSup">95</span></a> &#40;1995&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&#46;Poblaci&#243;n general&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Sontag et al<a class="elsevierStyleCrossRef" href="#bb0480"><span class="elsevierStyleSup">96</span></a> &#40;1994&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No hace un an&#225;lisis estrictamente de mayores de 60 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Stewart et al<a class="elsevierStyleCrossRef" href="#bb0485"><span class="elsevierStyleSup">97</span></a> &#40;1988&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Theiler et al<a class="elsevierStyleCrossRef" href="#bb0490"><span class="elsevierStyleSup">98</span></a> &#40;2002&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Todesco et al<a class="elsevierStyleCrossRef" href="#bb0495"><span class="elsevierStyleSup">99</span></a> &#40;1994&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Truitt et al<a class="elsevierStyleCrossRef" href="#bb0500"><span class="elsevierStyleSup">100</span></a> &#40;2001&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Vetter<a class="elsevierStyleCrossRef" href="#bb0505"><span class="elsevierStyleSup">101</span></a> &#40;1985&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Vonkeman et al<a class="elsevierStyleCrossRef" href="#bb0510"><span class="elsevierStyleSup">102</span></a> &#40;2007&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Whelton et al<a class="elsevierStyleCrossRef" href="#bb0515"><span class="elsevierStyleSup">103</span></a> &#40;2006&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">No hace un an&#225;lisis estrictamente de mayores de 60 a&#241;os&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Williams<a class="elsevierStyleCrossRef" href="#bb0520"><span class="elsevierStyleSup">104</span></a> &#40;1985&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Williams et al<a class="elsevierStyleCrossRef" href="#bb0525"><span class="elsevierStyleSup">105</span></a> &#40;1989&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Yajima et al<a class="elsevierStyleCrossRef" href="#bb0530"><span class="elsevierStyleSup">106</span></a> &#40;2007&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Insuficiente calidad del estudio&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab211962.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "es" => "<p id="sp0030" class="elsevierStyleSimplePara elsevierViewall">Estudios excluidos y causas de exclusi&#243;n</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bs0005"
          "bibliografiaReferencia" => array:106 [
            0 => array:3 [
              "identificador" => "bb0005"
              "etiqueta" => "1&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs&#46; A meta-analysis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [ …3]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Intern Med"
                        "fecha" => "1991"
                        "volumen" => "115"
                        "paginaInicial" => "787"
                        "paginaFinal" => "796"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bb0010"
              "etiqueta" => "2&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment of elderly patients with nabumetone or diclofenac&#58; gastrointestinal safety profile"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Gastroenterol"
                        "fecha" => "2001"
                        "volumen" => "32"
                        "paginaInicial" => "310"
                        "paginaFinal" => "314"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bb0015"
              "etiqueta" => "3&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A comparison of the upper gastrointestinal mucosal effects of valdecoxib&#44; naproxen and placebo in healthy elderly subjects"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Aliment Pharmacol Ther"
                        "fecha" => "2003"
                        "volumen" => "18"
                        "paginaInicial" => "125"
                        "paginaFinal" => "132"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bb0020"
              "etiqueta" => "4&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2165/00003088-198712020-00002"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Pharmacokinet"
                        "fecha" => "1987"
                        "volumen" => "12"
                        "paginaInicial" => "111"
                        "paginaFinal" => "122"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bb0025"
              "etiqueta" => "5&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Renal complications of nonsteroidal anti-inflammatory drugs"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Kidney Int"
                        "fecha" => "1993"
                        "volumen" => "44"
                        "paginaInicial" => "643"
                        "paginaFinal" => "653"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bb0030"
              "etiqueta" => "6&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Consumption of NSAIDs and the development of congestive heart failure in elderly patients&#58; an underrecognized public health problem"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Intern Med"
                        "fecha" => "2000"
                        "volumen" => "160"
                        "paginaInicial" => "777"
                        "paginaFinal" => "784"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bb0035"
              "etiqueta" => "7&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Renal tolerability of three commonly employed non-steroidal anti-inflammatory drugs in elderly patients with osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [ …3]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Exp Rheumatol"
                        "fecha" => "2002"
                        "volumen" => "20"
                        "paginaInicial" => "201"
                        "paginaFinal" => "207"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bb0040"
              "etiqueta" => "8&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Assessing the quality of reports of randomized clinical trials&#58; is blinding necessary"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Control Clin Trials"
                        "fecha" => "1996"
                        "volumen" => "17"
                        "paginaInicial" => "1"
                        "paginaFinal" => "12"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bb0045"
              "etiqueta" => "9&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Rofecoxib shows consistent efficacy in osteoarthritis clinical trials&#44; regardless of specific patient demographic and disease factors"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [ …5]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Rheumatol"
                        "fecha" => "2001"
                        "volumen" => "28"
                        "paginaInicial" => "2494"
                        "paginaFinal" => "2503"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bb0050"
              "etiqueta" => "10&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Meta-analysis&#58; upper gastrointestinal tolerability of valdecoxib&#44; a cyclooxygenase-2-specific inhibitor&#44; compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1365-2036.2005.02383.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Aliment Pharmacol Ther"
                        "fecha" => "2005"
                        "volumen" => "21"
                        "paginaInicial" => "591"
                        "paginaFinal" => "598"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bb0055"
              "etiqueta" => "11&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Functional status and health-related quality of life of elderly osteoarthritic patients treated with celecoxib"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [ …5]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Gerontol A Biol Sci Med Sci"
                        "fecha" => "2001"
                        "volumen" => "56"
                        "paginaInicial" => "M167"
                        "paginaFinal" => "M175"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bb0060"
              "etiqueta" => "12&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Comparison of the analgesic efficacy and safety of nonprescription doses of naproxen sodium and Ibuprofen in the treatment of osteoarthritis of the knee"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Rheumatol"
                        "fecha" => "2004"
                        "volumen" => "31"
                        "paginaInicial" => "1373"
                        "paginaFinal" => "1383"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bb0065"
              "etiqueta" => "13&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and tolerability of diclofenac dispersible in elderly patients with osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1185/03007999109111517"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Med Res Opin"
                        "fecha" => "1991"
                        "volumen" => "12"
                        "paginaInicial" => "459"
                        "paginaFinal" => "465"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bb0070"
              "etiqueta" => "14&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients&#58; results of a randomized double-blind trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Gastroenterology"
                        "fecha" => "2004"
                        "volumen" => "127"
                        "paginaInicial" => "1038"
                        "paginaFinal" => "1043"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bb0075"
              "etiqueta" => "15&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A double-masked comparison of the efficacy of once-daily sustained-release ibuprofen and once-daily piroxicam for 24-hour control of arthralgia due to osteoarthritis in the elderly"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [ …3]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Curr Ther Res Clin Exp"
                        "fecha" => "1996"
                        "volumen" => "57"
                        "paginaInicial" => "811"
                        "paginaFinal" => "821"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bb0080"
              "etiqueta" => "16&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effect of risk factors on complicated and uncomplicated ulcers in the TARGET lumiracoxib outcomes study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1053/j.gastro.2007.04.045"
                      "Revista" => array:6 [
                        "tituloSerie" => "Gastroenterology"
                        "fecha" => "2007"
                        "volumen" => "133"
                        "paginaInicial" => "57"
                        "paginaFinal" => "64"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bb0085"
              "etiqueta" => "17&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Therapeutic arthritis research and gastrointestinal event trial of lumiracoxib &#8211; study design and patient demographics"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1365-2036.2004.02026.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Aliment Pharmacol Ther"
                        "fecha" => "2004"
                        "volumen" => "20"
                        "paginaInicial" => "51"
                        "paginaFinal" => "63"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bb0090"
              "etiqueta" => "18&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The effect of different indomethacin formulations in young and elderly patients&#58; a comparative controlled clinical trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1185/03007998909115929"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Med Res Opin"
                        "fecha" => "1989"
                        "volumen" => "11"
                        "paginaInicial" => "427"
                        "paginaFinal" => "431"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bb0095"
              "etiqueta" => "19&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal mucosal injury&#58; risk factors for serious complications"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Dig Liver Dis"
                        "fecha" => "2000"
                        "volumen" => "32"
                        "paginaInicial" => "138"
                        "paginaFinal" => "151"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bb0100"
              "etiqueta" => "20&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevention of nsaid-associated gastrointestinal lesions&#58; a comparison study pantoprazole versus omeprazole"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1572-0241.2006.00686.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Gastroenterol"
                        "fecha" => "2006"
                        "volumen" => "101"
                        "paginaInicial" => "1747"
                        "paginaFinal" => "1755"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bb0105"
              "etiqueta" => "21&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs&#46; A randomized&#44; double-blind&#44; placebo-controlled trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Intern Med"
                        "fecha" => "1995"
                        "volumen" => "123"
                        "paginaInicial" => "241"
                        "paginaFinal" => "249"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bb0110"
              "etiqueta" => "22&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "SUCCESS-VII Investigators Effects of celecoxib and rofecoxib on blood pressure and edema in patients &#62; or &#61;65 years of age with systemic hypertension and osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [ …5]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Cardiol"
                        "fecha" => "2002"
                        "volumen" => "90"
                        "paginaInicial" => "959"
                        "paginaFinal" => "963"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bb0115"
              "etiqueta" => "23&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Nonsteroidal anti-inflammatory drug-associated gastropathy&#58; incidence and risk factor models"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Med"
                        "fecha" => "1991"
                        "volumen" => "91"
                        "paginaInicial" => "213"
                        "paginaFinal" => "222"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bb0120"
              "etiqueta" => "24&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety of ketoprofen in the elderly&#58; a prospective study on 20&#44;000 patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Scand J Rheumatol Suppl"
                        "fecha" => "1989"
                        "volumen" => "83"
                        "paginaInicial" => "21"
                        "paginaFinal" => "27"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bb0125"
              "etiqueta" => "25&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [ …5]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Ther"
                        "fecha" => "1999"
                        "volumen" => "21"
                        "paginaInicial" => "992"
                        "paginaFinal" => "1003"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bb0130"
              "etiqueta" => "26&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A study of sulindac versus ibuprofen in elderly patients with osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1185/03007998309112390"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Med Res Opin"
                        "fecha" => "1983"
                        "volumen" => "8"
                        "paginaInicial" => "315"
                        "paginaFinal" => "320"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bb0135"
              "etiqueta" => "27&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A comparison of ketoprofen SR and sulindac in the elderly with rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Clin Pract"
                        "fecha" => "1992"
                        "volumen" => "46"
                        "paginaInicial" => "229"
                        "paginaFinal" => "233"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bb0140"
              "etiqueta" => "28&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Long term study of ketoprofen sr in elderly patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Scand J Rheumatol Suppl"
                        "fecha" => "1989"
                        "volumen" => "83"
                        "paginaInicial" => "15"
                        "paginaFinal" => "19"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bb0145"
              "etiqueta" => "29&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety profile of etodolac in the elderly population"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur J Rheumatol Inflamm"
                        "fecha" => "1994"
                        "volumen" => "14"
                        "paginaInicial" => "19"
                        "paginaFinal" => "22"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            29 => array:3 [
              "identificador" => "bb0150"
              "etiqueta" => "30&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Aspirin and nsaid use in older women&#58; effect on bone mineral density and fracture risk"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/jbmr.5650110106"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Bone Miner Res"
                        "fecha" => "1996"
                        "volumen" => "11"
                        "paginaInicial" => "29"
                        "paginaFinal" => "35"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            30 => array:3 [
              "identificador" => "bb0155"
              "etiqueta" => "31&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effectiveness and tolerability of nimesulide in the treatment of osteoarthritic elderly patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Tissue React"
                        "fecha" => "1992"
                        "volumen" => "14"
                        "paginaInicial" => "263"
                        "paginaFinal" => "268"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            31 => array:3 [
              "identificador" => "bb0160"
              "etiqueta" => "32&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Reducing the dose of oral NSAIDs by use of Feldene Gel&#58; an open study in elderly patients with osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Adv Ther"
                        "fecha" => "1994"
                        "volumen" => "11"
                        "paginaInicial" => "198"
                        "paginaFinal" => "207"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            32 => array:3 [
              "identificador" => "bb0165"
              "etiqueta" => "33&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A long-term study of flurbiprofen in rheumatological disorders&#58; I&#46; Rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Int Med Res"
                        "fecha" => "1986"
                        "volumen" => "14"
                        "paginaInicial" => "1"
                        "paginaFinal" => "6"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            33 => array:3 [
              "identificador" => "bb0170"
              "etiqueta" => "34&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A long-term study of flurbiprofen in rheumatological disorders&#58; II&#46; Osteoarthrosis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Int Med Res"
                        "fecha" => "1986"
                        "volumen" => "14"
                        "paginaInicial" => "13"
                        "paginaFinal" => "18"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            34 => array:3 [
              "identificador" => "bb0175"
              "etiqueta" => "35&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety profile of a sustained release formulation of etodolac in patients with rheumatoid arthritis and osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Adv Ther"
                        "fecha" => "1993"
                        "volumen" => "10"
                        "paginaInicial" => "1"
                        "paginaFinal" => "8"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            35 => array:3 [
              "identificador" => "bb0180"
              "etiqueta" => "36&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A study of the safety of tenoxicam in general practice"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "N Z Med J"
                        "fecha" => "1989"
                        "volumen" => "102"
                        "paginaInicial" => "582"
                        "paginaFinal" => "583"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            36 => array:3 [
              "identificador" => "bb0185"
              "etiqueta" => "37&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and tolerance of naproxen instant suspension formulation&#58; a post-marketing survey"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [ …3]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Int Med Res"
                        "fecha" => "1988"
                        "volumen" => "16"
                        "paginaInicial" => "157"
                        "paginaFinal" => "165"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            37 => array:3 [
              "identificador" => "bb0190"
              "etiqueta" => "38&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Office-based evaluation of renal function in elderly patients receiving nonsteroidal anti-inflammatory drugs"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Board Fam Pract"
                        "fecha" => "1988"
                        "volumen" => "1"
                        "paginaInicial" => "77"
                        "paginaFinal" => "80"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            38 => array:3 [
              "identificador" => "bb0195"
              "etiqueta" => "39&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Symptomatic osteoarthritis in the elderly&#58; multicentre comparative study of sulindac and ibuprofen"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Clin Pract"
                        "fecha" => "1984"
                        "volumen" => "38"
                        "paginaInicial" => "176"
                        "paginaFinal" => "181"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            39 => array:3 [
              "identificador" => "bb0200"
              "etiqueta" => "40&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Multicenter comparative study of tiaprofenic acid in the treatment of patients with rheumatic diseases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Curr Ther Res Clin Exp"
                        "fecha" => "1987"
                        "volumen" => "42"
                        "paginaInicial" => "916"
                        "paginaFinal" => "921"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            40 => array:3 [
              "identificador" => "bb0205"
              "etiqueta" => "41&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Gender differences in nsaid use among older adults with osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [ …4]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1345/aph.1C418"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Pharmacother"
                        "fecha" => "2003"
                        "volumen" => "37"
                        "paginaInicial" => "1566"
                        "paginaFinal" => "1571"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            41 => array:3 [
              "identificador" => "bb0210"
              "etiqueta" => "42&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Long term tolerability profile of nimesulide in the treatment of osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:7 [
                        "tituloSerie" => "Drugs"
                        "fecha" => "1993"
                        "volumen" => "46"
                        "numero" => "Suppl 1"
                        "paginaInicial" => "270"
                        "paginaFinal" => "274"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            42 => array:3 [
              "identificador" => "bb0215"
              "etiqueta" => "43&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A double-blind trial of ketoprofen in the treatment of osteoarthritis of the hip"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Scand J Rheumatol Suppl"
                        "fecha" => "1976"
                        "volumen" => "1976"
                        "paginaInicial" => "129"
                        "paginaFinal" => "132"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            43 => array:3 [
              "identificador" => "bb0220"
              "etiqueta" => "44&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and tolerability of nimesulide in elderly patients with osteoarthritis&#58; double-blind trial versus naproxen"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Int Med Res"
                        "fecha" => "1989"
                        "volumen" => "17"
                        "paginaInicial" => "295"
                        "paginaFinal" => "303"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            44 => array:3 [
              "identificador" => "bb0225"
              "etiqueta" => "45&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Assessing and understanding patient risk"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [ …1]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Scand J Rheumatol Suppl"
                        "fecha" => "1992"
                        "volumen" => "92"
                        "paginaInicial" => "21"
                        "paginaFinal" => "24"
                        "link" => array:1 [
                          0 => array:2 [ …2]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            45 => array:3 [
              "identificador" => "bb0230"
              "etiqueta" => "46&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [ …6]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.20440"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2004"
                        "volumen" => "50"
                        "paginaInicial" => "2433"
                        "paginaFinal" => "2440"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            46 => array:3 [
              "identificador" => "bb0235"
              "etiqueta" => "47&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Evaluation of the renal protective effect of misoprostol in elderly&#44; osteoarthritic patients at risk for nonsteroidal anti-inflammatory drug-induced renal dysfunction"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Pharmacol"
                        "fecha" => "1993"
                        "volumen" => "33"
                        "paginaInicial" => "1225"
                        "paginaFinal" => "1232"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            47 => array:3 [
              "identificador" => "bb0240"
              "etiqueta" => "48&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/1529-0131(199710)40:10&lt;1873::AID-ART22&gt;3.0.CO;2-V"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "1997"
                        "volumen" => "40"
                        "paginaInicial" => "1873"
                        "paginaFinal" => "1878"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            48 => array:3 [
              "identificador" => "bb0245"
              "etiqueta" => "49&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Naproxen tolerability in the elderly&#58; a summary report"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Rheumatol"
                        "fecha" => "1987"
                        "volumen" => "14"
                        "paginaInicial" => "348"
                        "paginaFinal" => "354"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            49 => array:3 [
              "identificador" => "bb0250"
              "etiqueta" => "50&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Comparison of endoscopic gastric mucosa features after administration of piroxicam to meloxicam and their correlation with dyspepsia symptoms in elderly patient with knee osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Acta Med Indones"
                        "fecha" => "2004"
                        "volumen" => "36"
                        "paginaInicial" => "202"
                        "paginaFinal" => "206"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            50 => array:3 [
              "identificador" => "bb0255"
              "etiqueta" => "51&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The pharmacokinetics of isoxicam in elderly patients with rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1185/03007998709112411"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Med Res Opin"
                        "fecha" => "1987"
                        "volumen" => "10"
                        "paginaInicial" => "580"
                        "paginaFinal" => "591"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            51 => array:3 [
              "identificador" => "bb0260"
              "etiqueta" => "52&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Salicylate toxicity in elderly patients with rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Journal J Rheumatol"
                        "fecha" => "1987"
                        "volumen" => "14"
                        "paginaInicial" => "60"
                        "paginaFinal" => "66"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            52 => array:3 [
              "identificador" => "bb0265"
              "etiqueta" => "53&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Elderly patients with osteoarthritis&#58; treatment with nonselective&#44; nonsteroidial&#44; antiinflammatory drugs&#44; and the gastrointestinal consequences"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Gerontol Geriatr Suppl"
                        "fecha" => "2002"
                        "volumen" => "8"
                        "paginaInicial" => "165"
                        "paginaFinal" => "170"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            53 => array:3 [
              "identificador" => "bb0270"
              "etiqueta" => "54&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Indomethacin and phenylbutazone&#58; a comparison"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Br Med J"
                        "fecha" => "1965"
                        "volumen" => "2"
                        "paginaInicial" => "1281"
                        "paginaFinal" => "1284"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            54 => array:3 [
              "identificador" => "bb0275"
              "etiqueta" => "55&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "&#8216;Osmosin&#8217; &#40;sodium indomethacin trihydrate&#41; in the treatment of elderly patients with osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1185/03007998309109826"
                      "Revista" => array:7 [
                        "tituloSerie" => "Curr Med Res Opin"
                        "fecha" => "1983"
                        "volumen" => "8"
                        "numero" => "Suppl 2"
                        "paginaInicial" => "72"
                        "paginaFinal" => "82"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            55 => array:3 [
              "identificador" => "bb0280"
              "etiqueta" => "56&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Influence of risk factors on endoscopic and clinical ulcers in patients taking rofecoxib or ibuprofen in two randomized controlled trials"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Aliment Pharmacol Ther"
                        "fecha" => "2001"
                        "volumen" => "15"
                        "paginaInicial" => "1593"
                        "paginaFinal" => "1601"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            56 => array:3 [
              "identificador" => "bb0285"
              "etiqueta" => "57&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Consumption of non-steroidal anti-inflammatory drugs and the development of functional renal impairment in elderly subjects&#46; Results of a case-control study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Clin Pharmacol"
                        "fecha" => "1997"
                        "volumen" => "44"
                        "paginaInicial" => "85"
                        "paginaFinal" => "90"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            57 => array:3 [
              "identificador" => "bb0290"
              "etiqueta" => "58&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Which patients taking non-aspirin non-steroidal anti-inflammatory drugs bleed&#63; A case-control study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur J Gastroenterol Hepatol"
                        "fecha" => "1995"
                        "volumen" => "7"
                        "paginaInicial" => "419"
                        "paginaFinal" => "426"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            58 => array:3 [
              "identificador" => "bb0295"
              "etiqueta" => "59&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effect of rofecoxib on the glomerular filtration rate&#44; proteinuria and the renin-angiotensin-aldosterone system in elderly subjects with chronic renal impairment"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Clin Pharmacol Ther"
                        "fecha" => "2005"
                        "volumen" => "43"
                        "paginaInicial" => "413"
                        "paginaFinal" => "419"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            59 => array:3 [
              "identificador" => "bb0300"
              "etiqueta" => "60&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and tolerance of flurbiprofen in the elderly using liquid and tablet formulations"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1185/03007997709108988"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Med Res Opin"
                        "fecha" => "1977"
                        "volumen" => "5"
                        "paginaInicial" => "122"
                        "paginaFinal" => "126"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            60 => array:3 [
              "identificador" => "bb0305"
              "etiqueta" => "61&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety evaluation of nabumetone in United States clinical trials"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Med"
                        "fecha" => "1987"
                        "volumen" => "83"
                        "paginaInicial" => "115"
                        "paginaFinal" => "120"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            61 => array:3 [
              "identificador" => "bb0310"
              "etiqueta" => "62&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A multi-centre study of sulindac versus naproxen in the treatment of elderly osteoarthritic patients"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Pharmatherapeutica"
                        "fecha" => "1984"
                        "volumen" => "3"
                        "paginaInicial" => "663"
                        "paginaFinal" => "667"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            62 => array:3 [
              "identificador" => "bb0315"
              "etiqueta" => "63&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Nonsteroidal anti-inflammatory drugs and hypertension in the elderly&#58; a community-based cross-sectional study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Clin Pharmacol"
                        "fecha" => "1993"
                        "volumen" => "35"
                        "paginaInicial" => "455"
                        "paginaFinal" => "459"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            63 => array:3 [
              "identificador" => "bb0320"
              "etiqueta" => "64&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Stratifying the risk of NSAID-related upper gastrointestinal clinical events&#58; results of a double-blind outcomes study in patients with rheumatoid arthritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Gastroenterology"
                        "fecha" => "2002"
                        "volumen" => "123"
                        "paginaInicial" => "1006"
                        "paginaFinal" => "1012"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            64 => array:3 [
              "identificador" => "bb0325"
              "etiqueta" => "65&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.amjmed.2005.04.031"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Med"
                        "fecha" => "2005"
                        "volumen" => "118"
                        "paginaInicial" => "1271"
                        "paginaFinal" => "1278"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            65 => array:3 [
              "identificador" => "bb0330"
              "etiqueta" => "66&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Aspirin and nonsteroidal antiinflammatory drug use in elderly women&#58; effects on a marker of bone resorption"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Rheumatol"
                        "fecha" => "1997"
                        "volumen" => "24"
                        "paginaInicial" => "1132"
                        "paginaFinal" => "1136"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            66 => array:3 [
              "identificador" => "bb0335"
              "etiqueta" => "67&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Safety profile of rofecoxib as used in general practice in england&#58; results of a prescription-event monitoring study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Clin Pharmacol"
                        "fecha" => "2003"
                        "volumen" => "55"
                        "paginaInicial" => "166"
                        "paginaFinal" => "174"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            67 => array:3 [
              "identificador" => "bb0340"
              "etiqueta" => "68&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Therapeutic equivalence of diclofenac sustained-released 75 mg tablets and diclofenac enteric-coated 50 mg tablets in the treatment of painful osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Clin Pract"
                        "fecha" => "1997"
                        "volumen" => "51"
                        "paginaInicial" => "389"
                        "paginaFinal" => "393"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            68 => array:3 [
              "identificador" => "bb0345"
              "etiqueta" => "69&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Steroid sparing activity of tenidap in patients with polymyalgia rheumatica&#58; a multicenter double blind randomized placebo controlled study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Rheumatol"
                        "fecha" => "1995"
                        "volumen" => "22"
                        "paginaInicial" => "1097"
                        "paginaFinal" => "1103"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            69 => array:3 [
              "identificador" => "bb0350"
              "etiqueta" => "70&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "BMJ"
                        "fecha" => "2002"
                        "volumen" => "325"
                        "paginaInicial" => "624"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            70 => array:3 [
              "identificador" => "bb0355"
              "etiqueta" => "71&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Gastrointestinal-related complications in a longterm care population taking nsaids versus cox-2 inhibitor therapy"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Consult Pharm"
                        "fecha" => "2004"
                        "volumen" => "19"
                        "paginaInicial" => "602"
                        "paginaFinal" => "613"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            71 => array:3 [
              "identificador" => "bb0360"
              "etiqueta" => "72&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Nsaids &#8211; a double-edged sword"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Hospital Pharmacy"
                        "fecha" => "1993"
                        "volumen" => "28"
                        "numero" => "50"
                        "paginaInicial" => "53"
                        "paginaFinal" => "55"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            72 => array:3 [
              "identificador" => "bb0365"
              "etiqueta" => "73&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment of osteoarthritis&#58; a 3-month comparison between tiaprofenic acid and indomethacin"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1185/03007998309112387"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Med Res Opin"
                        "fecha" => "1983"
                        "volumen" => "8"
                        "paginaInicial" => "295"
                        "paginaFinal" => "301"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            73 => array:3 [
              "identificador" => "bb0370"
              "etiqueta" => "74&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Imidazole salicylate versus piroxicam in the treatment of arthrosis in elderly patients&#46; A double-blind clinical and endoscopic trial"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Geriatr Soc"
                        "fecha" => "1990"
                        "volumen" => "38"
                        "paginaInicial" => "985"
                        "paginaFinal" => "988"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            74 => array:3 [
              "identificador" => "bb0375"
              "etiqueta" => "75&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and safety of nabumetone versus diclofenac&#44; naproxen&#44; ibuprofen&#44; and piroxicam in the elderly"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Am J Med"
                        "fecha" => "1993"
                        "volumen" => "95"
                        "paginaInicial" => "S19"
                        "paginaFinal" => "27"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            75 => array:3 [
              "identificador" => "bb0380"
              "etiqueta" => "76&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Nonsteroidal anti-inflammatory drugs and bone mineral density in older women&#58; the Rancho Bernardo study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1359/jbmr.1998.13.12.1924"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Bone Miner Res"
                        "fecha" => "1998"
                        "volumen" => "13"
                        "paginaInicial" => "1924"
                        "paginaFinal" => "1931"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            76 => array:3 [
              "identificador" => "bb0385"
              "etiqueta" => "77&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Temporal relationship between use of nsaids&#44; including selective cox- 2 inhibitors&#44; and cardiovascular risk"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Drug Saf"
                        "fecha" => "2006"
                        "volumen" => "29"
                        "paginaInicial" => "621"
                        "paginaFinal" => "632"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            77 => array:3 [
              "identificador" => "bb0390"
              "etiqueta" => "78&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Protective effect of misoprostol on indomethacin induced renal dysfunction in elderly patients"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Rheumatol"
                        "fecha" => "1995"
                        "volumen" => "22"
                        "paginaInicial" => "713"
                        "paginaFinal" => "716"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            78 => array:3 [
              "identificador" => "bb0395"
              "etiqueta" => "79&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Comparison of changes in blood pressure measurements and antihypertensive therapy in older&#44; hypertensive&#44; ambulatory care patients prescribed celecoxib or rofecoxib"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Pharmacotherapy"
                        "fecha" => "2003"
                        "volumen" => "23"
                        "paginaInicial" => "1416"
                        "paginaFinal" => "1423"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            79 => array:3 [
              "identificador" => "bb0400"
              "etiqueta" => "80&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Long-term efficacy and safety of tolmetin sodium in treatment of geriatric patients with rheumatoid arthritis and osteoarthritis&#58; a retrospective study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Clin Pharmacol"
                        "fecha" => "1983"
                        "volumen" => "23"
                        "paginaInicial" => "309"
                        "paginaFinal" => "323"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            80 => array:3 [
              "identificador" => "bb0405"
              "etiqueta" => "81&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Double-blind comparison of the efficacy and safety of etodolac SR 600 mg u&#46;i&#46;d&#46; and of tenoxicam 20 mg u&#46;i&#46;d&#46; in elderly patients with osteoarthritis of the hip and of the knee"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Clin Pharmacol Res"
                        "fecha" => "1994"
                        "volumen" => "14"
                        "paginaInicial" => "203"
                        "paginaFinal" => "216"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            81 => array:3 [
              "identificador" => "bb0410"
              "etiqueta" => "82&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Evaluation of the effectiveness and safety of etodolac in prolonged treatment of active osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Clin Pharmacol Res"
                        "fecha" => "1991"
                        "volumen" => "11"
                        "paginaInicial" => "143"
                        "paginaFinal" => "158"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            82 => array:3 [
              "identificador" => "bb0415"
              "etiqueta" => "83&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A naturalistic study of the determinants of health related quality of life improvement in osteoarthritic patients treated with non-specific non-steroidal anti-inflammatory drugs"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/ard.2004.026658"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Rheum Dis"
                        "fecha" => "2005"
                        "volumen" => "64"
                        "paginaInicial" => "688"
                        "paginaFinal" => "693"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            83 => array:3 [
              "identificador" => "bb0420"
              "etiqueta" => "84&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Determinants of gastro-protective drugs co-prescription during treatment with nonselective nsaids&#58; a prospective survey of 2197 patients recruited in primary care"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.joca.2006.01.002"
                      "Revista" => array:6 [
                        "tituloSerie" => "Osteoarthritis Cartilage"
                        "fecha" => "2006"
                        "volumen" => "14"
                        "paginaInicial" => "625"
                        "paginaFinal" => "630"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            84 => array:3 [
              "identificador" => "bb0425"
              "etiqueta" => "85&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Use of nsaids&#44; cox-2 inhibitors&#44; and acetaminophen and associated coprescriptions of gastroprotective agents in an elderly population"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.10796"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2002"
                        "volumen" => "47"
                        "paginaInicial" => "595"
                        "paginaFinal" => "602"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            85 => array:3 [
              "identificador" => "bb0430"
              "etiqueta" => "86&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Risks and benefits of cox-2 inhibitors vs non-selective nsaids&#58; does their cardiovascular risk exceed their gastrointestinal benefit&#63; A retrospective cohort study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1093/rheumatology/kel428"
                      "Revista" => array:6 [
                        "tituloSerie" => "Rheumatology"
                        "fecha" => "2007"
                        "volumen" => "46"
                        "paginaInicial" => "435"
                        "paginaFinal" => "438"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            86 => array:3 [
              "identificador" => "bb0435"
              "etiqueta" => "87&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Do proton-pump inhibitors confer additional gastrointestinal protection in patients given celecoxib&#63;"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.22764"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2007"
                        "volumen" => "57"
                        "paginaInicial" => "748"
                        "paginaFinal" => "755"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            87 => array:3 [
              "identificador" => "bb0440"
              "etiqueta" => "88&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A controlled study comparing the effects of nabumetone&#44; ibuprofen&#44; and ibuprofen plus misoprostol on the upper gastrointestinal tract mucosa"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Intern Med"
                        "fecha" => "1993"
                        "volumen" => "153"
                        "paginaInicial" => "2565"
                        "paginaFinal" => "2571"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            88 => array:3 [
              "identificador" => "bb0445"
              "etiqueta" => "89&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Endoscopic evaluation of the long term effects of diclofenac sodium and naproxen in elderly patients with arthritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Clin Drug Investig"
                        "fecha" => "1995"
                        "volumen" => "9"
                        "paginaInicial" => "171"
                        "paginaFinal" => "179"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            89 => array:3 [
              "identificador" => "bb0450"
              "etiqueta" => "90&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "NSAIDs and faecal blood loss in elderly patients with osteoarthritis&#58; is plasma half-life relevant&#63;"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Aust N Z J Med"
                        "fecha" => "1998"
                        "volumen" => "28"
                        "paginaInicial" => "436"
                        "paginaFinal" => "439"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            90 => array:3 [
              "identificador" => "bb0455"
              "etiqueta" => "91&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Long-term safety of ketoprofen in an elderly population of arthritic patients"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Scand J Rheumatol Suppl"
                        "fecha" => "1991"
                        "volumen" => "91"
                        "paginaInicial" => "27"
                        "paginaFinal" => "36"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            91 => array:3 [
              "identificador" => "bb0460"
              "etiqueta" => "92&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The safety profile of sustained-release etodolac"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:7 [
                        "tituloSerie" => "Rheumatol Int"
                        "fecha" => "1993"
                        "volumen" => "13"
                        "numero" => "Suppl 2"
                        "paginaInicial" => "S31"
                        "paginaFinal" => "S35"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            92 => array:3 [
              "identificador" => "bb0465"
              "etiqueta" => "93&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee&#58; a 13-week&#44; randomized&#44; double-blind comparison with celecoxib and placebo"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.clinthera.2005.01.002"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Ther"
                        "fecha" => "2005"
                        "volumen" => "27"
                        "paginaInicial" => "64"
                        "paginaFinal" => "77"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            93 => array:3 [
              "identificador" => "bb0470"
              "etiqueta" => "94&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Nsaid use and bp in treated hypertensives&#58; a retrospective controlled observational study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/sj.jhh.1001839"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Hum Hypertens"
                        "fecha" => "2005"
                        "volumen" => "19"
                        "paginaInicial" => "445"
                        "paginaFinal" => "450"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            94 => array:3 [
              "identificador" => "bb0475"
              "etiqueta" => "95&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Epidemiol"
                        "fecha" => "1995"
                        "volumen" => "141"
                        "paginaInicial" => "539"
                        "paginaFinal" => "545"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            95 => array:3 [
              "identificador" => "bb0480"
              "etiqueta" => "96&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Healing of NSAID-induced gastric ulcers with a synthetic prostaglandin analog &#40;enprostil&#41;"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Gastroenterol"
                        "fecha" => "1994"
                        "volumen" => "89"
                        "paginaInicial" => "1014"
                        "paginaFinal" => "1020"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            96 => array:3 [
              "identificador" => "bb0485"
              "etiqueta" => "97&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Mefenamic acid compared with diclofenac sodium in elderly patients with osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Clin Pract"
                        "fecha" => "1988"
                        "volumen" => "42"
                        "paginaInicial" => "316"
                        "paginaFinal" => "320"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            97 => array:3 [
              "identificador" => "bb0490"
              "etiqueta" => "98&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Rofecoxib improves quality of life in patients with hip or knee osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "2002/39/smw-10075"
                      "Revista" => array:6 [
                        "tituloSerie" => "Swiss Med Wkly"
                        "fecha" => "2002"
                        "volumen" => "132"
                        "paginaInicial" => "566"
                        "paginaFinal" => "573"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            98 => array:3 [
              "identificador" => "bb0495"
              "etiqueta" => "99&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Efficacy and tolerability of etodolac in aged patients affected by degenerative joint disease &#40;osteoarthritis&#41; in its active phase"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Clin Pharmacol Res"
                        "fecha" => "1994"
                        "volumen" => "14"
                        "paginaInicial" => "11"
                        "paginaFinal" => "26"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            99 => array:3 [
              "identificador" => "bb0500"
              "etiqueta" => "100&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A multicenter&#44; randomized&#44; controlled trial to evaluate the safety profile&#44; tolerability&#44; and efficacy of rofecoxib in advanced elderly patients with osteoarthritis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Aging &#40;Milano&#41;"
                        "fecha" => "2001"
                        "volumen" => "13"
                        "paginaInicial" => "112"
                        "paginaFinal" => "121"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            100 => array:3 [
              "identificador" => "bb0505"
              "etiqueta" => "101&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A comparison of naproxen and diclofenac sodium in the treatment of osteoarthritis in elderly patients"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Clin Pract"
                        "fecha" => "1985"
                        "volumen" => "39"
                        "paginaInicial" => "276"
                        "paginaFinal" => "281"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            101 => array:3 [
              "identificador" => "bb0510"
              "etiqueta" => "102&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to nonsteroidal anti-inflammatory drugs&#58; a nested case-control study"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1186/ar2207"
                      "Revista" => array:5 [
                        "tituloSerie" => "Arthritis Res Ther"
                        "fecha" => "2007"
                        "volumen" => "9"
                        "paginaInicial" => "R52"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            102 => array:3 [
              "identificador" => "bb0515"
              "etiqueta" => "103&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/sj.ki.5001766"
                      "Revista" => array:6 [
                        "tituloSerie" => "Kidney Int"
                        "fecha" => "2006"
                        "volumen" => "70"
                        "paginaInicial" => "1495"
                        "paginaFinal" => "1502"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            103 => array:3 [
              "identificador" => "bb0520"
              "etiqueta" => "104&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Adverse effects of isoxicam in relation to age"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Med"
                        "fecha" => "1985"
                        "volumen" => "79"
                        "paginaInicial" => "38"
                        "paginaFinal" => "40"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            104 => array:3 [
              "identificador" => "bb0525"
              "etiqueta" => "105&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Etodolac therapy for osteoarthritis&#58; a double-blind&#44; placebo-controlled trial"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1185/03007998909115933"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Med Res Opin"
                        "fecha" => "1989"
                        "volumen" => "11"
                        "paginaInicial" => "463"
                        "paginaFinal" => "470"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            105 => array:3 [
              "identificador" => "bb0530"
              "etiqueta" => "106&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Up-to-date information on gastric mucosal lesions from long-term NSAID therapy in orthopedic outpatients&#58; a study using logistic regression analysis"
                      "autores" => array:1 [
                        0 => array:2 [ …2]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s00776-007-1139-9"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Orthop Sci"
                        "fecha" => "2007"
                        "volumen" => "12"
                        "paginaInicial" => "341"
                        "paginaFinal" => "346"
                        "link" => array:1 [ …1]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/1699258X/0000000400000005/v1_201305061804/S1699258X08724616/v1_201305061804/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "17499"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Originales"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/1699258X/0000000400000005/v1_201305061804/S1699258X08724616/v1_201305061804/es/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X08724616?idApp=UINPBA00004M"
]
Información del artículo
ISSN: 1699258X
Idioma original: Español
Datos actualizados diariamente
año/Mes Html Pdf Total
2024 Noviembre 43 13 56
2024 Octubre 410 38 448
2024 Septiembre 478 26 504
2024 Agosto 447 36 483
2024 Julio 371 42 413
2024 Junio 362 44 406
2024 Mayo 362 80 442
2024 Abril 358 34 392
2024 Marzo 483 44 527
2024 Febrero 420 37 457
2024 Enero 477 36 513
2023 Diciembre 315 21 336
2023 Noviembre 374 41 415
2023 Octubre 628 36 664
2023 Septiembre 557 39 596
2023 Agosto 270 22 292
2023 Julio 425 31 456
2023 Junio 395 39 434
2023 Mayo 327 36 363
2023 Abril 241 36 277
2023 Marzo 372 40 412
2023 Febrero 362 36 398
2023 Enero 215 32 247
2022 Diciembre 204 33 237
2022 Noviembre 306 49 355
2022 Octubre 300 51 351
2022 Septiembre 312 68 380
2022 Agosto 282 79 361
2022 Julio 245 55 300
2022 Junio 209 68 277
2022 Mayo 218 82 300
2022 Abril 240 52 292
2022 Marzo 259 67 326
2022 Febrero 242 64 306
2022 Enero 236 44 280
2021 Diciembre 188 58 246
2021 Noviembre 227 65 292
2021 Octubre 293 60 353
2021 Septiembre 255 83 338
2021 Agosto 167 71 238
2021 Julio 152 61 213
2021 Junio 206 79 285
2021 Mayo 234 70 304
2021 Abril 512 131 643
2021 Marzo 319 65 384
2021 Febrero 217 51 268
2021 Enero 180 66 246
2020 Diciembre 163 41 204
2020 Noviembre 259 51 310
2020 Octubre 198 47 245
2020 Septiembre 261 52 313
2020 Agosto 235 50 285
2020 Julio 401 59 460
2020 Junio 214 44 258
2020 Mayo 292 30 322
2020 Abril 243 35 278
2020 Marzo 191 42 233
2020 Febrero 177 31 208
2020 Enero 167 54 221
2019 Diciembre 86 35 121
2019 Noviembre 118 18 136
2019 Octubre 114 50 164
2019 Septiembre 123 46 169
2019 Agosto 122 37 159
2019 Julio 126 42 168
2019 Junio 64 44 108
2019 Mayo 99 64 163
2019 Abril 78 34 112
2019 Marzo 74 32 106
2019 Febrero 52 28 80
2019 Enero 46 32 78
2018 Diciembre 150 50 200
2018 Noviembre 390 21 411
2018 Octubre 111 13 124
2018 Septiembre 71 20 91
2018 Agosto 51 14 65
2018 Julio 32 4 36
2018 Mayo 5 0 5
2018 Abril 54 9 63
2018 Marzo 66 8 74
2018 Febrero 39 5 44
2018 Enero 36 5 41
2017 Diciembre 52 9 61
2017 Noviembre 53 16 69
2017 Octubre 77 14 91
2017 Septiembre 47 9 56
2017 Agosto 44 11 55
2017 Julio 59 7 66
2017 Junio 59 23 82
2017 Mayo 90 12 102
2017 Abril 73 5 78
2017 Marzo 110 24 134
2017 Febrero 279 5 284
2017 Enero 93 15 108
2016 Diciembre 113 19 132
2016 Noviembre 171 9 180
2016 Octubre 159 13 172
2016 Septiembre 167 24 191
2016 Agosto 109 10 119
2016 Julio 52 10 62
2016 Marzo 3 0 3
2016 Febrero 3 0 3
2016 Enero 1 0 1
2015 Diciembre 5 0 5
2015 Noviembre 1 0 1
2015 Octubre 2 0 2
2015 Septiembre 3 0 3
2015 Agosto 1 0 1
2015 Julio 92 5 97
2015 Junio 119 9 128
2015 Mayo 120 20 140
2015 Abril 95 17 112
2015 Marzo 93 6 99
2015 Febrero 84 6 90
2015 Enero 82 16 98
2014 Diciembre 122 12 134
2014 Noviembre 85 18 103
2014 Octubre 136 12 148
2014 Septiembre 89 7 96
2014 Agosto 76 14 90
2014 Julio 89 11 100
2014 Junio 103 21 124
2014 Mayo 107 25 132
2014 Abril 106 15 121
2014 Marzo 83 30 113
2014 Febrero 81 15 96
2014 Enero 69 12 81
2013 Diciembre 61 19 80
2013 Noviembre 81 37 118
2013 Octubre 74 27 101
2013 Septiembre 59 13 72
2013 Agosto 58 9 67
2013 Julio 59 7 66
2013 Junio 45 8 53
2013 Mayo 39 10 49
2013 Abril 55 15 70
2013 Marzo 49 19 68
2013 Febrero 35 7 42
2013 Enero 35 7 42
2012 Diciembre 31 2 33
2012 Noviembre 25 8 33
2012 Octubre 18 24 42
2012 Septiembre 11 6 17
2011 Mayo 2 0 2
2011 Abril 5 0 5
2011 Marzo 27 0 27
2011 Febrero 34 0 34
2011 Enero 17 0 17
2010 Diciembre 18 0 18
2010 Noviembre 16 0 16
2010 Octubre 10 0 10
2010 Septiembre 10 0 10
2010 Agosto 12 0 12
2010 Julio 23 0 23
2010 Junio 12 0 12
2010 Mayo 9 0 9
2010 Abril 5 0 5
2010 Marzo 4 0 4
2010 Febrero 11 0 11
2010 Enero 11 0 11
2009 Diciembre 12 0 12
2009 Noviembre 15 0 15
2009 Octubre 21 0 21
2009 Septiembre 17 0 17
2009 Agosto 12 0 12
2009 Julio 10 0 10
2009 Junio 11 0 11
2009 Mayo 21 0 21
2009 Abril 13 0 13
2009 Marzo 10 0 10
2009 Febrero 6 0 6
2009 Enero 9 0 9
2008 Diciembre 26 0 26
2008 Noviembre 31 0 31
2008 Octubre 1 0 1
Mostrar todo

Siga este enlace para acceder al texto completo del artículo

Idiomas
Reumatología Clínica
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?